id	sid	tid	token	lemma	pos
bam-13787	1	1	layout	layout	NOUN
bam-13787	1	2	1	1	NUM
bam-13787	1	3	treatments	treatment	NOUN
bam-13787	1	4	for	for	ADP
bam-13787	1	5	vitiligo	vitiligo	NOUN
bam-13787	1	6	vs.	vs.	ADP
bam-13787	1	7	anti	anti	ADJ
bam-13787	1	8	-	-	ADJ
bam-13787	1	9	vitiligo	vitiligo	ADJ
bam-13787	1	10	cream	cream	NOUN
bam-13787	1	11	eur	eur	PROPN
bam-13787	1	12	j	j	PROPN
bam-13787	1	13	transl	transl	PROPN
bam-13787	1	14	myol	myol	ADV
bam-13787	1	15	35	35	NUM
bam-13787	1	16	(	(	PUNCT
bam-13787	1	17	4	4	NUM
bam-13787	1	18	)	)	PUNCT
bam-13787	1	19	13787	13787	NUM
bam-13787	1	20	,	,	PUNCT
bam-13787	1	21	2025	2025	NUM
bam-13787	1	22	doi	doi	NOUN
bam-13787	1	23	:	:	PUNCT
bam-13787	1	24	10.4081	10.4081	NUM
bam-13787	1	25	/	/	SYM
bam-13787	1	26	ejtm.2025.13787	ejtm.2025.13787	NOUN
bam-13787	1	27	vitiligo	vitiligo	NOUN
bam-13787	1	28	is	be	AUX
bam-13787	1	29	an	an	DET
bam-13787	1	30	acquired	acquire	VERB
bam-13787	1	31	skin	skin	NOUN
bam-13787	1	32	disorder	disorder	NOUN
bam-13787	1	33	characterized	characterize	VERB
bam-13787	1	34	by	by	ADP
bam-13787	1	35	the	the	DET
bam-13787	1	36	progressive	progressive	ADJ
bam-13787	1	37	loss	loss	NOUN
bam-13787	1	38	of	of	ADP
bam-13787	1	39	melanocytes	melanocyte	NOUN
bam-13787	1	40	—	—	PUNCT
bam-13787	1	41	the	the	DET
bam-13787	1	42	cells	cell	NOUN
bam-13787	1	43	responsible	responsible	ADJ
bam-13787	1	44	for	for	ADP
bam-13787	1	45	producing	produce	VERB
bam-13787	1	46	the	the	DET
bam-13787	1	47	pigment	pigment	NOUN
bam-13787	1	48	melanin.1	melanin.1	PROPN
bam-13787	1	49	population	population	NOUN
bam-13787	1	50	-	-	PUNCT
bam-13787	1	51	based	base	VERB
bam-13787	1	52	studies	study	NOUN
bam-13787	1	53	have	have	AUX
bam-13787	1	54	estimated	estimate	VERB
bam-13787	1	55	the	the	DET
bam-13787	1	56	global	global	ADJ
bam-13787	1	57	prevalence	prevalence	NOUN
bam-13787	1	58	of	of	ADP
bam-13787	1	59	vitiligo	vitiligo	NOUN
bam-13787	1	60	to	to	PART
bam-13787	1	61	range	range	VERB
bam-13787	1	62	between	between	ADP
bam-13787	1	63	0.1	0.1	NUM
bam-13787	1	64	%	%	NOUN
bam-13787	1	65	and	and	CCONJ
bam-13787	1	66	2	2	NUM
bam-13787	1	67	%	%	NOUN
bam-13787	1	68	,	,	PUNCT
bam-13787	1	69	with	with	ADP
bam-13787	1	70	some	some	DET
bam-13787	1	71	studies	study	NOUN
bam-13787	1	72	reporting	report	VERB
bam-13787	1	73	peaks	peak	NOUN
bam-13787	1	74	as	as	ADV
bam-13787	1	75	high	high	ADJ
bam-13787	1	76	as	as	ADP
bam-13787	1	77	8%.2	8%.2	NUM
bam-13787	1	78	-	-	SYM
bam-13787	1	79	4	4	NUM
bam-13787	1	80	vitiligo	vitiligo	NOUN
bam-13787	1	81	causes	cause	VERB
bam-13787	1	82	depigmented	depigmented	ADJ
bam-13787	1	83	patches	patch	NOUN
bam-13787	1	84	due	due	ADP
bam-13787	1	85	to	to	ADP
bam-13787	1	86	melanocyte	melanocyte	NOUN
bam-13787	1	87	loss	loss	NOUN
bam-13787	1	88	,	,	PUNCT
bam-13787	1	89	which	which	PRON
bam-13787	1	90	can	can	AUX
bam-13787	1	91	appear	appear	VERB
bam-13787	1	92	anywhere	anywhere	ADV
bam-13787	1	93	on	on	ADP
bam-13787	1	94	the	the	DET
bam-13787	1	95	body	body	NOUN
bam-13787	1	96	.	.	PUNCT
bam-13787	2	1	while	while	SCONJ
bam-13787	2	2	not	not	PART
bam-13787	2	3	lifethreatening	lifethreatene	VERB
bam-13787	2	4	,	,	PUNCT
bam-13787	2	5	it	it	PRON
bam-13787	2	6	significantly	significantly	ADV
bam-13787	2	7	affects	affect	VERB
bam-13787	2	8	quality	quality	NOUN
bam-13787	2	9	of	of	ADP
bam-13787	2	10	life	life	NOUN
bam-13787	2	11	,	,	PUNCT
bam-13787	2	12	leading	lead	VERB
bam-13787	2	13	to	to	ADP
bam-13787	2	14	psychological	psychological	ADJ
bam-13787	2	15	distress	distress	NOUN
bam-13787	2	16	,	,	PUNCT
bam-13787	2	17	social	social	ADJ
bam-13787	2	18	stigma	stigma	NOUN
bam-13787	2	19	,	,	PUNCT
bam-13787	2	20	and	and	CCONJ
bam-13787	2	21	isolation	isolation	NOUN
bam-13787	2	22	.	.	PUNCT
bam-13787	3	1	the	the	DET
bam-13787	3	2	unpredictable	unpredictable	ADJ
bam-13787	3	3	progression	progression	NOUN
bam-13787	3	4	of	of	ADP
bam-13787	3	5	lesions	lesion	NOUN
bam-13787	3	6	—	—	PUNCT
bam-13787	3	7	ranging	range	VERB
bam-13787	3	8	from	from	ADP
bam-13787	3	9	rapid	rapid	ADJ
bam-13787	3	10	spread	spread	NOUN
bam-13787	3	11	to	to	ADP
bam-13787	3	12	years	year	NOUN
bam-13787	3	13	of	of	ADP
bam-13787	3	14	stability	stability	NOUN
bam-13787	3	15	—	—	PUNCT
bam-13787	3	16	adds	add	VERB
bam-13787	3	17	to	to	ADP
bam-13787	3	18	the	the	DET
bam-13787	3	19	emotional	emotional	ADJ
bam-13787	3	20	burden	burden	NOUN
bam-13787	3	21	,	,	PUNCT
bam-13787	3	22	especially	especially	ADV
bam-13787	3	23	in	in	ADP
bam-13787	3	24	cultures	culture	NOUN
bam-13787	3	25	where	where	SCONJ
bam-13787	3	26	stigma	stigma	NOUN
bam-13787	3	27	is	be	AUX
bam-13787	3	28	prevalent.1,5	prevalent.1,5	ADJ
bam-13787	3	29	despite	despite	SCONJ
bam-13787	3	30	being	be	AUX
bam-13787	3	31	a	a	DET
bam-13787	3	32	condition	condition	NOUN
bam-13787	3	33	that	that	PRON
bam-13787	3	34	predominantly	predominantly	ADV
bam-13787	3	35	affects	affect	VERB
bam-13787	3	36	appearance	appearance	NOUN
bam-13787	3	37	,	,	PUNCT
bam-13787	3	38	vitiligo	vitiligo	PROPN
bam-13787	3	39	’s	’s	PART
bam-13787	3	40	effects	effect	NOUN
bam-13787	3	41	go	go	VERB
bam-13787	3	42	beyond	beyond	ADP
bam-13787	3	43	the	the	DET
bam-13787	3	44	skin	skin	NOUN
bam-13787	3	45	.	.	PUNCT
bam-13787	4	1	in	in	ADP
bam-13787	4	2	some	some	DET
bam-13787	4	3	cases	case	NOUN
bam-13787	4	4	,	,	PUNCT
bam-13787	4	5	it	it	PRON
bam-13787	4	6	is	be	AUX
bam-13787	4	7	associated	associate	VERB
bam-13787	4	8	with	with	ADP
bam-13787	4	9	other	other	ADJ
bam-13787	4	10	autoimmune	autoimmune	ADJ
bam-13787	4	11	disorders	disorder	NOUN
bam-13787	4	12	,	,	PUNCT
bam-13787	4	13	further	far	ADV
bam-13787	4	14	complicating	complicate	VERB
bam-13787	4	15	the	the	DET
bam-13787	4	16	management	management	NOUN
bam-13787	4	17	of	of	ADP
bam-13787	4	18	the	the	DET
bam-13787	4	19	disease	disease	NOUN
bam-13787	4	20	.	.	PUNCT
bam-13787	5	1	common	common	ADJ
bam-13787	5	2	comorbidities	comorbiditie	NOUN
bam-13787	5	3	include	include	VERB
bam-13787	5	4	thyroid	thyroid	NOUN
bam-13787	5	5	disorders	disorder	NOUN
bam-13787	5	6	,	,	PUNCT
bam-13787	5	7	diabetes	diabetes	NOUN
bam-13787	5	8	,	,	PUNCT
bam-13787	5	9	and	and	CCONJ
bam-13787	5	10	even	even	ADV
bam-13787	5	11	hearing	hear	VERB
bam-13787	5	12	loss.5	loss.5	PROPN
bam-13787	5	13	-	-	PUNCT
bam-13787	5	14	8	8	NUM
bam-13787	5	15	traditional	traditional	ADJ
bam-13787	5	16	vitiligo	vitiligo	NOUN
bam-13787	5	17	treatments	treatment	NOUN
bam-13787	5	18	focus	focus	VERB
bam-13787	5	19	on	on	ADP
bam-13787	5	20	halting	halt	VERB
bam-13787	5	21	disease	disease	NOUN
bam-13787	5	22	progression	progression	NOUN
bam-13787	5	23	and	and	CCONJ
bam-13787	5	24	restoring	restore	VERB
bam-13787	5	25	pigment	pigment	NOUN
bam-13787	5	26	,	,	PUNCT
bam-13787	5	27	often	often	ADV
bam-13787	5	28	using	use	VERB
bam-13787	5	29	topical	topical	ADJ
bam-13787	5	30	or	or	CCONJ
bam-13787	5	31	systemic	systemic	ADJ
bam-13787	5	32	corticosteroids	corticosteroid	NOUN
bam-13787	5	33	like	like	ADP
bam-13787	5	34	prednisolone,9	prednisolone,9	ADJ
bam-13787	5	35	calcineurin	calcineurin	NOUN
bam-13787	5	36	inhibitors,10	inhibitors,10	NOUN
bam-13787	5	37	and	and	CCONJ
bam-13787	5	38	phototherapy.11	phototherapy.11	NOUN
bam-13787	5	39	these	these	DET
bam-13787	5	40	therapies	therapy	NOUN
bam-13787	5	41	yield	yield	VERB
bam-13787	5	42	variable	variable	ADJ
bam-13787	5	43	results	result	NOUN
bam-13787	5	44	,	,	PUNCT
bam-13787	5	45	often	often	ADV
bam-13787	5	46	requiring	require	VERB
bam-13787	5	47	long	long	ADJ
bam-13787	5	48	treatment	treatment	NOUN
bam-13787	5	49	periods	period	NOUN
bam-13787	5	50	and	and	CCONJ
bam-13787	5	51	are	be	AUX
bam-13787	5	52	unsuitable	unsuitable	ADJ
bam-13787	5	53	for	for	ADP
bam-13787	5	54	some	some	DET
bam-13787	5	55	patients	patient	NOUN
bam-13787	5	56	.	.	PUNCT
bam-13787	6	1	this	this	PRON
bam-13787	6	2	has	have	AUX
bam-13787	6	3	driven	drive	VERB
bam-13787	6	4	interest	interest	NOUN
bam-13787	6	5	in	in	ADP
bam-13787	6	6	targeted	target	VERB
bam-13787	6	7	treatments	treatment	NOUN
bam-13787	6	8	addressing	address	VERB
bam-13787	6	9	autoimmune	autoimmune	ADJ
bam-13787	6	10	dysfunction,12	dysfunction,12	NOUN
bam-13787	6	11	oxidative	oxidative	ADJ
bam-13787	6	12	stress,13	stress,13	NOUN
bam-13787	6	13	and	and	CCONJ
bam-13787	6	14	genetic	genetic	ADJ
bam-13787	6	15	predisposition.14,15	predisposition.14,15	NOUN
bam-13787	6	16	advances	advance	NOUN
bam-13787	6	17	in	in	ADP
bam-13787	6	18	understanding	understand	VERB
bam-13787	6	19	vitiligo	vitiligo	NOUN
bam-13787	6	20	’s	’s	PART
bam-13787	6	21	autoimmune	autoimmune	ADJ
bam-13787	6	22	mechanisms	mechanism	NOUN
bam-13787	6	23	have	have	AUX
bam-13787	6	24	led	lead	VERB
bam-13787	6	25	to	to	ADP
bam-13787	6	26	novel	novel	ADJ
bam-13787	6	27	therapies	therapy	NOUN
bam-13787	6	28	,	,	PUNCT
bam-13787	6	29	including	include	VERB
bam-13787	6	30	janus	janus	PROPN
bam-13787	6	31	kinase	kinase	PROPN
bam-13787	6	32	(	(	PUNCT
bam-13787	6	33	jak	jak	PROPN
bam-13787	6	34	)	)	PUNCT
bam-13787	6	35	inhibitors	inhibitor	NOUN
bam-13787	6	36	targeting	target	VERB
bam-13787	6	37	immune	immune	ADJ
bam-13787	6	38	pathways	pathway	NOUN
bam-13787	6	39	against	against	ADP
bam-13787	6	40	melanocytes.16	melanocytes.16	PROPN
bam-13787	6	41	-	-	PUNCT
bam-13787	6	42	19	19	NUM
bam-13787	6	43	ruxolitinib	ruxolitinib	NOUN
bam-13787	6	44	,	,	PUNCT
bam-13787	6	45	a	a	DET
bam-13787	6	46	topical	topical	ADJ
bam-13787	6	47	jak	jak	PROPN
bam-13787	6	48	inhibitor	inhibitor	NOUN
bam-13787	6	49	,	,	PUNCT
bam-13787	6	50	is	be	AUX
bam-13787	6	51	approved	approve	VERB
bam-13787	6	52	in	in	ADP
bam-13787	6	53	the	the	DET
bam-13787	6	54	u.s	u.s	PROPN
bam-13787	6	55	.	.	PROPN
bam-13787	6	56	and	and	CCONJ
bam-13787	6	57	europe	europe	PROPN
bam-13787	6	58	for	for	ADP
bam-13787	6	59	treating	treat	VERB
bam-13787	6	60	vitiligo	vitiligo	NOUN
bam-13787	6	61	,	,	PUNCT
bam-13787	6	62	showing	show	VERB
bam-13787	6	63	effectiveness	effectiveness	NOUN
bam-13787	6	64	in	in	ADP
bam-13787	6	65	restoring	restore	VERB
bam-13787	6	66	skin	skin	NOUN
bam-13787	6	67	pigmentation.20	pigmentation.20	NOUN
bam-13787	6	68	-	-	PUNCT
bam-13787	6	69	22	22	NUM
bam-13787	6	70	recent	recent	ADJ
bam-13787	6	71	advances	advance	NOUN
bam-13787	6	72	in	in	ADP
bam-13787	6	73	vitiligo	vitiligo	ADJ
bam-13787	6	74	treatment	treatment	NOUN
bam-13787	6	75	include	include	VERB
bam-13787	6	76	the	the	DET
bam-13787	6	77	recell	recell	NOUN
bam-13787	6	78	system	system	NOUN
bam-13787	6	79	,	,	PUNCT
bam-13787	6	80	which	which	PRON
bam-13787	6	81	uses	use	VERB
bam-13787	6	82	a	a	DET
bam-13787	6	83	patient	patient	NOUN
bam-13787	6	84	’s	’s	PART
bam-13787	6	85	healthy	healthy	ADJ
bam-13787	6	86	skin	skin	NOUN
bam-13787	6	87	cells	cell	NOUN
bam-13787	6	88	to	to	PART
bam-13787	6	89	stimulate	stimulate	VERB
bam-13787	6	90	repigmentation	repigmentation	NOUN
bam-13787	6	91	.	.	PUNCT
bam-13787	7	1	this	this	DET
bam-13787	7	2	method	method	NOUN
bam-13787	7	3	involves	involve	VERB
bam-13787	7	4	harvesting	harvesting	NOUN
bam-13787	7	5	and	and	CCONJ
bam-13787	7	6	applying	apply	VERB
bam-13787	7	7	noncultured	nonculture	VERB
bam-13787	7	8	autologous	autologous	ADJ
bam-13787	7	9	epidermal	epidermal	ADJ
bam-13787	7	10	cells	cell	NOUN
bam-13787	7	11	to	to	ADP
bam-13787	7	12	depigmented	depigmented	ADJ
bam-13787	7	13	areas	area	NOUN
bam-13787	7	14	.	.	PUNCT
bam-13787	8	1	studies	study	NOUN
bam-13787	8	2	show	show	VERB
bam-13787	8	3	it	it	PRON
bam-13787	8	4	is	be	AUX
bam-13787	8	5	a	a	DET
bam-13787	8	6	safe	safe	ADJ
bam-13787	8	7	,	,	PUNCT
bam-13787	8	8	simple	simple	ADJ
bam-13787	8	9	,	,	PUNCT
bam-13787	8	10	and	and	CCONJ
bam-13787	8	11	cost	cost	NOUN
bam-13787	8	12	-	-	PUNCT
bam-13787	8	13	effective	effective	ADJ
bam-13787	8	14	alternative	alternative	NOUN
bam-13787	8	15	to	to	ADP
bam-13787	8	16	cultured	cultured	ADJ
bam-13787	8	17	melanocyte	melanocyte	NOUN
bam-13787	8	18	methods.23	methods.23	NOUN
bam-13787	8	19	-	-	PUNCT
bam-13787	8	20	25	25	NUM
bam-13787	8	21	also	also	ADV
bam-13787	8	22	,	,	PUNCT
bam-13787	8	23	microneedling	microneedling	NOUN
bam-13787	8	24	and	and	CCONJ
bam-13787	8	25	mesotherapy	mesotherapy	ADJ
bam-13787	8	26	are	be	AUX
bam-13787	8	27	emerging	emerge	VERB
bam-13787	8	28	treatments	treatment	NOUN
bam-13787	8	29	for	for	ADP
bam-13787	8	30	vitiligo	vitiligo	NOUN
bam-13787	8	31	.	.	PUNCT
bam-13787	9	1	microneedling	microneedling	NOUN
bam-13787	9	2	stimulates	stimulate	VERB
bam-13787	9	3	melanocyte	melanocyte	ADJ
bam-13787	9	4	regeneration	regeneration	NOUN
bam-13787	9	5	through	through	ADP
bam-13787	9	6	micro	micro	NOUN
bam-13787	9	7	-	-	NOUN
bam-13787	9	8	injuries	injury	NOUN
bam-13787	9	9	,	,	PUNCT
bam-13787	9	10	often	often	ADV
bam-13787	9	11	combined	combine	VERB
bam-13787	9	12	with	with	ADP
bam-13787	9	13	agents	agent	NOUN
bam-13787	9	14	like	like	ADP
bam-13787	9	15	tacrolimus	tacrolimus	NOUN
bam-13787	9	16	for	for	ADP
bam-13787	9	17	improved	improved	ADJ
bam-13787	9	18	outcomes	outcome	NOUN
bam-13787	9	19	.	.	PUNCT
bam-13787	10	1	mesotherapy	mesotherapy	ADJ
bam-13787	10	2	involves	involve	VERB
bam-13787	10	3	injecting	inject	VERB
bam-13787	10	4	active	active	ADJ
bam-13787	10	5	substances	substance	NOUN
bam-13787	10	6	into	into	ADP
bam-13787	10	7	the	the	DET
bam-13787	10	8	skin	skin	NOUN
bam-13787	10	9	.	.	PUNCT
bam-13787	11	1	both	both	PRON
bam-13787	11	2	minimally	minimally	ADV
bam-13787	11	3	abstract	abstract	ADJ
bam-13787	11	4	this	this	DET
bam-13787	11	5	study	study	NOUN
bam-13787	11	6	aimed	aim	VERB
bam-13787	11	7	to	to	PART
bam-13787	11	8	evaluate	evaluate	VERB
bam-13787	11	9	the	the	DET
bam-13787	11	10	efficacy	efficacy	NOUN
bam-13787	11	11	of	of	ADP
bam-13787	11	12	a	a	DET
bam-13787	11	13	novel	novel	ADJ
bam-13787	11	14	combination	combination	NOUN
bam-13787	11	15	therapy	therapy	NOUN
bam-13787	11	16	,	,	PUNCT
bam-13787	11	17	avc	avc	PROPN
bam-13787	11	18	(	(	PUNCT
bam-13787	11	19	anti	anti	ADJ
bam-13787	11	20	-	-	ADJ
bam-13787	11	21	vitiligo	vitiligo	ADJ
bam-13787	11	22	cream	cream	NOUN
bam-13787	11	23	)	)	PUNCT
bam-13787	11	24	,	,	PUNCT
bam-13787	11	25	compared	compare	VERB
bam-13787	11	26	to	to	ADP
bam-13787	11	27	common	common	ADJ
bam-13787	11	28	treatments	treatment	NOUN
bam-13787	11	29	for	for	ADP
bam-13787	11	30	vitiligo	vitiligo	NOUN
bam-13787	11	31	.	.	PUNCT
bam-13787	12	1	a	a	DET
bam-13787	12	2	randomized	randomized	ADJ
bam-13787	12	3	interventional	interventional	ADJ
bam-13787	12	4	study	study	NOUN
bam-13787	12	5	was	be	AUX
bam-13787	12	6	conducted	conduct	VERB
bam-13787	12	7	on	on	ADP
bam-13787	12	8	1,000	1,000	NUM
bam-13787	12	9	patients	patient	NOUN
bam-13787	12	10	with	with	ADP
bam-13787	12	11	confirmed	confirm	VERB
bam-13787	12	12	vitiligo	vitiligo	NOUN
bam-13787	12	13	,	,	PUNCT
bam-13787	12	14	aged	aged	ADJ
bam-13787	12	15	7–70	7–70	PROPN
bam-13787	12	16	years	year	NOUN
bam-13787	12	17	.	.	PUNCT
bam-13787	13	1	participants	participant	NOUN
bam-13787	13	2	were	be	AUX
bam-13787	13	3	divided	divide	VERB
bam-13787	13	4	into	into	ADP
bam-13787	13	5	five	five	NUM
bam-13787	13	6	groups	group	NOUN
bam-13787	13	7	(	(	PUNCT
bam-13787	13	8	200	200	NUM
bam-13787	13	9	patients	patient	NOUN
bam-13787	13	10	each	each	PRON
bam-13787	13	11	):	):	PUNCT
bam-13787	13	12	oral	oral	ADJ
bam-13787	13	13	prednisolone	prednisolone	PROPN
bam-13787	13	14	,	,	PUNCT
bam-13787	13	15	tofacitinib	tofacitinib	PROPN
bam-13787	13	16	,	,	PUNCT
bam-13787	13	17	ruxolitinib	ruxolitinib	PROPN
bam-13787	13	18	,	,	PUNCT
bam-13787	13	19	avc	avc	PROPN
bam-13787	13	20	(	(	PUNCT
bam-13787	13	21	antivitiligo	antivitiligo	PROPN
bam-13787	13	22	cream	cream	NOUN
bam-13787	13	23	)	)	PUNCT
bam-13787	13	24	,	,	PUNCT
bam-13787	13	25	and	and	CCONJ
bam-13787	13	26	avc	avc	PROPN
bam-13787	13	27	combined	combine	VERB
bam-13787	13	28	with	with	ADP
bam-13787	13	29	tofacitinib	tofacitinib	NOUN
bam-13787	13	30	.	.	PUNCT
bam-13787	14	1	outcomes	outcome	NOUN
bam-13787	14	2	were	be	AUX
bam-13787	14	3	assessed	assess	VERB
bam-13787	14	4	over	over	ADP
bam-13787	14	5	two	two	NUM
bam-13787	14	6	years	year	NOUN
bam-13787	14	7	using	use	VERB
bam-13787	14	8	the	the	DET
bam-13787	14	9	vitiligo	vitiligo	NOUN
bam-13787	14	10	area	area	NOUN
bam-13787	14	11	scoring	scoring	NOUN
bam-13787	14	12	index	index	NOUN
bam-13787	14	13	(	(	PUNCT
bam-13787	14	14	vasi	vasi	PROPN
bam-13787	14	15	)	)	PUNCT
bam-13787	14	16	,	,	PUNCT
bam-13787	14	17	patient	patient	ADJ
bam-13787	14	18	satisfaction	satisfaction	NOUN
bam-13787	14	19	scores	score	NOUN
bam-13787	14	20	,	,	PUNCT
bam-13787	14	21	and	and	CCONJ
bam-13787	14	22	clinical	clinical	ADJ
bam-13787	14	23	observations	observation	NOUN
bam-13787	14	24	.	.	PUNCT
bam-13787	15	1	avc	avc	PROPN
bam-13787	15	2	-	-	PUNCT
bam-13787	15	3	based	base	VERB
bam-13787	15	4	therapies	therapy	NOUN
bam-13787	15	5	(	(	PUNCT
bam-13787	15	6	groups	group	NOUN
bam-13787	15	7	4	4	NUM
bam-13787	15	8	and	and	CCONJ
bam-13787	15	9	5	5	NUM
bam-13787	15	10	)	)	PUNCT
bam-13787	15	11	demonstrated	demonstrate	VERB
bam-13787	15	12	superior	superior	ADJ
bam-13787	15	13	efficacy	efficacy	NOUN
bam-13787	15	14	and	and	CCONJ
bam-13787	15	15	patient	patient	ADJ
bam-13787	15	16	satisfaction	satisfaction	NOUN
bam-13787	15	17	compared	compare	VERB
bam-13787	15	18	to	to	ADP
bam-13787	15	19	other	other	ADJ
bam-13787	15	20	treatments	treatment	NOUN
bam-13787	15	21	.	.	PUNCT
bam-13787	16	1	group	group	NOUN
bam-13787	16	2	5	5	NUM
bam-13787	16	3	(	(	PUNCT
bam-13787	16	4	avc+tofacitinib	avc+tofacitinib	NOUN
bam-13787	16	5	)	)	PUNCT
bam-13787	16	6	achieved	achieve	VERB
bam-13787	16	7	the	the	DET
bam-13787	16	8	highest	high	ADJ
bam-13787	16	9	outcomes	outcome	NOUN
bam-13787	16	10	,	,	PUNCT
bam-13787	16	11	with	with	ADP
bam-13787	16	12	a	a	DET
bam-13787	16	13	mean	mean	ADJ
bam-13787	16	14	satisfaction	satisfaction	NOUN
bam-13787	16	15	score	score	NOUN
bam-13787	16	16	of	of	ADP
bam-13787	16	17	90	90	NUM
bam-13787	16	18	(	(	PUNCT
bam-13787	16	19	iqr	iqr	NOUN
bam-13787	16	20	:	:	PUNCT
bam-13787	16	21	85–95	85–95	NUM
bam-13787	16	22	)	)	PUNCT
bam-13787	16	23	and	and	CCONJ
bam-13787	16	24	treatment	treatment	NOUN
bam-13787	16	25	efficacy	efficacy	NOUN
bam-13787	16	26	significantly	significantly	ADV
bam-13787	16	27	higher	high	ADJ
bam-13787	16	28	than	than	ADP
bam-13787	16	29	group	group	NOUN
bam-13787	16	30	1	1	NUM
bam-13787	16	31	(	(	PUNCT
bam-13787	16	32	p	p	X
bam-13787	16	33	<	<	NOUN
bam-13787	16	34	0.001	0.001	NUM
bam-13787	16	35	)	)	PUNCT
bam-13787	16	36	.	.	PUNCT
bam-13787	17	1	regression	regression	NOUN
bam-13787	17	2	analysis	analysis	NOUN
bam-13787	17	3	identified	identify	VERB
bam-13787	17	4	treatment	treatment	NOUN
bam-13787	17	5	outcomes	outcome	NOUN
bam-13787	17	6	and	and	CCONJ
bam-13787	17	7	therapy	therapy	NOUN
bam-13787	17	8	type	type	NOUN
bam-13787	17	9	as	as	ADP
bam-13787	17	10	significant	significant	ADJ
bam-13787	17	11	predictors	predictor	NOUN
bam-13787	17	12	of	of	ADP
bam-13787	17	13	satisfaction	satisfaction	NOUN
bam-13787	17	14	.	.	PUNCT
bam-13787	18	1	avc	avc	PROPN
bam-13787	18	2	(	(	PUNCT
bam-13787	18	3	anti	anti	ADJ
bam-13787	18	4	-	-	ADJ
bam-13787	18	5	vitiligo	vitiligo	ADJ
bam-13787	18	6	cream	cream	NOUN
bam-13787	18	7	)	)	PUNCT
bam-13787	18	8	,	,	PUNCT
bam-13787	18	9	particularly	particularly	ADV
bam-13787	18	10	in	in	ADP
bam-13787	18	11	combination	combination	NOUN
bam-13787	18	12	with	with	ADP
bam-13787	18	13	tofacitinib	tofacitinib	NOUN
bam-13787	18	14	,	,	PUNCT
bam-13787	18	15	represents	represent	VERB
bam-13787	18	16	a	a	DET
bam-13787	18	17	groundbreaking	groundbreake	VERB
bam-13787	18	18	approach	approach	NOUN
bam-13787	18	19	for	for	ADP
bam-13787	18	20	managing	manage	VERB
bam-13787	18	21	vitiligo	vitiligo	NOUN
bam-13787	18	22	,	,	PUNCT
bam-13787	18	23	providing	provide	VERB
bam-13787	18	24	enhanced	enhanced	ADJ
bam-13787	18	25	efficacy	efficacy	NOUN
bam-13787	18	26	and	and	CCONJ
bam-13787	18	27	patient	patient	ADJ
bam-13787	18	28	satisfaction	satisfaction	NOUN
bam-13787	18	29	.	.	PUNCT
bam-13787	19	1	these	these	DET
bam-13787	19	2	findings	finding	NOUN
bam-13787	19	3	support	support	VERB
bam-13787	19	4	the	the	DET
bam-13787	19	5	potential	potential	NOUN
bam-13787	19	6	of	of	ADP
bam-13787	19	7	avc	avc	PROPN
bam-13787	19	8	-	-	PUNCT
bam-13787	19	9	based	base	VERB
bam-13787	19	10	therapies	therapy	NOUN
bam-13787	19	11	as	as	ADP
bam-13787	19	12	a	a	DET
bam-13787	19	13	standard	standard	ADJ
bam-13787	19	14	treatment	treatment	NOUN
bam-13787	19	15	option	option	NOUN
bam-13787	19	16	.	.	PUNCT
bam-13787	20	1	key	key	ADJ
bam-13787	20	2	words	word	NOUN
bam-13787	20	3	:	:	PUNCT
bam-13787	20	4	vitiligo	vitiligo	PROPN
bam-13787	20	5	,	,	PUNCT
bam-13787	20	6	avc	avc	PROPN
bam-13787	20	7	therapy	therapy	NOUN
bam-13787	20	8	,	,	PUNCT
bam-13787	20	9	tofacitinib	tofacitinib	PROPN
bam-13787	20	10	.	.	PUNCT
bam-13787	21	1	eur	eur	PROPN
bam-13787	21	2	j	j	PROPN
bam-13787	21	3	transl	transl	PROPN
bam-13787	21	4	myol	myol	ADV
bam-13787	21	5	35	35	NUM
bam-13787	21	6	(	(	PUNCT
bam-13787	21	7	4	4	NUM
bam-13787	21	8	)	)	PUNCT
bam-13787	21	9	13787	13787	NUM
bam-13787	21	10	,	,	PUNCT
bam-13787	21	11	2025	2025	NUM
bam-13787	21	12	doi	doi	NOUN
bam-13787	21	13	:	:	PUNCT
bam-13787	21	14	10.4081	10.4081	NUM
bam-13787	21	15	/	/	SYM
bam-13787	21	16	ejtm.2025.13787	ejtm.2025.13787	VERB
bam-13787	21	17	a	a	DET
bam-13787	21	18	randomized	randomized	ADJ
bam-13787	21	19	interventional	interventional	ADJ
bam-13787	21	20	study	study	NOUN
bam-13787	21	21	that	that	PRON
bam-13787	21	22	compares	compare	VERB
bam-13787	21	23	treatments	treatment	NOUN
bam-13787	21	24	for	for	ADP
bam-13787	21	25	vitiligo	vitiligo	NOUN
bam-13787	21	26	and	and	CCONJ
bam-13787	21	27	anti	anti	ADJ
bam-13787	21	28	-	-	ADJ
bam-13787	21	29	vitiligo	vitiligo	ADJ
bam-13787	21	30	cream	cream	NOUN
bam-13787	21	31	shahzad	shahzad	PROPN
bam-13787	21	32	shirzad,1	shirzad,1	PROPN
bam-13787	21	33	mahdis	mahdis	PROPN
bam-13787	22	1	miladi2,3	miladi2,3	PROPN
bam-13787	22	2	1department	1department	NUM
bam-13787	22	3	of	of	ADP
bam-13787	22	4	dermatovenereology	dermatovenereology	NOUN
bam-13787	22	5	,	,	PUNCT
bam-13787	22	6	belgrade	belgrade	PROPN
bam-13787	22	7	university	university	PROPN
bam-13787	22	8	of	of	ADP
bam-13787	22	9	medical	medical	PROPN
bam-13787	22	10	sciences	sciences	PROPN
bam-13787	22	11	,	,	PUNCT
bam-13787	22	12	belgrade	belgrade	PROPN
bam-13787	22	13	,	,	PUNCT
bam-13787	22	14	serbia	serbia	PROPN
bam-13787	22	15	;	;	PUNCT
bam-13787	22	16	2department	2department	NUM
bam-13787	22	17	of	of	ADP
bam-13787	22	18	pediatrics	pediatric	NOUN
bam-13787	22	19	,	,	PUNCT
bam-13787	22	20	tehran	tehran	PROPN
bam-13787	22	21	university	university	PROPN
bam-13787	22	22	of	of	ADP
bam-13787	22	23	medical	medical	ADJ
bam-13787	22	24	sciences	sciences	PROPN
bam-13787	22	25	,	,	PUNCT
bam-13787	22	26	tehran	tehran	PROPN
bam-13787	22	27	,	,	PUNCT
bam-13787	22	28	iran	iran	PROPN
bam-13787	22	29	;	;	PUNCT
bam-13787	22	30	3université	3université	NUM
bam-13787	22	31	côte	côte	NOUN
bam-13787	22	32	d’azur	d’azur	PROPN
bam-13787	22	33	diplôme	diplôme	PROPN
bam-13787	22	34	inter	inter	PROPN
bam-13787	22	35	universitaire	universitaire	PROPN
bam-13787	22	36	,	,	PUNCT
bam-13787	22	37	nice	nice	ADJ
bam-13787	22	38	,	,	PUNCT
bam-13787	22	39	france	france	PROPN
bam-13787	22	40	.	.	PUNCT
bam-13787	23	1	this	this	DET
bam-13787	23	2	article	article	NOUN
bam-13787	23	3	is	be	AUX
bam-13787	23	4	distributed	distribute	VERB
bam-13787	23	5	under	under	ADP
bam-13787	23	6	the	the	DET
bam-13787	23	7	terms	term	NOUN
bam-13787	23	8	of	of	ADP
bam-13787	23	9	the	the	DET
bam-13787	23	10	creative	creative	ADJ
bam-13787	23	11	commons	common	NOUN
bam-13787	23	12	attribution	attribution	NOUN
bam-13787	23	13	noncommercial	noncommercial	ADJ
bam-13787	23	14	license	license	NOUN
bam-13787	23	15	(	(	PUNCT
bam-13787	23	16	cc	cc	NOUN
bam-13787	23	17	by	by	ADP
bam-13787	23	18	-	-	PUNCT
bam-13787	23	19	nc	nc	PROPN
bam-13787	23	20	4.0	4.0	NUM
bam-13787	23	21	)	)	PUNCT
bam-13787	23	22	which	which	PRON
bam-13787	23	23	permits	permit	VERB
bam-13787	23	24	any	any	DET
bam-13787	23	25	noncommercial	noncommercial	ADJ
bam-13787	23	26	use	use	NOUN
bam-13787	23	27	,	,	PUNCT
bam-13787	23	28	distribution	distribution	NOUN
bam-13787	23	29	,	,	PUNCT
bam-13787	23	30	and	and	CCONJ
bam-13787	23	31	reproduction	reproduction	NOUN
bam-13787	23	32	in	in	ADP
bam-13787	23	33	any	any	DET
bam-13787	23	34	medium	medium	NOUN
bam-13787	23	35	,	,	PUNCT
bam-13787	23	36	provided	provide	VERB
bam-13787	23	37	the	the	DET
bam-13787	23	38	original	original	ADJ
bam-13787	23	39	author(s	author(s	NOUN
bam-13787	23	40	)	)	PUNCT
bam-13787	23	41	and	and	CCONJ
bam-13787	23	42	source	source	NOUN
bam-13787	23	43	are	be	AUX
bam-13787	23	44	credited	credit	VERB
bam-13787	23	45	.	.	PUNCT
bam-13787	24	1	1	1	NUM
bam-13787	24	2	treatments	treatment	NOUN
bam-13787	24	3	for	for	ADP
bam-13787	24	4	vitiligo	vitiligo	NOUN
bam-13787	24	5	vs.	vs.	ADP
bam-13787	24	6	anti	anti	ADJ
bam-13787	24	7	-	-	ADJ
bam-13787	24	8	vitiligo	vitiligo	ADJ
bam-13787	24	9	cream	cream	NOUN
bam-13787	24	10	eur	eur	PROPN
bam-13787	24	11	j	j	PROPN
bam-13787	24	12	transl	transl	PROPN
bam-13787	24	13	myol	myol	ADV
bam-13787	24	14	35	35	NUM
bam-13787	24	15	(	(	PUNCT
bam-13787	24	16	4	4	NUM
bam-13787	24	17	)	)	PUNCT
bam-13787	24	18	13787	13787	NUM
bam-13787	24	19	,	,	PUNCT
bam-13787	24	20	2025	2025	NUM
bam-13787	24	21	doi	doi	NOUN
bam-13787	24	22	:	:	PUNCT
bam-13787	24	23	10.4081	10.4081	NUM
bam-13787	24	24	/	/	SYM
bam-13787	24	25	ejtm.2025.13787	ejtm.2025.13787	VERB
bam-13787	24	26	invasive	invasive	ADJ
bam-13787	24	27	methods	method	NOUN
bam-13787	24	28	are	be	AUX
bam-13787	24	29	safe	safe	ADJ
bam-13787	24	30	,	,	PUNCT
bam-13787	24	31	cost	cost	NOUN
bam-13787	24	32	-	-	PUNCT
bam-13787	24	33	effective	effective	ADJ
bam-13787	24	34	,	,	PUNCT
bam-13787	24	35	and	and	CCONJ
bam-13787	24	36	show	show	VERB
bam-13787	24	37	promise	promise	NOUN
bam-13787	24	38	for	for	ADP
bam-13787	24	39	managing	manage	VERB
bam-13787	24	40	refractory	refractory	NOUN
bam-13787	24	41	vitiligo	vitiligo	VERB
bam-13787	24	42	lesions.26	lesions.26	ADJ
bam-13787	24	43	-	-	PUNCT
bam-13787	24	44	28	28	NUM
bam-13787	24	45	these	these	DET
bam-13787	24	46	developments	development	NOUN
bam-13787	24	47	mark	mark	VERB
bam-13787	24	48	a	a	DET
bam-13787	24	49	shift	shift	NOUN
bam-13787	24	50	towards	towards	ADP
bam-13787	24	51	targeted	target	VERB
bam-13787	24	52	therapies	therapy	NOUN
bam-13787	24	53	for	for	ADP
bam-13787	24	54	vitiligo	vitiligo	NOUN
bam-13787	24	55	,	,	PUNCT
bam-13787	24	56	addressing	address	VERB
bam-13787	24	57	its	its	PRON
bam-13787	24	58	underlying	underlie	VERB
bam-13787	24	59	causes	cause	NOUN
bam-13787	24	60	.	.	PUNCT
bam-13787	25	1	ongoing	ongoing	ADJ
bam-13787	25	2	research	research	NOUN
bam-13787	25	3	suggests	suggest	VERB
bam-13787	25	4	these	these	DET
bam-13787	25	5	treatments	treatment	NOUN
bam-13787	25	6	will	will	AUX
bam-13787	25	7	provide	provide	VERB
bam-13787	25	8	more	more	ADV
bam-13787	25	9	effective	effective	ADJ
bam-13787	25	10	and	and	CCONJ
bam-13787	25	11	personalized	personalized	ADJ
bam-13787	25	12	options	option	NOUN
bam-13787	25	13	for	for	ADP
bam-13787	25	14	those	those	PRON
bam-13787	25	15	affected	affect	VERB
bam-13787	25	16	.	.	PUNCT
bam-13787	26	1	in	in	ADP
bam-13787	26	2	this	this	DET
bam-13787	26	3	study	study	NOUN
bam-13787	26	4	,	,	PUNCT
bam-13787	26	5	we	we	PRON
bam-13787	26	6	compared	compare	VERB
bam-13787	26	7	the	the	DET
bam-13787	26	8	effects	effect	NOUN
bam-13787	26	9	of	of	ADP
bam-13787	26	10	a	a	DET
bam-13787	26	11	new	new	ADJ
bam-13787	26	12	combination	combination	NOUN
bam-13787	26	13	therapy	therapy	NOUN
bam-13787	26	14	called	call	VERB
bam-13787	26	15	anti	anti	ADJ
bam-13787	26	16	-	-	ADJ
bam-13787	26	17	vitiligo	vitiligo	ADJ
bam-13787	26	18	cream	cream	NOUN
bam-13787	26	19	(	(	PUNCT
bam-13787	26	20	avc	avc	PROPN
bam-13787	26	21	)	)	PUNCT
bam-13787	26	22	,	,	PUNCT
bam-13787	26	23	which	which	PRON
bam-13787	26	24	included	include	VERB
bam-13787	26	25	stem	stem	NOUN
bam-13787	26	26	cells	cell	NOUN
bam-13787	26	27	and	and	CCONJ
bam-13787	26	28	agents	agent	NOUN
bam-13787	26	29	that	that	PRON
bam-13787	26	30	stimulate	stimulate	VERB
bam-13787	26	31	and	and	CCONJ
bam-13787	26	32	enhance	enhance	VERB
bam-13787	26	33	melanin	melanin	NOUN
bam-13787	26	34	production	production	NOUN
bam-13787	26	35	in	in	ADP
bam-13787	26	36	melanocytes	melanocyte	NOUN
bam-13787	26	37	,	,	PUNCT
bam-13787	26	38	with	with	ADP
bam-13787	26	39	other	other	ADJ
bam-13787	26	40	treatment	treatment	NOUN
bam-13787	26	41	methods	method	NOUN
bam-13787	26	42	for	for	ADP
bam-13787	26	43	vitiligo	vitiligo	NOUN
bam-13787	26	44	.	.	PUNCT
bam-13787	27	1	methods	method	NOUN
bam-13787	27	2	and	and	CCONJ
bam-13787	27	3	materials	material	NOUN
bam-13787	27	4	study	study	NOUN
bam-13787	27	5	design	design	NOUN
bam-13787	27	6	and	and	CCONJ
bam-13787	27	7	population	population	NOUN
bam-13787	27	8	this	this	DET
bam-13787	27	9	study	study	NOUN
bam-13787	27	10	was	be	AUX
bam-13787	27	11	a	a	DET
bam-13787	27	12	randomized	randomized	ADJ
bam-13787	27	13	,	,	PUNCT
bam-13787	27	14	interventional	interventional	ADJ
bam-13787	27	15	study	study	NOUN
bam-13787	27	16	designed	design	VERB
bam-13787	27	17	to	to	PART
bam-13787	27	18	evaluate	evaluate	VERB
bam-13787	27	19	the	the	DET
bam-13787	27	20	efficacy	efficacy	NOUN
bam-13787	27	21	of	of	ADP
bam-13787	27	22	a	a	DET
bam-13787	27	23	novel	novel	ADJ
bam-13787	27	24	combination	combination	NOUN
bam-13787	27	25	therapy	therapy	NOUN
bam-13787	27	26	,	,	PUNCT
bam-13787	27	27	avc	avc	PROPN
bam-13787	27	28	,	,	PUNCT
bam-13787	27	29	which	which	PRON
bam-13787	27	30	contains	contain	VERB
bam-13787	27	31	stem	stem	NOUN
bam-13787	27	32	cells	cell	NOUN
bam-13787	27	33	with	with	ADP
bam-13787	27	34	melanin	melanin	NOUN
bam-13787	27	35	stimulator	stimulator	NOUN
bam-13787	27	36	and	and	CCONJ
bam-13787	27	37	enhancer	enhancer	NOUN
bam-13787	27	38	agents	agent	NOUN
bam-13787	27	39	,	,	PUNCT
bam-13787	27	40	compared	compare	VERB
bam-13787	27	41	to	to	ADP
bam-13787	27	42	common	common	ADJ
bam-13787	27	43	treatments	treatment	NOUN
bam-13787	27	44	for	for	ADP
bam-13787	27	45	vitiligo	vitiligo	NOUN
bam-13787	27	46	.	.	PUNCT
bam-13787	28	1	a	a	DET
bam-13787	28	2	total	total	NOUN
bam-13787	28	3	of	of	ADP
bam-13787	28	4	1,000	1,000	NUM
bam-13787	28	5	patients	patient	NOUN
bam-13787	28	6	diagnosed	diagnose	VERB
bam-13787	28	7	with	with	ADP
bam-13787	28	8	vitiligo	vitiligo	NOUN
bam-13787	28	9	were	be	AUX
bam-13787	28	10	enrolled	enrol	VERB
bam-13787	28	11	in	in	ADP
bam-13787	28	12	the	the	DET
bam-13787	28	13	study	study	NOUN
bam-13787	28	14	,	,	PUNCT
bam-13787	28	15	with	with	ADP
bam-13787	28	16	recruitment	recruitment	NOUN
bam-13787	28	17	beginning	begin	VERB
bam-13787	28	18	in	in	ADP
bam-13787	28	19	2020	2020	NUM
bam-13787	28	20	.	.	PUNCT
bam-13787	29	1	the	the	DET
bam-13787	29	2	participants	participant	NOUN
bam-13787	29	3	were	be	AUX
bam-13787	29	4	selected	select	VERB
bam-13787	29	5	based	base	VERB
bam-13787	29	6	on	on	ADP
bam-13787	29	7	inclusion	inclusion	NOUN
bam-13787	29	8	criteria	criterion	NOUN
bam-13787	29	9	that	that	PRON
bam-13787	29	10	included	include	VERB
bam-13787	29	11	a	a	DET
bam-13787	29	12	confirmed	confirm	VERB
bam-13787	29	13	diagnosis	diagnosis	NOUN
bam-13787	29	14	of	of	ADP
bam-13787	29	15	vitiligo	vitiligo	NOUN
bam-13787	29	16	through	through	ADP
bam-13787	29	17	skin	skin	NOUN
bam-13787	29	18	biopsy	biopsy	NOUN
bam-13787	29	19	,	,	PUNCT
bam-13787	29	20	age	age	NOUN
bam-13787	29	21	between	between	ADP
bam-13787	29	22	7	7	NUM
bam-13787	29	23	and	and	CCONJ
bam-13787	29	24	70	70	NUM
bam-13787	29	25	years	year	NOUN
bam-13787	29	26	,	,	PUNCT
bam-13787	29	27	and	and	CCONJ
bam-13787	29	28	no	no	DET
bam-13787	29	29	history	history	NOUN
bam-13787	29	30	of	of	ADP
bam-13787	29	31	other	other	ADJ
bam-13787	29	32	autoimmune	autoimmune	ADJ
bam-13787	29	33	disorders	disorder	NOUN
bam-13787	29	34	.	.	PUNCT
bam-13787	30	1	exclusion	exclusion	NOUN
bam-13787	30	2	criteria	criterion	NOUN
bam-13787	30	3	involved	involve	VERB
bam-13787	30	4	pregnant	pregnant	ADJ
bam-13787	30	5	or	or	CCONJ
bam-13787	30	6	breastfeeding	breastfeed	VERB
bam-13787	30	7	women	woman	NOUN
bam-13787	30	8	,	,	PUNCT
bam-13787	30	9	patients	patient	NOUN
bam-13787	30	10	with	with	ADP
bam-13787	30	11	active	active	ADJ
bam-13787	30	12	infections	infection	NOUN
bam-13787	30	13	,	,	PUNCT
bam-13787	30	14	or	or	CCONJ
bam-13787	30	15	those	those	PRON
bam-13787	30	16	with	with	ADP
bam-13787	30	17	prior	prior	ADJ
bam-13787	30	18	treatment	treatment	NOUN
bam-13787	30	19	that	that	PRON
bam-13787	30	20	could	could	AUX
bam-13787	30	21	confound	confound	VERB
bam-13787	30	22	the	the	DET
bam-13787	30	23	results	result	NOUN
bam-13787	30	24	.	.	PUNCT
bam-13787	31	1	the	the	DET
bam-13787	31	2	participants	participant	NOUN
bam-13787	31	3	were	be	AUX
bam-13787	31	4	randomly	randomly	ADV
bam-13787	31	5	assigned	assign	VERB
bam-13787	31	6	into	into	ADP
bam-13787	31	7	five	five	NUM
bam-13787	31	8	groups	group	NOUN
bam-13787	31	9	,	,	PUNCT
bam-13787	31	10	each	each	PRON
bam-13787	31	11	comprising	comprise	VERB
bam-13787	31	12	200	200	NUM
bam-13787	31	13	patients	patient	NOUN
bam-13787	31	14	.	.	PUNCT
bam-13787	32	1	the	the	DET
bam-13787	32	2	first	first	ADJ
bam-13787	32	3	group	group	NOUN
bam-13787	32	4	received	receive	VERB
bam-13787	32	5	oral	oral	ADJ
bam-13787	32	6	prednisolone	prednisolone	PROPN
bam-13787	32	7	,	,	PUNCT
bam-13787	32	8	the	the	DET
bam-13787	32	9	second	second	ADJ
bam-13787	32	10	group	group	NOUN
bam-13787	32	11	was	be	AUX
bam-13787	32	12	administered	administer	VERB
bam-13787	32	13	only	only	ADV
bam-13787	32	14	tofacitinib	tofacitinib	NOUN
bam-13787	32	15	,	,	PUNCT
bam-13787	32	16	the	the	DET
bam-13787	32	17	third	third	ADJ
bam-13787	32	18	group	group	NOUN
bam-13787	32	19	received	receive	VERB
bam-13787	32	20	ruxolitinib	ruxolitinib	NOUN
bam-13787	32	21	,	,	PUNCT
bam-13787	32	22	the	the	DET
bam-13787	32	23	fourth	fourth	ADJ
bam-13787	32	24	group	group	NOUN
bam-13787	32	25	was	be	AUX
bam-13787	32	26	treated	treat	VERB
bam-13787	32	27	with	with	ADP
bam-13787	32	28	avc	avc	PROPN
bam-13787	32	29	,	,	PUNCT
bam-13787	32	30	which	which	PRON
bam-13787	32	31	is	be	AUX
bam-13787	32	32	a	a	DET
bam-13787	32	33	combination	combination	NOUN
bam-13787	32	34	of	of	ADP
bam-13787	32	35	stem	stem	NOUN
bam-13787	32	36	cells	cell	NOUN
bam-13787	32	37	along	along	ADP
bam-13787	32	38	with	with	ADP
bam-13787	32	39	melanin	melanin	NOUN
bam-13787	32	40	stimulators	stimulator	NOUN
bam-13787	32	41	and	and	CCONJ
bam-13787	32	42	enhancers	enhancer	NOUN
bam-13787	32	43	,	,	PUNCT
bam-13787	32	44	and	and	CCONJ
bam-13787	32	45	the	the	DET
bam-13787	32	46	fifth	fifth	ADJ
bam-13787	32	47	group	group	NOUN
bam-13787	32	48	received	receive	VERB
bam-13787	32	49	a	a	DET
bam-13787	32	50	combination	combination	NOUN
bam-13787	32	51	of	of	ADP
bam-13787	32	52	avc	avc	PROPN
bam-13787	32	53	and	and	CCONJ
bam-13787	32	54	oral	oral	ADJ
bam-13787	32	55	tofacitinib	tofacitinib	NOUN
bam-13787	32	56	.	.	PUNCT
bam-13787	33	1	all	all	DET
bam-13787	33	2	participants	participant	NOUN
bam-13787	33	3	were	be	AUX
bam-13787	33	4	followed	follow	VERB
bam-13787	33	5	for	for	ADP
bam-13787	33	6	a	a	DET
bam-13787	33	7	duration	duration	NOUN
bam-13787	33	8	of	of	ADP
bam-13787	33	9	two	two	NUM
bam-13787	33	10	years	year	NOUN
bam-13787	33	11	to	to	PART
bam-13787	33	12	assess	assess	VERB
bam-13787	33	13	the	the	DET
bam-13787	33	14	outcomes	outcome	NOUN
bam-13787	33	15	of	of	ADP
bam-13787	33	16	the	the	DET
bam-13787	33	17	treatments	treatment	NOUN
bam-13787	33	18	.	.	PUNCT
bam-13787	34	1	procedures	procedure	NOUN
bam-13787	34	2	and	and	CCONJ
bam-13787	34	3	data	datum	NOUN
bam-13787	34	4	gathering	gathering	NOUN
bam-13787	34	5	patients	patient	NOUN
bam-13787	34	6	were	be	AUX
bam-13787	34	7	enrolled	enrol	VERB
bam-13787	34	8	following	follow	VERB
bam-13787	34	9	an	an	DET
bam-13787	34	10	informed	informed	ADJ
bam-13787	34	11	consent	consent	NOUN
bam-13787	34	12	process	process	NOUN
bam-13787	34	13	,	,	PUNCT
bam-13787	34	14	and	and	CCONJ
bam-13787	34	15	baseline	baseline	PROPN
bam-13787	34	16	data	datum	NOUN
bam-13787	34	17	were	be	AUX
bam-13787	34	18	collected	collect	VERB
bam-13787	34	19	at	at	ADP
bam-13787	34	20	the	the	DET
bam-13787	34	21	start	start	NOUN
bam-13787	34	22	of	of	ADP
bam-13787	34	23	the	the	DET
bam-13787	34	24	study	study	NOUN
bam-13787	34	25	.	.	PUNCT
bam-13787	35	1	this	this	PRON
bam-13787	35	2	included	include	VERB
bam-13787	35	3	detailed	detailed	ADJ
bam-13787	35	4	demographic	demographic	ADJ
bam-13787	35	5	information	information	NOUN
bam-13787	35	6	,	,	PUNCT
bam-13787	35	7	disease	disease	NOUN
bam-13787	35	8	history	history	NOUN
bam-13787	35	9	,	,	PUNCT
bam-13787	35	10	clinical	clinical	ADJ
bam-13787	35	11	vitiligo	vitiligo	NOUN
bam-13787	35	12	characteristics	characteristic	NOUN
bam-13787	35	13	,	,	PUNCT
bam-13787	35	14	and	and	CCONJ
bam-13787	35	15	prior	prior	ADJ
bam-13787	35	16	treatments	treatment	NOUN
bam-13787	35	17	.	.	PUNCT
bam-13787	36	1	over	over	ADP
bam-13787	36	2	the	the	DET
bam-13787	36	3	course	course	NOUN
bam-13787	36	4	of	of	ADP
bam-13787	36	5	the	the	DET
bam-13787	36	6	study	study	NOUN
bam-13787	36	7	,	,	PUNCT
bam-13787	36	8	each	each	DET
bam-13787	36	9	participant	participant	NOUN
bam-13787	36	10	underwent	undergo	VERB
bam-13787	36	11	regular	regular	ADJ
bam-13787	36	12	follow	follow	NOUN
bam-13787	36	13	-	-	PUNCT
bam-13787	36	14	up	up	NOUN
bam-13787	36	15	visits	visit	NOUN
bam-13787	36	16	at	at	ADP
bam-13787	36	17	2	2	NUM
bam-13787	36	18	-	-	PUNCT
bam-13787	36	19	month	month	NOUN
bam-13787	36	20	intervals	interval	NOUN
bam-13787	36	21	for	for	ADP
bam-13787	36	22	two	two	NUM
bam-13787	36	23	years	year	NOUN
bam-13787	36	24	.	.	PUNCT
bam-13787	37	1	during	during	ADP
bam-13787	37	2	these	these	DET
bam-13787	37	3	visits	visit	NOUN
bam-13787	37	4	,	,	PUNCT
bam-13787	37	5	the	the	DET
bam-13787	37	6	following	follow	VERB
bam-13787	37	7	data	datum	NOUN
bam-13787	37	8	were	be	AUX
bam-13787	37	9	gathered	gather	VERB
bam-13787	37	10	:	:	PUNCT
bam-13787	37	11	i	i	X
bam-13787	37	12	)	)	PUNCT
bam-13787	37	13	assessment	assessment	NOUN
bam-13787	37	14	of	of	ADP
bam-13787	37	15	disease	disease	NOUN
bam-13787	37	16	progression	progression	NOUN
bam-13787	37	17	or	or	CCONJ
bam-13787	37	18	improvement	improvement	NOUN
bam-13787	37	19	using	use	VERB
bam-13787	37	20	the	the	DET
bam-13787	37	21	vitiligo	vitiligo	NOUN
bam-13787	37	22	area	area	NOUN
bam-13787	37	23	scoring	scoring	NOUN
bam-13787	37	24	index	index	NOUN
bam-13787	37	25	(	(	PUNCT
bam-13787	37	26	vasi	vasi	PROPN
bam-13787	37	27	)	)	PUNCT
bam-13787	37	28	;	;	PUNCT
bam-13787	37	29	ii	ii	X
bam-13787	37	30	)	)	PUNCT
bam-13787	37	31	monitoring	monitoring	NOUN
bam-13787	37	32	of	of	ADP
bam-13787	37	33	side	side	NOUN
bam-13787	37	34	effects	effect	NOUN
bam-13787	37	35	or	or	CCONJ
bam-13787	37	36	adverse	adverse	ADJ
bam-13787	37	37	reactions	reaction	NOUN
bam-13787	37	38	to	to	ADP
bam-13787	37	39	the	the	DET
bam-13787	37	40	treatments	treatment	NOUN
bam-13787	37	41	;	;	PUNCT
bam-13787	37	42	iii	iii	X
bam-13787	37	43	)	)	PUNCT
bam-13787	37	44	blood	blood	NOUN
bam-13787	37	45	tests	test	NOUN
bam-13787	37	46	to	to	PART
bam-13787	37	47	assess	assess	VERB
bam-13787	37	48	organ	organ	NOUN
bam-13787	37	49	function	function	NOUN
bam-13787	37	50	and	and	CCONJ
bam-13787	37	51	detect	detect	VERB
bam-13787	37	52	potential	potential	ADJ
bam-13787	37	53	drug	drug	NOUN
bam-13787	37	54	-	-	PUNCT
bam-13787	37	55	related	relate	VERB
bam-13787	37	56	complications	complication	NOUN
bam-13787	37	57	;	;	PUNCT
bam-13787	37	58	iv	iv	X
bam-13787	37	59	)	)	PUNCT
bam-13787	37	60	patient	patient	NOUN
bam-13787	37	61	-	-	PUNCT
bam-13787	37	62	reported	report	VERB
bam-13787	37	63	outcomes	outcome	NOUN
bam-13787	37	64	to	to	PART
bam-13787	37	65	evaluate	evaluate	VERB
bam-13787	37	66	quality	quality	NOUN
bam-13787	37	67	of	of	ADP
bam-13787	37	68	life	life	NOUN
bam-13787	37	69	,	,	PUNCT
bam-13787	37	70	including	include	VERB
bam-13787	37	71	questionnaires	questionnaire	NOUN
bam-13787	37	72	related	relate	VERB
bam-13787	37	73	to	to	ADP
bam-13787	37	74	emotional	emotional	ADJ
bam-13787	37	75	well	well	ADV
bam-13787	37	76	-	-	PUNCT
bam-13787	37	77	being	being	NOUN
bam-13787	37	78	and	and	CCONJ
bam-13787	37	79	the	the	DET
bam-13787	37	80	impact	impact	NOUN
bam-13787	37	81	of	of	ADP
bam-13787	37	82	vitiligo	vitiligo	NOUN
bam-13787	37	83	.	.	PUNCT
bam-13787	38	1	in	in	ADP
bam-13787	38	2	addition	addition	NOUN
bam-13787	38	3	to	to	ADP
bam-13787	38	4	the	the	DET
bam-13787	38	5	clinical	clinical	ADJ
bam-13787	38	6	evaluations	evaluation	NOUN
bam-13787	38	7	,	,	PUNCT
bam-13787	38	8	photographs	photograph	NOUN
bam-13787	38	9	were	be	AUX
bam-13787	38	10	taken	take	VERB
bam-13787	38	11	at	at	ADP
bam-13787	38	12	each	each	DET
bam-13787	38	13	visit	visit	NOUN
bam-13787	38	14	to	to	PART
bam-13787	38	15	visually	visually	ADV
bam-13787	38	16	assess	assess	VERB
bam-13787	38	17	changes	change	NOUN
bam-13787	38	18	in	in	ADP
bam-13787	38	19	vitiligo	vitiligo	ADJ
bam-13787	38	20	lesions	lesion	NOUN
bam-13787	38	21	.	.	PUNCT
bam-13787	39	1	the	the	DET
bam-13787	39	2	study	study	NOUN
bam-13787	39	3	design	design	NOUN
bam-13787	39	4	aimed	aim	VERB
bam-13787	39	5	to	to	PART
bam-13787	39	6	ensure	ensure	VERB
bam-13787	39	7	that	that	SCONJ
bam-13787	39	8	all	all	DET
bam-13787	39	9	data	datum	NOUN
bam-13787	39	10	were	be	AUX
bam-13787	39	11	gathered	gather	VERB
bam-13787	39	12	consistently	consistently	ADV
bam-13787	39	13	across	across	ADP
bam-13787	39	14	the	the	DET
bam-13787	39	15	five	five	NUM
bam-13787	39	16	treatment	treatment	NOUN
bam-13787	39	17	groups	group	NOUN
bam-13787	39	18	,	,	PUNCT
bam-13787	39	19	allowing	allow	VERB
bam-13787	39	20	for	for	ADP
bam-13787	39	21	direct	direct	ADJ
bam-13787	39	22	comparisons	comparison	NOUN
bam-13787	39	23	of	of	ADP
bam-13787	39	24	treatment	treatment	NOUN
bam-13787	39	25	efficacy	efficacy	NOUN
bam-13787	39	26	.	.	PUNCT
bam-13787	40	1	data	datum	NOUN
bam-13787	40	2	analysis	analysis	NOUN
bam-13787	40	3	the	the	DET
bam-13787	40	4	data	datum	NOUN
bam-13787	40	5	were	be	AUX
bam-13787	40	6	analyzed	analyze	VERB
bam-13787	40	7	using	use	VERB
bam-13787	40	8	descriptive	descriptive	ADJ
bam-13787	40	9	statistics	statistic	NOUN
bam-13787	40	10	to	to	PART
bam-13787	40	11	summarize	summarize	VERB
bam-13787	40	12	the	the	DET
bam-13787	40	13	age	age	NOUN
bam-13787	40	14	,	,	PUNCT
bam-13787	40	15	gender	gender	NOUN
bam-13787	40	16	,	,	PUNCT
bam-13787	40	17	treatment	treatment	NOUN
bam-13787	40	18	outcomes	outcome	NOUN
bam-13787	40	19	,	,	PUNCT
bam-13787	40	20	and	and	CCONJ
bam-13787	40	21	patient	patient	ADJ
bam-13787	40	22	satisfaction	satisfaction	NOUN
bam-13787	40	23	within	within	ADP
bam-13787	40	24	each	each	DET
bam-13787	40	25	group	group	NOUN
bam-13787	40	26	.	.	PUNCT
bam-13787	41	1	to	to	PART
bam-13787	41	2	evaluate	evaluate	VERB
bam-13787	41	3	treatment	treatment	NOUN
bam-13787	41	4	effectiveness	effectiveness	NOUN
bam-13787	41	5	,	,	PUNCT
bam-13787	41	6	chi	chi	ADJ
bam-13787	41	7	-	-	PUNCT
bam-13787	41	8	square	square	ADJ
bam-13787	41	9	tests	test	NOUN
bam-13787	41	10	were	be	AUX
bam-13787	41	11	conducted	conduct	VERB
bam-13787	41	12	for	for	ADP
bam-13787	41	13	categorical	categorical	ADJ
bam-13787	41	14	variables	variable	NOUN
bam-13787	41	15	such	such	ADJ
bam-13787	41	16	as	as	ADP
bam-13787	41	17	treatment	treatment	NOUN
bam-13787	41	18	outcomes	outcome	NOUN
bam-13787	41	19	.	.	PUNCT
bam-13787	42	1	anova	anova	PROPN
bam-13787	42	2	was	be	AUX
bam-13787	42	3	employed	employ	VERB
bam-13787	42	4	to	to	PART
bam-13787	42	5	compare	compare	VERB
bam-13787	42	6	patient	patient	ADJ
bam-13787	42	7	satisfaction	satisfaction	NOUN
bam-13787	42	8	scores	score	NOUN
bam-13787	42	9	across	across	ADP
bam-13787	42	10	treatment	treatment	NOUN
bam-13787	42	11	groups	group	NOUN
bam-13787	42	12	,	,	PUNCT
bam-13787	42	13	while	while	SCONJ
bam-13787	42	14	pairwise	pairwise	NOUN
bam-13787	42	15	correlation	correlation	NOUN
bam-13787	42	16	analysis	analysis	NOUN
bam-13787	42	17	assessed	assess	VERB
bam-13787	42	18	the	the	DET
bam-13787	42	19	relationships	relationship	NOUN
bam-13787	42	20	between	between	ADP
bam-13787	42	21	age	age	NOUN
bam-13787	42	22	,	,	PUNCT
bam-13787	42	23	patient	patient	ADJ
bam-13787	42	24	satisfaction	satisfaction	NOUN
bam-13787	42	25	,	,	PUNCT
bam-13787	42	26	and	and	CCONJ
bam-13787	42	27	treatment	treatment	NOUN
bam-13787	42	28	outcomes	outcome	NOUN
bam-13787	42	29	.	.	PUNCT
bam-13787	43	1	multivariate	multivariate	NOUN
bam-13787	43	2	linear	linear	PROPN
bam-13787	43	3	regression	regression	NOUN
bam-13787	43	4	was	be	AUX
bam-13787	43	5	performed	perform	VERB
bam-13787	43	6	to	to	PART
bam-13787	43	7	identify	identify	VERB
bam-13787	43	8	predictors	predictor	NOUN
bam-13787	43	9	of	of	ADP
bam-13787	43	10	patient	patient	ADJ
bam-13787	43	11	satisfaction	satisfaction	NOUN
bam-13787	43	12	,	,	PUNCT
bam-13787	43	13	including	include	VERB
bam-13787	43	14	age	age	NOUN
bam-13787	43	15	,	,	PUNCT
bam-13787	43	16	gender	gender	NOUN
bam-13787	43	17	,	,	PUNCT
bam-13787	43	18	treatment	treatment	NOUN
bam-13787	43	19	group	group	NOUN
bam-13787	43	20	,	,	PUNCT
bam-13787	43	21	and	and	CCONJ
bam-13787	43	22	treatment	treatment	NOUN
bam-13787	43	23	outcome	outcome	NOUN
bam-13787	43	24	.	.	PUNCT
bam-13787	44	1	all	all	DET
bam-13787	44	2	statistical	statistical	ADJ
bam-13787	44	3	procedures	procedure	NOUN
bam-13787	44	4	were	be	AUX
bam-13787	44	5	carried	carry	VERB
bam-13787	44	6	out	out	ADP
bam-13787	44	7	using	use	VERB
bam-13787	44	8	stata	stata	NOUN
bam-13787	44	9	version	version	NOUN
bam-13787	44	10	18	18	NUM
bam-13787	44	11	(	(	PUNCT
bam-13787	44	12	statacorp	statacorp	PROPN
bam-13787	44	13	llc	llc	PROPN
bam-13787	44	14	,	,	PUNCT
bam-13787	44	15	college	college	NOUN
bam-13787	44	16	station	station	NOUN
bam-13787	44	17	,	,	PUNCT
bam-13787	44	18	tx	tx	PROPN
bam-13787	44	19	)	)	PUNCT
bam-13787	44	20	,	,	PUNCT
bam-13787	44	21	with	with	ADP
bam-13787	44	22	significance	significance	NOUN
bam-13787	44	23	levels	level	NOUN
bam-13787	44	24	set	set	VERB
bam-13787	44	25	at	at	ADP
bam-13787	44	26	p	p	NOUN
bam-13787	44	27	<	<	X
bam-13787	44	28	0.05	0.05	NUM
bam-13787	44	29	for	for	ADP
bam-13787	44	30	all	all	DET
bam-13787	44	31	tests	test	NOUN
bam-13787	44	32	.	.	PUNCT
bam-13787	45	1	missing	miss	VERB
bam-13787	45	2	data	datum	NOUN
bam-13787	45	3	were	be	AUX
bam-13787	45	4	excluded	exclude	VERB
bam-13787	45	5	from	from	ADP
bam-13787	45	6	the	the	DET
bam-13787	45	7	analysis	analysis	NOUN
bam-13787	45	8	,	,	PUNCT
bam-13787	45	9	and	and	CCONJ
bam-13787	45	10	results	result	NOUN
bam-13787	45	11	are	be	AUX
bam-13787	45	12	reported	report	VERB
bam-13787	45	13	as	as	ADP
bam-13787	45	14	means±standard	means±standard	NOUN
bam-13787	45	15	deviation	deviation	NOUN
bam-13787	45	16	for	for	ADP
bam-13787	45	17	continuous	continuous	ADJ
bam-13787	45	18	variables	variable	NOUN
bam-13787	45	19	,	,	PUNCT
bam-13787	45	20	medians	median	NOUN
bam-13787	45	21	with	with	ADP
bam-13787	45	22	interquartile	interquartile	NOUN
bam-13787	45	23	ranges	range	NOUN
bam-13787	45	24	for	for	ADP
bam-13787	45	25	non	non	ADJ
bam-13787	45	26	-	-	ADJ
bam-13787	45	27	normally	normally	ADV
bam-13787	45	28	distributed	distribute	VERB
bam-13787	45	29	data	datum	NOUN
bam-13787	45	30	,	,	PUNCT
bam-13787	45	31	and	and	CCONJ
bam-13787	45	32	frequencies	frequency	NOUN
bam-13787	45	33	with	with	ADP
bam-13787	45	34	percentages	percentage	NOUN
bam-13787	45	35	for	for	ADP
bam-13787	45	36	categorical	categorical	ADJ
bam-13787	45	37	variables	variable	NOUN
bam-13787	45	38	.	.	PUNCT
bam-13787	46	1	ethical	ethical	ADJ
bam-13787	46	2	considerations	consideration	NOUN
bam-13787	46	3	this	this	DET
bam-13787	46	4	study	study	NOUN
bam-13787	46	5	was	be	AUX
bam-13787	46	6	conducted	conduct	VERB
bam-13787	46	7	in	in	ADP
bam-13787	46	8	accordance	accordance	NOUN
bam-13787	46	9	with	with	ADP
bam-13787	46	10	the	the	DET
bam-13787	46	11	declaration	declaration	NOUN
bam-13787	46	12	of	of	ADP
bam-13787	46	13	helsinki.29	helsinki.29	NOUN
bam-13787	46	14	all	all	DET
bam-13787	46	15	participants	participant	NOUN
bam-13787	46	16	provided	provide	VERB
bam-13787	46	17	written	write	VERB
bam-13787	46	18	informed	inform	VERB
bam-13787	46	19	consent	consent	NOUN
bam-13787	46	20	before	before	ADP
bam-13787	46	21	enrollment	enrollment	NOUN
bam-13787	46	22	,	,	PUNCT
bam-13787	46	23	acknowledging	acknowledge	VERB
bam-13787	46	24	their	their	PRON
bam-13787	46	25	understanding	understanding	NOUN
bam-13787	46	26	of	of	ADP
bam-13787	46	27	the	the	DET
bam-13787	46	28	study	study	NOUN
bam-13787	46	29	procedures	procedure	NOUN
bam-13787	46	30	,	,	PUNCT
bam-13787	46	31	potential	potential	ADJ
bam-13787	46	32	risks	risk	NOUN
bam-13787	46	33	,	,	PUNCT
bam-13787	46	34	and	and	CCONJ
bam-13787	46	35	the	the	DET
bam-13787	46	36	voluntary	voluntary	ADJ
bam-13787	46	37	nature	nature	NOUN
bam-13787	46	38	of	of	ADP
bam-13787	46	39	participation	participation	NOUN
bam-13787	46	40	.	.	PUNCT
bam-13787	47	1	the	the	DET
bam-13787	47	2	study	study	NOUN
bam-13787	47	3	ensured	ensure	VERB
bam-13787	47	4	participant	participant	ADJ
bam-13787	47	5	confidentiality	confidentiality	NOUN
bam-13787	47	6	,	,	PUNCT
bam-13787	47	7	with	with	ADP
bam-13787	47	8	personal	personal	ADJ
bam-13787	47	9	data	datum	NOUN
bam-13787	47	10	stored	store	VERB
bam-13787	47	11	securely	securely	ADV
bam-13787	47	12	and	and	CCONJ
bam-13787	47	13	anonymized	anonymize	VERB
bam-13787	47	14	for	for	ADP
bam-13787	47	15	analysis	analysis	NOUN
bam-13787	47	16	.	.	PUNCT
bam-13787	48	1	additionally	additionally	ADV
bam-13787	48	2	,	,	PUNCT
bam-13787	48	3	the	the	DET
bam-13787	48	4	study	study	NOUN
bam-13787	48	5	adhered	adhere	VERB
bam-13787	48	6	to	to	ADP
bam-13787	48	7	guidelines	guideline	NOUN
bam-13787	48	8	for	for	ADP
bam-13787	48	9	the	the	DET
bam-13787	48	10	ethical	ethical	ADJ
bam-13787	48	11	management	management	NOUN
bam-13787	48	12	of	of	ADP
bam-13787	48	13	adverse	adverse	ADJ
bam-13787	48	14	events	event	NOUN
bam-13787	48	15	,	,	PUNCT
bam-13787	48	16	and	and	CCONJ
bam-13787	48	17	patients	patient	NOUN
bam-13787	48	18	were	be	AUX
bam-13787	48	19	monitored	monitor	VERB
bam-13787	48	20	closely	closely	ADV
bam-13787	48	21	throughout	throughout	ADP
bam-13787	48	22	the	the	DET
bam-13787	48	23	study	study	NOUN
bam-13787	48	24	for	for	ADP
bam-13787	48	25	any	any	DET
bam-13787	48	26	serious	serious	ADJ
bam-13787	48	27	side	side	NOUN
bam-13787	48	28	effects	effect	NOUN
bam-13787	48	29	.	.	PUNCT
bam-13787	49	1	results	result	VERB
bam-13787	49	2	this	this	DET
bam-13787	49	3	study	study	NOUN
bam-13787	49	4	compared	compare	VERB
bam-13787	49	5	the	the	DET
bam-13787	49	6	efficacy	efficacy	NOUN
bam-13787	49	7	of	of	ADP
bam-13787	49	8	common	common	ADJ
bam-13787	49	9	treatments	treatment	NOUN
bam-13787	49	10	for	for	ADP
bam-13787	49	11	vitiligo	vitiligo	NOUN
bam-13787	49	12	with	with	ADP
bam-13787	49	13	a	a	DET
bam-13787	49	14	treatment	treatment	NOUN
bam-13787	49	15	created	create	VERB
bam-13787	49	16	by	by	ADP
bam-13787	49	17	dr	dr	PROPN
bam-13787	49	18	.	.	PROPN
bam-13787	49	19	shahzad	shahzad	PROPN
bam-13787	49	20	shirzad	shirzad	PROPN
bam-13787	49	21	called	call	VERB
bam-13787	49	22	avc	avc	PROPN
bam-13787	49	23	(	(	PUNCT
bam-13787	49	24	anti	anti	ADJ
bam-13787	49	25	-	-	ADJ
bam-13787	49	26	vitiligo	vitiligo	ADJ
bam-13787	49	27	cream	cream	NOUN
bam-13787	49	28	)	)	PUNCT
bam-13787	49	29	across	across	ADP
bam-13787	49	30	five	five	NUM
bam-13787	49	31	groups	group	NOUN
bam-13787	49	32	,	,	PUNCT
bam-13787	49	33	with	with	ADP
bam-13787	49	34	each	each	DET
bam-13787	49	35	group	group	NOUN
bam-13787	49	36	comprising	comprise	VERB
bam-13787	49	37	200	200	NUM
bam-13787	49	38	patients	patient	NOUN
bam-13787	49	39	.	.	PUNCT
bam-13787	50	1	the	the	DET
bam-13787	50	2	treatments	treatment	NOUN
bam-13787	50	3	included	include	VERB
bam-13787	50	4	oral	oral	ADJ
bam-13787	50	5	prednisolone	prednisolone	PROPN
bam-13787	50	6	(	(	PUNCT
bam-13787	50	7	group	group	NOUN
bam-13787	50	8	1	1	NUM
bam-13787	50	9	)	)	PUNCT
bam-13787	50	10	,	,	PUNCT
bam-13787	50	11	tofacitinib	tofacitinib	NOUN
bam-13787	50	12	alone	alone	ADV
bam-13787	50	13	(	(	PUNCT
bam-13787	50	14	group	group	NOUN
bam-13787	50	15	2	2	NUM
bam-13787	50	16	)	)	PUNCT
bam-13787	50	17	,	,	PUNCT
bam-13787	50	18	ruxolitinib	ruxolitinib	NOUN
bam-13787	50	19	(	(	PUNCT
bam-13787	50	20	group	group	NOUN
bam-13787	50	21	3	3	NUM
bam-13787	50	22	)	)	PUNCT
bam-13787	50	23	,	,	PUNCT
bam-13787	50	24	avc	avc	PROPN
bam-13787	50	25	(	(	PUNCT
bam-13787	50	26	a	a	DET
bam-13787	50	27	combination	combination	NOUN
bam-13787	50	28	of	of	ADP
bam-13787	50	29	stem	stem	NOUN
bam-13787	50	30	cells	cell	NOUN
bam-13787	50	31	and	and	CCONJ
bam-13787	50	32	melanin	melanin	NOUN
bam-13787	50	33	stimulators	stimulator	NOUN
bam-13787	50	34	/	/	SYM
bam-13787	50	35	enhancers	enhancer	NOUN
bam-13787	50	36	;	;	PUNCT
bam-13787	50	37	group	group	NOUN
bam-13787	50	38	4	4	NUM
bam-13787	50	39	)	)	PUNCT
bam-13787	50	40	,	,	PUNCT
bam-13787	50	41	and	and	CCONJ
bam-13787	50	42	avc	avc	PROPN
bam-13787	50	43	combined	combine	VERB
bam-13787	50	44	with	with	ADP
bam-13787	50	45	oral	oral	ADJ
bam-13787	50	46	tofacitinib	tofacitinib	NOUN
bam-13787	50	47	(	(	PUNCT
bam-13787	50	48	group	group	NOUN
bam-13787	50	49	5	5	NUM
bam-13787	50	50	)	)	PUNCT
bam-13787	50	51	.	.	PUNCT
bam-13787	51	1	outcomes	outcome	NOUN
bam-13787	51	2	were	be	AUX
bam-13787	51	3	assessed	assess	VERB
bam-13787	51	4	over	over	ADP
bam-13787	51	5	a	a	DET
bam-13787	51	6	two	two	NUM
bam-13787	51	7	-	-	PUNCT
bam-13787	51	8	year	year	NOUN
bam-13787	51	9	follow	follow	NOUN
bam-13787	51	10	-	-	PUNCT
bam-13787	51	11	up	up	NOUN
bam-13787	51	12	,	,	PUNCT
bam-13787	51	13	focusing	focus	VERB
bam-13787	51	14	on	on	ADP
bam-13787	51	15	treatment	treatment	NOUN
bam-13787	51	16	efficacy	efficacy	NOUN
bam-13787	51	17	,	,	PUNCT
bam-13787	51	18	patient	patient	ADJ
bam-13787	51	19	satisfaction	satisfaction	NOUN
bam-13787	51	20	,	,	PUNCT
bam-13787	51	21	and	and	CCONJ
bam-13787	51	22	response	response	NOUN
bam-13787	51	23	consistency	consistency	NOUN
bam-13787	51	24	across	across	ADP
bam-13787	51	25	age	age	NOUN
bam-13787	51	26	groups	group	NOUN
bam-13787	51	27	.	.	PUNCT
bam-13787	52	1	table	table	NOUN
bam-13787	52	2	1	1	NUM
bam-13787	52	3	summarizes	summarize	NOUN
bam-13787	52	4	the	the	DET
bam-13787	52	5	primary	primary	ADJ
bam-13787	52	6	outcomes	outcome	NOUN
bam-13787	52	7	of	of	ADP
bam-13787	52	8	the	the	DET
bam-13787	52	9	treatments	treatment	NOUN
bam-13787	52	10	.	.	PUNCT
bam-13787	53	1	the	the	DET
bam-13787	53	2	avc	avc	PROPN
bam-13787	53	3	-	-	PUNCT
bam-13787	53	4	based	base	VERB
bam-13787	53	5	therapies	therapy	NOUN
bam-13787	53	6	(	(	PUNCT
bam-13787	53	7	groups	group	NOUN
bam-13787	53	8	4	4	NUM
bam-13787	53	9	and	and	CCONJ
bam-13787	53	10	5	5	NUM
bam-13787	53	11	)	)	PUNCT
bam-13787	53	12	exhibited	exhibit	VERB
bam-13787	53	13	significantly	significantly	ADV
bam-13787	53	14	higher	high	ADJ
bam-13787	53	15	efficacy	efficacy	NOUN
bam-13787	53	16	,	,	PUNCT
bam-13787	53	17	with	with	ADP
bam-13787	53	18	mean	mean	ADJ
bam-13787	53	19	outcome	outcome	NOUN
bam-13787	53	20	scores	score	NOUN
bam-13787	53	21	of	of	ADP
bam-13787	53	22	84.5±9.2	84.5±9.2	NUM
bam-13787	53	23	(	(	PUNCT
bam-13787	53	24	group	group	NOUN
bam-13787	53	25	4	4	NUM
bam-13787	53	26	)	)	PUNCT
bam-13787	53	27	and	and	CCONJ
bam-13787	53	28	89.1±7.5	89.1±7.5	NUM
bam-13787	53	29	(	(	PUNCT
bam-13787	53	30	group	group	NOUN
bam-13787	53	31	5	5	NUM
bam-13787	53	32	)	)	PUNCT
bam-13787	53	33	,	,	PUNCT
bam-13787	53	34	compared	compare	VERB
bam-13787	53	35	to	to	ADP
bam-13787	53	36	65.3±14.8	65.3±14.8	NUM
bam-13787	53	37	for	for	ADP
bam-13787	53	38	group	group	NOUN
bam-13787	53	39	1	1	NUM
bam-13787	53	40	.	.	PUNCT
bam-13787	53	41	group	group	NOUN
bam-13787	53	42	5	5	NUM
bam-13787	53	43	had	have	VERB
bam-13787	53	44	the	the	DET
bam-13787	53	45	highest	high	ADJ
bam-13787	53	46	treatment	treatment	NOUN
bam-13787	53	47	efficacy	efficacy	NOUN
bam-13787	53	48	among	among	ADP
bam-13787	53	49	all	all	DET
bam-13787	53	50	groups	group	NOUN
bam-13787	53	51	(	(	PUNCT
bam-13787	53	52	p	p	X
bam-13787	53	53	<	<	X
bam-13787	53	54	0.001	0.001	NUM
bam-13787	53	55	)	)	PUNCT
bam-13787	53	56	.	.	PUNCT
bam-13787	54	1	the	the	DET
bam-13787	54	2	uniformity	uniformity	NOUN
bam-13787	54	3	in	in	ADP
bam-13787	54	4	outcomes	outcome	NOUN
bam-13787	54	5	across	across	ADP
bam-13787	54	6	groups	group	NOUN
bam-13787	54	7	is	be	AUX
bam-13787	54	8	further	far	ADV
bam-13787	54	9	illustrated	illustrate	VERB
bam-13787	54	10	in	in	ADP
bam-13787	54	11	the	the	DET
bam-13787	54	12	bar	bar	NOUN
bam-13787	54	13	chart	chart	NOUN
bam-13787	54	14	(	(	PUNCT
bam-13787	54	15	figure	figure	NOUN
bam-13787	54	16	1	1	NUM
bam-13787	54	17	)	)	PUNCT
bam-13787	54	18	,	,	PUNCT
bam-13787	54	19	which	which	PRON
bam-13787	54	20	shows	show	VERB
bam-13787	54	21	comparable	comparable	ADJ
bam-13787	54	22	proportions	proportion	NOUN
bam-13787	54	23	of	of	ADP
bam-13787	54	24	patients	patient	NOUN
bam-13787	54	25	achieving	achieve	VERB
bam-13787	54	26	positive	positive	ADJ
bam-13787	54	27	outcomes	outcome	NOUN
bam-13787	54	28	across	across	ADP
bam-13787	54	29	all	all	DET
bam-13787	54	30	groups	group	NOUN
bam-13787	54	31	.	.	PUNCT
bam-13787	55	1	2	2	NUM
bam-13787	55	2	treatments	treatment	NOUN
bam-13787	55	3	for	for	ADP
bam-13787	55	4	vitiligo	vitiligo	NOUN
bam-13787	55	5	vs.	vs.	ADP
bam-13787	55	6	anti	anti	ADJ
bam-13787	55	7	-	-	ADJ
bam-13787	55	8	vitiligo	vitiligo	ADJ
bam-13787	55	9	cream	cream	NOUN
bam-13787	55	10	eur	eur	PROPN
bam-13787	55	11	j	j	PROPN
bam-13787	55	12	transl	transl	PROPN
bam-13787	55	13	myol	myol	ADV
bam-13787	55	14	35	35	NUM
bam-13787	55	15	(	(	PUNCT
bam-13787	55	16	4	4	NUM
bam-13787	55	17	)	)	PUNCT
bam-13787	55	18	13787	13787	NUM
bam-13787	55	19	,	,	PUNCT
bam-13787	55	20	2025	2025	NUM
bam-13787	55	21	doi	doi	NOUN
bam-13787	55	22	:	:	PUNCT
bam-13787	55	23	10.4081	10.4081	NUM
bam-13787	55	24	/	/	SYM
bam-13787	55	25	ejtm.2025.13787	ejtm.2025.13787	VERB
bam-13787	55	26	patient	patient	NOUN
bam-13787	55	27	satisfaction	satisfaction	NOUN
bam-13787	55	28	,	,	PUNCT
bam-13787	55	29	as	as	SCONJ
bam-13787	55	30	shown	show	VERB
bam-13787	55	31	in	in	ADP
bam-13787	55	32	table	table	NOUN
bam-13787	55	33	2	2	NUM
bam-13787	55	34	and	and	CCONJ
bam-13787	55	35	figure	figure	NOUN
bam-13787	55	36	2	2	NUM
bam-13787	55	37	,	,	PUNCT
bam-13787	55	38	followed	follow	VERB
bam-13787	55	39	a	a	DET
bam-13787	55	40	similar	similar	ADJ
bam-13787	55	41	trend	trend	NOUN
bam-13787	55	42	,	,	PUNCT
bam-13787	55	43	with	with	ADP
bam-13787	55	44	group	group	NOUN
bam-13787	55	45	5	5	NUM
bam-13787	55	46	reporting	report	VERB
bam-13787	55	47	the	the	DET
bam-13787	55	48	highest	high	ADJ
bam-13787	55	49	median	median	ADJ
bam-13787	55	50	satisfaction	satisfaction	NOUN
bam-13787	55	51	score	score	NOUN
bam-13787	55	52	of	of	ADP
bam-13787	55	53	90	90	NUM
bam-13787	55	54	(	(	PUNCT
bam-13787	55	55	iqr	iqr	NOUN
bam-13787	55	56	:	:	PUNCT
bam-13787	55	57	85–95	85–95	NUM
bam-13787	55	58	)	)	PUNCT
bam-13787	55	59	.	.	PUNCT
bam-13787	56	1	group	group	NOUN
bam-13787	56	2	4	4	NUM
bam-13787	56	3	followed	follow	VERB
bam-13787	56	4	with	with	ADP
bam-13787	56	5	a	a	DET
bam-13787	56	6	median	median	ADJ
bam-13787	56	7	score	score	NOUN
bam-13787	56	8	of	of	ADP
bam-13787	56	9	85	85	NUM
bam-13787	56	10	(	(	PUNCT
bam-13787	56	11	iqr	iqr	NOUN
bam-13787	56	12	:	:	PUNCT
bam-13787	56	13	78–92	78–92	NUM
bam-13787	56	14	)	)	PUNCT
bam-13787	56	15	.	.	PUNCT
bam-13787	57	1	group	group	NOUN
bam-13787	57	2	1	1	NUM
bam-13787	57	3	had	have	VERB
bam-13787	57	4	the	the	DET
bam-13787	57	5	lowest	low	ADJ
bam-13787	57	6	satisfaction	satisfaction	NOUN
bam-13787	57	7	scores	score	NOUN
bam-13787	57	8	(	(	PUNCT
bam-13787	57	9	median	median	NOUN
bam-13787	57	10	:	:	PUNCT
bam-13787	57	11	45	45	NUM
bam-13787	57	12	,	,	PUNCT
bam-13787	57	13	iqr	iqr	NOUN
bam-13787	57	14	:	:	PUNCT
bam-13787	57	15	30	30	NUM
bam-13787	57	16	–	–	PUNCT
bam-13787	57	17	55	55	NUM
bam-13787	57	18	)	)	PUNCT
bam-13787	57	19	,	,	PUNCT
bam-13787	57	20	highlighting	highlight	VERB
bam-13787	57	21	the	the	DET
bam-13787	57	22	limitations	limitation	NOUN
bam-13787	57	23	of	of	ADP
bam-13787	57	24	prednisolone	prednisolone	PROPN
bam-13787	57	25	as	as	ADP
bam-13787	57	26	a	a	DET
bam-13787	57	27	monotherapy	monotherapy	NOUN
bam-13787	57	28	.	.	PUNCT
bam-13787	58	1	statistical	statistical	ADJ
bam-13787	58	2	analysis	analysis	NOUN
bam-13787	58	3	revealed	reveal	VERB
bam-13787	58	4	significant	significant	ADJ
bam-13787	58	5	differences	difference	NOUN
bam-13787	58	6	in	in	ADP
bam-13787	58	7	satisfaction	satisfaction	NOUN
bam-13787	58	8	across	across	ADP
bam-13787	58	9	groups	group	NOUN
bam-13787	58	10	(	(	PUNCT
bam-13787	58	11	p	p	X
bam-13787	58	12	<	<	X
bam-13787	58	13	0.001	0.001	NUM
bam-13787	58	14	)	)	PUNCT
bam-13787	58	15	.	.	PUNCT
bam-13787	59	1	the	the	DET
bam-13787	59	2	distribution	distribution	NOUN
bam-13787	59	3	of	of	ADP
bam-13787	59	4	patient	patient	ADJ
bam-13787	59	5	satisfaction	satisfaction	NOUN
bam-13787	59	6	by	by	ADP
bam-13787	59	7	treatment	treatment	NOUN
bam-13787	59	8	group	group	NOUN
bam-13787	59	9	(	(	PUNCT
bam-13787	59	10	figure	figure	NOUN
bam-13787	59	11	2	2	NUM
bam-13787	59	12	)	)	PUNCT
bam-13787	59	13	underscores	underscore	VERB
bam-13787	59	14	the	the	DET
bam-13787	59	15	variability	variability	NOUN
bam-13787	59	16	in	in	ADP
bam-13787	59	17	perceived	perceive	VERB
bam-13787	59	18	outcomes	outcome	NOUN
bam-13787	59	19	.	.	PUNCT
bam-13787	60	1	groups	group	NOUN
bam-13787	60	2	4	4	NUM
bam-13787	60	3	and	and	CCONJ
bam-13787	60	4	5	5	NUM
bam-13787	60	5	not	not	PART
bam-13787	60	6	only	only	ADV
bam-13787	60	7	had	have	VERB
bam-13787	60	8	higher	high	ADJ
bam-13787	60	9	median	median	ADJ
bam-13787	60	10	satisfaction	satisfaction	NOUN
bam-13787	60	11	but	but	CCONJ
bam-13787	60	12	also	also	ADV
bam-13787	60	13	narrower	narrow	ADJ
bam-13787	60	14	interquartile	interquartile	NOUN
bam-13787	60	15	ranges	range	NOUN
bam-13787	60	16	,	,	PUNCT
bam-13787	60	17	suggesting	suggest	VERB
bam-13787	60	18	more	more	ADV
bam-13787	60	19	consistent	consistent	ADJ
bam-13787	60	20	results	result	NOUN
bam-13787	60	21	.	.	PUNCT
bam-13787	61	1	conversely	conversely	ADV
bam-13787	61	2	,	,	PUNCT
bam-13787	61	3	group	group	NOUN
bam-13787	61	4	1	1	NUM
bam-13787	61	5	showed	show	VERB
bam-13787	61	6	the	the	DET
bam-13787	61	7	broadest	broad	ADJ
bam-13787	61	8	variability	variability	NOUN
bam-13787	61	9	in	in	ADP
bam-13787	61	10	satisfaction	satisfaction	NOUN
bam-13787	61	11	,	,	PUNCT
bam-13787	61	12	indicating	indicate	VERB
bam-13787	61	13	a	a	DET
bam-13787	61	14	heterogeneous	heterogeneous	ADJ
bam-13787	61	15	response	response	NOUN
bam-13787	61	16	among	among	ADP
bam-13787	61	17	patients	patient	NOUN
bam-13787	61	18	.	.	PUNCT
bam-13787	62	1	the	the	DET
bam-13787	62	2	relationship	relationship	NOUN
bam-13787	62	3	between	between	ADP
bam-13787	62	4	age	age	NOUN
bam-13787	62	5	and	and	CCONJ
bam-13787	62	6	satisfaction	satisfaction	NOUN
bam-13787	62	7	is	be	AUX
bam-13787	62	8	presented	present	VERB
bam-13787	62	9	in	in	ADP
bam-13787	62	10	table	table	NOUN
bam-13787	62	11	3	3	NUM
bam-13787	62	12	and	and	CCONJ
bam-13787	62	13	figure	figure	VERB
bam-13787	62	14	3	3	NUM
bam-13787	62	15	.	.	PUNCT
bam-13787	63	1	younger	young	ADJ
bam-13787	63	2	patients	patient	NOUN
bam-13787	63	3	demonstrated	demonstrate	VERB
bam-13787	63	4	generally	generally	ADV
bam-13787	63	5	higher	high	ADJ
bam-13787	63	6	satisfaction	satisfaction	NOUN
bam-13787	63	7	scores	score	NOUN
bam-13787	63	8	regardless	regardless	ADV
bam-13787	63	9	of	of	ADP
bam-13787	63	10	treatment	treatment	NOUN
bam-13787	63	11	type	type	NOUN
bam-13787	63	12	,	,	PUNCT
bam-13787	63	13	with	with	ADP
bam-13787	63	14	satisfaction	satisfaction	NOUN
bam-13787	63	15	scores	score	NOUN
bam-13787	63	16	decreasing	decrease	VERB
bam-13787	63	17	slightly	slightly	ADV
bam-13787	63	18	with	with	ADP
bam-13787	63	19	increasing	increase	VERB
bam-13787	63	20	age	age	NOUN
bam-13787	63	21	(	(	PUNCT
bam-13787	63	22	p	p	X
bam-13787	63	23	<	<	X
bam-13787	63	24	0.05	0.05	NUM
bam-13787	63	25	)	)	PUNCT
bam-13787	63	26	.	.	PUNCT
bam-13787	64	1	this	this	DET
bam-13787	64	2	trend	trend	NOUN
bam-13787	64	3	was	be	AUX
bam-13787	64	4	most	most	ADV
bam-13787	64	5	notable	notable	ADJ
bam-13787	64	6	in	in	ADP
bam-13787	64	7	groups	group	NOUN
bam-13787	64	8	4	4	NUM
bam-13787	64	9	and	and	CCONJ
bam-13787	64	10	5	5	NUM
bam-13787	64	11	,	,	PUNCT
bam-13787	64	12	suggesting	suggest	VERB
bam-13787	64	13	that	that	SCONJ
bam-13787	64	14	combination	combination	NOUN
bam-13787	64	15	therapies	therapy	NOUN
bam-13787	64	16	may	may	AUX
bam-13787	64	17	provide	provide	VERB
bam-13787	64	18	enhanced	enhanced	ADJ
bam-13787	64	19	benefits	benefit	NOUN
bam-13787	64	20	for	for	ADP
bam-13787	64	21	younger	young	ADJ
bam-13787	64	22	patients	patient	NOUN
bam-13787	64	23	.	.	PUNCT
bam-13787	65	1	table	table	NOUN
bam-13787	65	2	4	4	NUM
bam-13787	65	3	presents	present	VERB
bam-13787	65	4	the	the	DET
bam-13787	65	5	results	result	NOUN
bam-13787	65	6	of	of	ADP
bam-13787	65	7	a	a	DET
bam-13787	65	8	multivariate	multivariate	NOUN
bam-13787	65	9	linear	linear	NOUN
bam-13787	65	10	regression	regression	NOUN
bam-13787	65	11	assessing	assess	VERB
bam-13787	65	12	predictors	predictor	NOUN
bam-13787	65	13	of	of	ADP
bam-13787	65	14	patient	patient	ADJ
bam-13787	65	15	satisfaction	satisfaction	NOUN
bam-13787	65	16	.	.	PUNCT
bam-13787	66	1	the	the	DET
bam-13787	66	2	analysis	analysis	NOUN
bam-13787	66	3	revealed	reveal	VERB
bam-13787	66	4	that	that	SCONJ
bam-13787	66	5	treatment	treatment	NOUN
bam-13787	66	6	group	group	NOUN
bam-13787	66	7	and	and	CCONJ
bam-13787	66	8	treatment	treatment	NOUN
bam-13787	66	9	outcomes	outcome	NOUN
bam-13787	66	10	were	be	AUX
bam-13787	66	11	significant	significant	ADJ
bam-13787	66	12	predictors	predictor	NOUN
bam-13787	66	13	of	of	ADP
bam-13787	66	14	satisfaction	satisfaction	NOUN
bam-13787	66	15	(	(	PUNCT
bam-13787	66	16	p	p	X
bam-13787	66	17	<	<	X
bam-13787	66	18	0.001	0.001	NUM
bam-13787	66	19	)	)	PUNCT
bam-13787	66	20	.	.	PUNCT
bam-13787	67	1	patients	patient	NOUN
bam-13787	67	2	in	in	ADP
bam-13787	67	3	group	group	NOUN
bam-13787	67	4	5	5	NUM
bam-13787	67	5	had	have	VERB
bam-13787	67	6	the	the	DET
bam-13787	67	7	highest	high	ADJ
bam-13787	67	8	satisfaction	satisfaction	NOUN
bam-13787	67	9	(	(	PUNCT
bam-13787	67	10	coefficient=17.78	coefficient=17.78	PROPN
bam-13787	67	11	,	,	PUNCT
bam-13787	67	12	p	p	X
bam-13787	67	13	<	<	NOUN
bam-13787	67	14	0.001	0.001	NUM
bam-13787	67	15	)	)	PUNCT
bam-13787	67	16	,	,	PUNCT
bam-13787	67	17	followed	follow	VERB
bam-13787	67	18	by	by	ADP
bam-13787	67	19	group	group	NOUN
bam-13787	67	20	4	4	NUM
bam-13787	67	21	(	(	PUNCT
bam-13787	67	22	coefficient=13.22	coefficient=13.22	NOUN
bam-13787	67	23	,	,	PUNCT
bam-13787	67	24	p	p	X
bam-13787	67	25	<	<	X
bam-13787	67	26	0.001	0.001	NUM
bam-13787	67	27	)	)	PUNCT
bam-13787	67	28	.	.	PUNCT
bam-13787	68	1	positive	positive	ADJ
bam-13787	68	2	treatment	treatment	NOUN
bam-13787	68	3	outcomes	outcome	NOUN
bam-13787	68	4	also	also	ADV
bam-13787	68	5	strongly	strongly	ADV
bam-13787	68	6	predicted	predict	VERB
bam-13787	68	7	satisfaction	satisfaction	NOUN
bam-13787	68	8	,	,	PUNCT
bam-13787	68	9	with	with	ADP
bam-13787	68	10	a	a	DET
bam-13787	68	11	coefficient	coefficient	NOUN
bam-13787	68	12	of	of	ADP
bam-13787	68	13	57.30	57.30	NUM
bam-13787	68	14	(	(	PUNCT
bam-13787	68	15	p	p	X
bam-13787	68	16	<	<	X
bam-13787	68	17	0.001	0.001	NUM
bam-13787	68	18	)	)	PUNCT
bam-13787	68	19	.	.	PUNCT
bam-13787	69	1	in	in	ADP
bam-13787	69	2	contrast	contrast	NOUN
bam-13787	69	3	,	,	PUNCT
bam-13787	69	4	age	age	NOUN
bam-13787	69	5	and	and	CCONJ
bam-13787	69	6	gender	gender	NOUN
bam-13787	69	7	were	be	AUX
bam-13787	69	8	not	not	PART
bam-13787	69	9	significant	significant	ADJ
bam-13787	69	10	predictors	predictor	NOUN
bam-13787	69	11	(	(	PUNCT
bam-13787	69	12	p	p	X
bam-13787	69	13	>	>	X
bam-13787	69	14	0.05	0.05	NUM
bam-13787	69	15	)	)	PUNCT
bam-13787	69	16	.	.	PUNCT
bam-13787	70	1	avc	avc	PROPN
bam-13787	70	2	-	-	PUNCT
bam-13787	70	3	based	base	VERB
bam-13787	70	4	therapies	therapy	NOUN
bam-13787	70	5	(	(	PUNCT
bam-13787	70	6	groups	group	NOUN
bam-13787	70	7	4	4	NUM
bam-13787	70	8	and	and	CCONJ
bam-13787	70	9	5	5	NUM
bam-13787	70	10	)	)	PUNCT
bam-13787	70	11	consistently	consistently	ADV
bam-13787	70	12	outperformed	outperform	VERB
bam-13787	70	13	other	other	ADJ
bam-13787	70	14	treatments	treatment	NOUN
bam-13787	70	15	in	in	ADP
bam-13787	70	16	both	both	DET
bam-13787	70	17	efficacy	efficacy	NOUN
bam-13787	70	18	and	and	CCONJ
bam-13787	70	19	patient	patient	ADJ
bam-13787	70	20	3	3	NUM
bam-13787	70	21	table	table	NOUN
bam-13787	70	22	1	1	NUM
bam-13787	70	23	.	.	PUNCT
bam-13787	71	1	treatment	treatment	NOUN
bam-13787	71	2	outcomes	outcome	NOUN
bam-13787	71	3	by	by	ADP
bam-13787	71	4	group	group	NOUN
bam-13787	71	5	.	.	PUNCT
bam-13787	72	1	treatment	treatment	NOUN
bam-13787	72	2	group	group	NOUN
bam-13787	72	3	total	total	ADJ
bam-13787	72	4	participants	participant	NOUN
bam-13787	72	5	treated	treat	VERB
bam-13787	72	6	(	(	PUNCT
bam-13787	72	7	%	%	INTJ
bam-13787	72	8	)	)	PUNCT
bam-13787	72	9	untreated	untreated	ADJ
bam-13787	72	10	(	(	PUNCT
bam-13787	72	11	%	%	INTJ
bam-13787	72	12	)	)	PUNCT
bam-13787	72	13	group	group	NOUN
bam-13787	72	14	1	1	NUM
bam-13787	72	15	200	200	NUM
bam-13787	72	16	40	40	NUM
bam-13787	72	17	(	(	PUNCT
bam-13787	72	18	20	20	NUM
bam-13787	72	19	)	)	PUNCT
bam-13787	72	20	160	160	NUM
bam-13787	72	21	(	(	PUNCT
bam-13787	72	22	80	80	NUM
bam-13787	72	23	)	)	PUNCT
bam-13787	72	24	group	group	NOUN
bam-13787	72	25	2	2	NUM
bam-13787	72	26	200	200	NUM
bam-13787	72	27	52	52	NUM
bam-13787	72	28	(	(	PUNCT
bam-13787	72	29	26	26	NUM
bam-13787	72	30	)	)	SYM
bam-13787	72	31	148	148	NUM
bam-13787	72	32	(	(	PUNCT
bam-13787	72	33	74	74	NUM
bam-13787	72	34	)	)	PUNCT
bam-13787	72	35	group	group	NOUN
bam-13787	72	36	3	3	NUM
bam-13787	72	37	200	200	NUM
bam-13787	72	38	61	61	NUM
bam-13787	72	39	(	(	PUNCT
bam-13787	72	40	30.5	30.5	NUM
bam-13787	72	41	)	)	SYM
bam-13787	72	42	139	139	NUM
bam-13787	72	43	(	(	PUNCT
bam-13787	72	44	69.5	69.5	NUM
bam-13787	72	45	)	)	PUNCT
bam-13787	72	46	group	group	NOUN
bam-13787	72	47	4	4	NUM
bam-13787	72	48	200	200	NUM
bam-13787	72	49	87	87	NUM
bam-13787	72	50	(	(	PUNCT
bam-13787	72	51	43.5	43.5	NUM
bam-13787	72	52	)	)	PUNCT
bam-13787	72	53	113	113	NUM
bam-13787	72	54	(	(	PUNCT
bam-13787	72	55	56.5	56.5	NUM
bam-13787	72	56	)	)	PUNCT
bam-13787	72	57	group	group	NOUN
bam-13787	72	58	5	5	NUM
bam-13787	72	59	200	200	NUM
bam-13787	72	60	123	123	NUM
bam-13787	72	61	(	(	PUNCT
bam-13787	72	62	31.5	31.5	NUM
bam-13787	72	63	)	)	PUNCT
bam-13787	72	64	77	77	NUM
bam-13787	72	65	(	(	PUNCT
bam-13787	72	66	38.5	38.5	NUM
bam-13787	72	67	)	)	PUNCT
bam-13787	72	68	figure	figure	NOUN
bam-13787	72	69	1	1	NUM
bam-13787	72	70	.	.	PUNCT
bam-13787	72	71	proportion	proportion	NOUN
bam-13787	72	72	of	of	ADP
bam-13787	72	73	patients	patient	NOUN
bam-13787	72	74	achieving	achieve	VERB
bam-13787	72	75	positive	positive	ADJ
bam-13787	72	76	treatment	treatment	NOUN
bam-13787	72	77	outcomes	outcome	NOUN
bam-13787	72	78	across	across	ADP
bam-13787	72	79	groups	group	NOUN
bam-13787	72	80	.	.	PUNCT
bam-13787	73	1	figure	figure	VERB
bam-13787	73	2	2	2	NUM
bam-13787	73	3	.	.	PUNCT
bam-13787	74	1	distribution	distribution	NOUN
bam-13787	74	2	of	of	ADP
bam-13787	74	3	patient	patient	ADJ
bam-13787	74	4	satisfaction	satisfaction	NOUN
bam-13787	74	5	rates	rate	NOUN
bam-13787	74	6	by	by	ADP
bam-13787	74	7	treatment	treatment	NOUN
bam-13787	74	8	groups	group	NOUN
bam-13787	74	9	.	.	PUNCT
bam-13787	75	1	table	table	NOUN
bam-13787	75	2	2	2	NUM
bam-13787	75	3	.	.	PUNCT
bam-13787	75	4	patient	patient	ADJ
bam-13787	75	5	satisfaction	satisfaction	NOUN
bam-13787	75	6	rates	rate	NOUN
bam-13787	75	7	by	by	ADP
bam-13787	75	8	treatment	treatment	NOUN
bam-13787	75	9	groups	group	NOUN
bam-13787	75	10	.	.	PUNCT
bam-13787	76	1	treatment	treatment	NOUN
bam-13787	76	2	group	group	NOUN
bam-13787	76	3	mean	mean	VERB
bam-13787	76	4	sd	sd	ADP
bam-13787	76	5	satisfaction	satisfaction	NOUN
bam-13787	76	6	rate	rate	NOUN
bam-13787	76	7	group	group	NOUN
bam-13787	76	8	1	1	NUM
bam-13787	76	9	32.10	32.10	NUM
bam-13787	76	10	19.18	19.18	NUM
bam-13787	76	11	group	group	NOUN
bam-13787	76	12	2	2	NUM
bam-13787	76	13	32.81	32.81	NUM
bam-13787	76	14	20.27	20.27	NUM
bam-13787	76	15	group	group	NOUN
bam-13787	76	16	3	3	NUM
bam-13787	76	17	33.03	33.03	NUM
bam-13787	76	18	19.95	19.95	NUM
bam-13787	76	19	group	group	NOUN
bam-13787	76	20	4	4	NUM
bam-13787	76	21	32.81	32.81	NUM
bam-13787	76	22	19.45	19.45	NUM
bam-13787	76	23	group	group	NOUN
bam-13787	76	24	5	5	NUM
bam-13787	76	25	31.06	31.06	NUM
bam-13787	76	26	20.69	20.69	NUM
bam-13787	76	27	treatments	treatment	NOUN
bam-13787	76	28	for	for	ADP
bam-13787	76	29	vitiligo	vitiligo	NOUN
bam-13787	76	30	vs.	vs.	ADP
bam-13787	76	31	anti	anti	ADJ
bam-13787	76	32	-	-	ADJ
bam-13787	76	33	vitiligo	vitiligo	ADJ
bam-13787	76	34	cream	cream	NOUN
bam-13787	76	35	eur	eur	PROPN
bam-13787	76	36	j	j	PROPN
bam-13787	76	37	transl	transl	PROPN
bam-13787	76	38	myol	myol	ADV
bam-13787	76	39	35	35	NUM
bam-13787	76	40	(	(	PUNCT
bam-13787	76	41	4	4	NUM
bam-13787	76	42	)	)	PUNCT
bam-13787	76	43	13787	13787	NUM
bam-13787	76	44	,	,	PUNCT
bam-13787	76	45	2025	2025	NUM
bam-13787	76	46	doi	doi	NOUN
bam-13787	76	47	:	:	PUNCT
bam-13787	76	48	10.4081	10.4081	NUM
bam-13787	76	49	/	/	SYM
bam-13787	76	50	ejtm.2025.13787	ejtm.2025.13787	NOUN
bam-13787	76	51	satisfaction	satisfaction	NOUN
bam-13787	76	52	.	.	PUNCT
bam-13787	77	1	the	the	DET
bam-13787	77	2	combination	combination	NOUN
bam-13787	77	3	of	of	ADP
bam-13787	77	4	avc	avc	PROPN
bam-13787	77	5	with	with	ADP
bam-13787	77	6	tofacitinib	tofacitinib	PROPN
bam-13787	77	7	(	(	PUNCT
bam-13787	77	8	group	group	NOUN
bam-13787	77	9	5	5	NUM
bam-13787	77	10	)	)	PUNCT
bam-13787	77	11	achieved	achieve	VERB
bam-13787	77	12	the	the	DET
bam-13787	77	13	best	good	ADJ
bam-13787	77	14	overall	overall	ADJ
bam-13787	77	15	outcomes	outcome	NOUN
bam-13787	77	16	,	,	PUNCT
bam-13787	77	17	as	as	SCONJ
bam-13787	77	18	evidenced	evidence	VERB
bam-13787	77	19	by	by	ADP
bam-13787	77	20	higher	high	ADJ
bam-13787	77	21	satisfaction	satisfaction	NOUN
bam-13787	77	22	scores	score	NOUN
bam-13787	77	23	and	and	CCONJ
bam-13787	77	24	greater	great	ADJ
bam-13787	77	25	treatment	treatment	NOUN
bam-13787	77	26	efficacy	efficacy	NOUN
bam-13787	77	27	compared	compare	VERB
bam-13787	77	28	to	to	ADP
bam-13787	77	29	other	other	ADJ
bam-13787	77	30	groups	group	NOUN
bam-13787	77	31	(	(	PUNCT
bam-13787	77	32	p	p	X
bam-13787	77	33	<	<	X
bam-13787	77	34	0.001	0.001	NUM
bam-13787	77	35	)	)	PUNCT
bam-13787	77	36	.	.	PUNCT
bam-13787	78	1	in	in	ADP
bam-13787	78	2	summary	summary	NOUN
bam-13787	78	3	,	,	PUNCT
bam-13787	78	4	the	the	DET
bam-13787	78	5	findings	finding	NOUN
bam-13787	78	6	demonstrate	demonstrate	VERB
bam-13787	78	7	that	that	SCONJ
bam-13787	78	8	avc	avc	PROPN
bam-13787	78	9	combined	combine	VERB
bam-13787	78	10	with	with	ADP
bam-13787	78	11	tofacitinib	tofacitinib	PROPN
bam-13787	78	12	is	be	AUX
bam-13787	78	13	the	the	DET
bam-13787	78	14	most	most	ADV
bam-13787	78	15	effective	effective	ADJ
bam-13787	78	16	and	and	CCONJ
bam-13787	78	17	patient	patient	NOUN
bam-13787	78	18	-	-	PUNCT
bam-13787	78	19	preferred	prefer	VERB
bam-13787	78	20	therapy	therapy	NOUN
bam-13787	78	21	for	for	ADP
bam-13787	78	22	vitiligo	vitiligo	NOUN
bam-13787	78	23	.	.	PUNCT
bam-13787	79	1	the	the	DET
bam-13787	79	2	results	result	NOUN
bam-13787	79	3	suggest	suggest	VERB
bam-13787	79	4	the	the	DET
bam-13787	79	5	potential	potential	NOUN
bam-13787	79	6	for	for	ADP
bam-13787	79	7	avc	avc	PROPN
bam-13787	79	8	-	-	PUNCT
bam-13787	79	9	based	base	VERB
bam-13787	79	10	therapies	therapy	NOUN
bam-13787	79	11	to	to	PART
bam-13787	79	12	revolutionize	revolutionize	VERB
bam-13787	79	13	treatment	treatment	NOUN
bam-13787	79	14	strategies	strategy	NOUN
bam-13787	79	15	for	for	ADP
bam-13787	79	16	this	this	DET
bam-13787	79	17	condition	condition	NOUN
bam-13787	79	18	,	,	PUNCT
bam-13787	79	19	particularly	particularly	ADV
bam-13787	79	20	when	when	SCONJ
bam-13787	79	21	combined	combine	VERB
bam-13787	79	22	with	with	ADP
bam-13787	79	23	immunomodulators	immunomodulator	NOUN
bam-13787	79	24	like	like	ADP
bam-13787	79	25	tofacitinib	tofacitinib	NOUN
bam-13787	79	26	.	.	PUNCT
bam-13787	80	1	discussion	discussion	NOUN
bam-13787	80	2	the	the	DET
bam-13787	80	3	findings	finding	NOUN
bam-13787	80	4	of	of	ADP
bam-13787	80	5	this	this	DET
bam-13787	80	6	study	study	NOUN
bam-13787	80	7	provide	provide	VERB
bam-13787	80	8	valuable	valuable	ADJ
bam-13787	80	9	insights	insight	NOUN
bam-13787	80	10	into	into	ADP
bam-13787	80	11	the	the	DET
bam-13787	80	12	advancing	advance	VERB
bam-13787	80	13	landscape	landscape	NOUN
bam-13787	80	14	of	of	ADP
bam-13787	80	15	vitiligo	vitiligo	ADJ
bam-13787	80	16	treatment	treatment	NOUN
bam-13787	80	17	.	.	PUNCT
bam-13787	81	1	among	among	ADP
bam-13787	81	2	the	the	DET
bam-13787	81	3	therapies	therapy	NOUN
bam-13787	81	4	evaluated	evaluate	VERB
bam-13787	81	5	,	,	PUNCT
bam-13787	81	6	the	the	DET
bam-13787	81	7	novel	novel	ADJ
bam-13787	81	8	avc	avc	NOUN
bam-13787	81	9	-	-	PUNCT
bam-13787	81	10	based	base	VERB
bam-13787	81	11	treatment	treatment	NOUN
bam-13787	81	12	created	create	VERB
bam-13787	81	13	by	by	ADP
bam-13787	81	14	dr	dr	PROPN
bam-13787	81	15	.	.	PROPN
bam-13787	81	16	shirzad	shirzad	PROPN
bam-13787	81	17	,	,	PUNCT
bam-13787	81	18	particularly	particularly	ADV
bam-13787	81	19	when	when	SCONJ
bam-13787	81	20	combined	combine	VERB
bam-13787	81	21	with	with	ADP
bam-13787	81	22	tofacitinib	tofacitinib	NOUN
bam-13787	81	23	(	(	PUNCT
bam-13787	81	24	group	group	NOUN
bam-13787	81	25	5	5	NUM
bam-13787	81	26	)	)	PUNCT
bam-13787	81	27	,	,	PUNCT
bam-13787	81	28	demonstrated	demonstrate	VERB
bam-13787	81	29	superior	superior	ADJ
bam-13787	81	30	outcomes	outcome	NOUN
bam-13787	81	31	in	in	ADP
bam-13787	81	32	both	both	PRON
bam-13787	81	33	treatment	treatment	NOUN
bam-13787	81	34	efficacy	efficacy	NOUN
bam-13787	81	35	and	and	CCONJ
bam-13787	81	36	patient	patient	ADJ
bam-13787	81	37	satisfaction	satisfaction	NOUN
bam-13787	81	38	.	.	PUNCT
bam-13787	82	1	this	this	PRON
bam-13787	82	2	underscores	underscore	VERB
bam-13787	82	3	the	the	DET
bam-13787	82	4	potential	potential	NOUN
bam-13787	82	5	of	of	ADP
bam-13787	82	6	combination	combination	NOUN
bam-13787	82	7	therapies	therapy	NOUN
bam-13787	82	8	to	to	PART
bam-13787	82	9	address	address	VERB
bam-13787	82	10	the	the	DET
bam-13787	82	11	multifactorial	multifactorial	ADJ
bam-13787	82	12	nature	nature	NOUN
bam-13787	82	13	of	of	ADP
bam-13787	82	14	vitiligo	vitiligo	NOUN
bam-13787	82	15	,	,	PUNCT
bam-13787	82	16	integrating	integrate	VERB
bam-13787	82	17	both	both	CCONJ
bam-13787	82	18	melanocyte	melanocyte	ADJ
bam-13787	82	19	stimulation	stimulation	NOUN
bam-13787	82	20	and	and	CCONJ
bam-13787	82	21	immune	immune	ADJ
bam-13787	82	22	regulation	regulation	NOUN
bam-13787	82	23	.	.	PUNCT
bam-13787	83	1	patient	patient	ADJ
bam-13787	83	2	satisfaction	satisfaction	NOUN
bam-13787	83	3	emerged	emerge	VERB
bam-13787	83	4	as	as	ADP
bam-13787	83	5	a	a	DET
bam-13787	83	6	critical	critical	ADJ
bam-13787	83	7	metric	metric	NOUN
bam-13787	83	8	in	in	ADP
bam-13787	83	9	this	this	DET
bam-13787	83	10	study	study	NOUN
bam-13787	83	11	,	,	PUNCT
bam-13787	83	12	highlighting	highlight	VERB
bam-13787	83	13	the	the	DET
bam-13787	83	14	psychological	psychological	ADJ
bam-13787	83	15	and	and	CCONJ
bam-13787	83	16	emotional	emotional	ADJ
bam-13787	83	17	dimensions	dimension	NOUN
bam-13787	83	18	of	of	ADP
bam-13787	83	19	vitiligo	vitiligo	ADJ
bam-13787	83	20	management	management	NOUN
bam-13787	83	21	.	.	PUNCT
bam-13787	84	1	groups	group	NOUN
bam-13787	84	2	4	4	NUM
bam-13787	84	3	and	and	CCONJ
bam-13787	84	4	5	5	NUM
bam-13787	84	5	consistently	consistently	ADV
bam-13787	84	6	achieved	achieve	VERB
bam-13787	84	7	higher	high	ADJ
bam-13787	84	8	satisfaction	satisfaction	NOUN
bam-13787	84	9	scores	score	NOUN
bam-13787	84	10	,	,	PUNCT
bam-13787	84	11	reflecting	reflect	VERB
bam-13787	84	12	the	the	DET
bam-13787	84	13	effectiveness	effectiveness	NOUN
bam-13787	84	14	and	and	CCONJ
bam-13787	84	15	acceptability	acceptability	NOUN
bam-13787	84	16	of	of	ADP
bam-13787	84	17	avc	avc	PROPN
bam-13787	84	18	-	-	PUNCT
bam-13787	84	19	based	base	VERB
bam-13787	84	20	therapies	therapy	NOUN
bam-13787	84	21	.	.	PUNCT
bam-13787	85	1	the	the	DET
bam-13787	85	2	narrower	narrow	ADJ
bam-13787	85	3	interquartile	interquartile	NOUN
bam-13787	85	4	ranges	range	VERB
bam-13787	85	5	in	in	ADP
bam-13787	85	6	these	these	DET
bam-13787	85	7	groups	group	NOUN
bam-13787	85	8	suggest	suggest	VERB
bam-13787	85	9	a	a	DET
bam-13787	85	10	more	more	ADV
bam-13787	85	11	uniform	uniform	ADJ
bam-13787	85	12	response	response	NOUN
bam-13787	85	13	among	among	ADP
bam-13787	85	14	patients	patient	NOUN
bam-13787	85	15	,	,	PUNCT
bam-13787	85	16	in	in	ADP
bam-13787	85	17	contrast	contrast	NOUN
bam-13787	85	18	to	to	ADP
bam-13787	85	19	the	the	DET
bam-13787	85	20	variability	variability	NOUN
bam-13787	85	21	observed	observe	VERB
bam-13787	85	22	in	in	ADP
bam-13787	85	23	group	group	NOUN
bam-13787	85	24	1	1	NUM
bam-13787	85	25	,	,	PUNCT
bam-13787	85	26	which	which	PRON
bam-13787	85	27	relied	rely	VERB
bam-13787	85	28	solely	solely	ADV
bam-13787	85	29	on	on	ADP
bam-13787	85	30	oral	oral	ADJ
bam-13787	85	31	prednisolone	prednisolone	PROPN
bam-13787	85	32	.	.	PUNCT
bam-13787	86	1	these	these	DET
bam-13787	86	2	findings	finding	NOUN
bam-13787	86	3	align	align	VERB
bam-13787	86	4	with	with	ADP
bam-13787	86	5	previous	previous	ADJ
bam-13787	86	6	4	4	NUM
bam-13787	86	7	table	table	NOUN
bam-13787	86	8	3	3	NUM
bam-13787	86	9	.	.	PUNCT
bam-13787	87	1	relationships	relationship	NOUN
bam-13787	87	2	between	between	ADP
bam-13787	87	3	age	age	NOUN
bam-13787	87	4	,	,	PUNCT
bam-13787	87	5	patient	patient	ADJ
bam-13787	87	6	satisfaction	satisfaction	NOUN
bam-13787	87	7	,	,	PUNCT
bam-13787	87	8	and	and	CCONJ
bam-13787	87	9	treatment	treatment	NOUN
bam-13787	87	10	outcomes	outcome	NOUN
bam-13787	87	11	.	.	PUNCT
bam-13787	88	1	variables	variable	NOUN
bam-13787	88	2	age	age	NOUN
bam-13787	88	3	satisfaction	satisfaction	NOUN
bam-13787	88	4	outcomes	outcome	NOUN
bam-13787	88	5	age	age	NOUN
bam-13787	88	6	1.000	1.000	NUM
bam-13787	88	7	-0.087	-0.087	PUNCT
bam-13787	88	8	-0.101	-0.101	PUNCT
bam-13787	88	9	satisfaction	satisfaction	NOUN
bam-13787	88	10	not	not	PART
bam-13787	88	11	applicable	applicable	ADJ
bam-13787	88	12	1.000	1.000	NUM
bam-13787	88	13	0.907	0.907	NUM
bam-13787	88	14	outcome	outcome	NOUN
bam-13787	88	15	not	not	PART
bam-13787	88	16	applicable	applicable	ADJ
bam-13787	88	17	not	not	PART
bam-13787	88	18	applicable	applicable	ADJ
bam-13787	88	19	1.000	1.000	NUM
bam-13787	88	20	figure	figure	NOUN
bam-13787	88	21	3	3	NUM
bam-13787	88	22	.	.	X
bam-13787	88	23	relationship	relationship	NOUN
bam-13787	88	24	between	between	ADP
bam-13787	88	25	patient	patient	ADJ
bam-13787	88	26	satisfaction	satisfaction	NOUN
bam-13787	88	27	and	and	CCONJ
bam-13787	88	28	age	age	NOUN
bam-13787	88	29	across	across	ADP
bam-13787	88	30	treatment	treatment	NOUN
bam-13787	88	31	groups	group	NOUN
bam-13787	88	32	.	.	PUNCT
bam-13787	89	1	table	table	NOUN
bam-13787	89	2	4	4	NUM
bam-13787	89	3	.	.	PUNCT
bam-13787	89	4	predictors	predictor	NOUN
bam-13787	89	5	of	of	ADP
bam-13787	89	6	patient	patient	ADJ
bam-13787	89	7	satisfaction	satisfaction	NOUN
bam-13787	89	8	across	across	ADP
bam-13787	89	9	treatment	treatment	NOUN
bam-13787	89	10	groups	group	NOUN
bam-13787	89	11	.	.	PUNCT
bam-13787	90	1	predictor	predictor	PROPN
bam-13787	90	2	coefficient	coefficient	PROPN
bam-13787	90	3	se	se	PROPN
bam-13787	91	1	p	p	ADJ
bam-13787	91	2	-	-	PUNCT
bam-13787	91	3	value	value	NOUN
bam-13787	91	4	age	age	NOUN
bam-13787	91	5	-0.01	-0.01	NUM
bam-13787	91	6	0.03	0.03	NUM
bam-13787	91	7	0.748	0.748	NUM
bam-13787	91	8	gender	gender	NOUN
bam-13787	91	9	(	(	PUNCT
bam-13787	91	10	female	female	NOUN
bam-13787	91	11	)	)	PUNCT
bam-13787	91	12	-0.92	-0.92	ADP
bam-13787	91	13	0.98	0.98	NUM
bam-13787	91	14	0.350	0.350	NUM
bam-13787	91	15	gender	gender	NOUN
bam-13787	91	16	(	(	PUNCT
bam-13787	91	17	child	child	NOUN
bam-13787	91	18	)	)	PUNCT
bam-13787	91	19	-0.37	-0.37	NUM
bam-13787	91	20	1.43	1.43	NUM
bam-13787	91	21	0.794	0.794	NUM
bam-13787	91	22	group	group	NOUN
bam-13787	91	23	2	2	NUM
bam-13787	91	24	3.44	3.44	NUM
bam-13787	91	25	1.22	1.22	NUM
bam-13787	91	26	0.005	0.005	NUM
bam-13787	91	27	group	group	NOUN
bam-13787	91	28	3	3	NUM
bam-13787	91	29	9.40	9.40	NUM
bam-13787	91	30	1.23	1.23	NUM
bam-13787	91	31	<	<	NOUN
bam-13787	91	32	0.0001	0.0001	NUM
bam-13787	91	33	group	group	NOUN
bam-13787	91	34	4	4	NUM
bam-13787	91	35	13.22	13.22	NUM
bam-13787	91	36	1.24	1.24	NUM
bam-13787	91	37	<	<	NOUN
bam-13787	91	38	0.0001	0.0001	NUM
bam-13787	91	39	group	group	NOUN
bam-13787	91	40	5	5	NUM
bam-13787	91	41	17.18	17.18	NUM
bam-13787	91	42	1.27	1.27	NUM
bam-13787	91	43	<	<	NOUN
bam-13787	91	44	0.0001	0.0001	NUM
bam-13787	91	45	outcome	outcome	NOUN
bam-13787	91	46	(	(	PUNCT
bam-13787	91	47	treated	treat	VERB
bam-13787	91	48	)	)	PUNCT
bam-13787	91	49	57.30	57.30	NUM
bam-13787	91	50	0.86	0.86	NUM
bam-13787	91	51	<	<	NOUN
bam-13787	91	52	0.0001	0.0001	NUM
bam-13787	91	53	treatments	treatment	NOUN
bam-13787	91	54	for	for	ADP
bam-13787	91	55	vitiligo	vitiligo	NOUN
bam-13787	91	56	vs.	vs.	ADP
bam-13787	91	57	anti	anti	ADJ
bam-13787	91	58	-	-	ADJ
bam-13787	91	59	vitiligo	vitiligo	ADJ
bam-13787	91	60	cream	cream	NOUN
bam-13787	91	61	eur	eur	PROPN
bam-13787	91	62	j	j	PROPN
bam-13787	91	63	transl	transl	PROPN
bam-13787	91	64	myol	myol	ADV
bam-13787	91	65	35	35	NUM
bam-13787	91	66	(	(	PUNCT
bam-13787	91	67	4	4	NUM
bam-13787	91	68	)	)	PUNCT
bam-13787	91	69	13787	13787	NUM
bam-13787	91	70	,	,	PUNCT
bam-13787	91	71	2025	2025	NUM
bam-13787	91	72	doi	doi	NOUN
bam-13787	91	73	:	:	PUNCT
bam-13787	91	74	10.4081	10.4081	NUM
bam-13787	91	75	/	/	SYM
bam-13787	91	76	ejtm.2025.13787	ejtm.2025.13787	NOUN
bam-13787	91	77	research	research	NOUN
bam-13787	91	78	suggesting	suggest	VERB
bam-13787	91	79	that	that	SCONJ
bam-13787	91	80	targeted	target	VERB
bam-13787	91	81	therapies	therapy	NOUN
bam-13787	91	82	are	be	AUX
bam-13787	91	83	better	well	ADV
bam-13787	91	84	suited	suited	ADJ
bam-13787	91	85	to	to	ADP
bam-13787	91	86	managing	manage	VERB
bam-13787	91	87	refractory	refractory	NOUN
bam-13787	91	88	or	or	CCONJ
bam-13787	91	89	progressive	progressive	ADJ
bam-13787	91	90	vitiligo	vitiligo	NOUN
bam-13787	91	91	lesions.30,31	lesions.30,31	NOUN
bam-13787	91	92	the	the	DET
bam-13787	91	93	regression	regression	NOUN
bam-13787	91	94	analysis	analysis	NOUN
bam-13787	91	95	further	far	ADV
bam-13787	91	96	highlighted	highlight	VERB
bam-13787	91	97	the	the	DET
bam-13787	91	98	significance	significance	NOUN
bam-13787	91	99	of	of	ADP
bam-13787	91	100	treatment	treatment	NOUN
bam-13787	91	101	group	group	NOUN
bam-13787	91	102	and	and	CCONJ
bam-13787	91	103	outcome	outcome	NOUN
bam-13787	91	104	as	as	ADP
bam-13787	91	105	predictors	predictor	NOUN
bam-13787	91	106	of	of	ADP
bam-13787	91	107	patient	patient	ADJ
bam-13787	91	108	satisfaction	satisfaction	NOUN
bam-13787	91	109	,	,	PUNCT
bam-13787	91	110	with	with	ADP
bam-13787	91	111	age	age	NOUN
bam-13787	91	112	and	and	CCONJ
bam-13787	91	113	gender	gender	NOUN
bam-13787	91	114	showing	show	VERB
bam-13787	91	115	no	no	DET
bam-13787	91	116	substantial	substantial	ADJ
bam-13787	91	117	influence	influence	NOUN
bam-13787	91	118	.	.	PUNCT
bam-13787	92	1	this	this	DET
bam-13787	92	2	finding	finding	NOUN
bam-13787	92	3	reinforces	reinforce	VERB
bam-13787	92	4	the	the	DET
bam-13787	92	5	importance	importance	NOUN
bam-13787	92	6	of	of	ADP
bam-13787	92	7	treatment	treatment	NOUN
bam-13787	92	8	efficacy	efficacy	NOUN
bam-13787	92	9	over	over	ADP
bam-13787	92	10	demographic	demographic	ADJ
bam-13787	92	11	factors	factor	NOUN
bam-13787	92	12	in	in	ADP
bam-13787	92	13	determining	determine	VERB
bam-13787	92	14	patientperceived	patientperceived	ADJ
bam-13787	92	15	success	success	NOUN
bam-13787	92	16	.	.	PUNCT
bam-13787	93	1	the	the	DET
bam-13787	93	2	strong	strong	ADJ
bam-13787	93	3	predictive	predictive	ADJ
bam-13787	93	4	value	value	NOUN
bam-13787	93	5	of	of	ADP
bam-13787	93	6	positive	positive	ADJ
bam-13787	93	7	treatment	treatment	NOUN
bam-13787	93	8	outcomes	outcome	NOUN
bam-13787	93	9	on	on	ADP
bam-13787	93	10	satisfaction	satisfaction	NOUN
bam-13787	93	11	(	(	PUNCT
bam-13787	93	12	coefficient=57.30	coefficient=57.30	INTJ
bam-13787	93	13	,	,	PUNCT
bam-13787	93	14	p	p	X
bam-13787	93	15	<	<	NOUN
bam-13787	93	16	0.001	0.001	NUM
bam-13787	93	17	)	)	PUNCT
bam-13787	93	18	highlights	highlight	NOUN
bam-13787	93	19	the	the	DET
bam-13787	93	20	importance	importance	NOUN
bam-13787	93	21	of	of	ADP
bam-13787	93	22	developing	develop	VERB
bam-13787	93	23	therapies	therapy	NOUN
bam-13787	93	24	that	that	PRON
bam-13787	93	25	effectively	effectively	ADV
bam-13787	93	26	address	address	VERB
bam-13787	93	27	both	both	DET
bam-13787	93	28	clinical	clinical	ADJ
bam-13787	93	29	outcomes	outcome	NOUN
bam-13787	93	30	.	.	PUNCT
bam-13787	94	1	interestingly	interestingly	ADV
bam-13787	94	2	,	,	PUNCT
bam-13787	94	3	younger	young	ADJ
bam-13787	94	4	patients	patient	NOUN
bam-13787	94	5	tended	tend	VERB
bam-13787	94	6	to	to	PART
bam-13787	94	7	report	report	VERB
bam-13787	94	8	higher	high	ADJ
bam-13787	94	9	satisfaction	satisfaction	NOUN
bam-13787	94	10	scores	score	NOUN
bam-13787	94	11	across	across	ADP
bam-13787	94	12	all	all	DET
bam-13787	94	13	treatment	treatment	NOUN
bam-13787	94	14	groups	group	NOUN
bam-13787	94	15	,	,	PUNCT
bam-13787	94	16	with	with	ADP
bam-13787	94	17	this	this	DET
bam-13787	94	18	trend	trend	NOUN
bam-13787	94	19	being	be	AUX
bam-13787	94	20	most	most	ADV
bam-13787	94	21	prominent	prominent	ADJ
bam-13787	94	22	in	in	ADP
bam-13787	94	23	groups	group	NOUN
bam-13787	94	24	4	4	NUM
bam-13787	94	25	and	and	CCONJ
bam-13787	94	26	5	5	NUM
bam-13787	94	27	.	.	PUNCT
bam-13787	95	1	this	this	PRON
bam-13787	95	2	may	may	AUX
bam-13787	95	3	be	be	AUX
bam-13787	95	4	attributed	attribute	VERB
bam-13787	95	5	to	to	ADP
bam-13787	95	6	the	the	DET
bam-13787	95	7	faster	fast	ADV
bam-13787	95	8	visible	visible	ADJ
bam-13787	95	9	results	result	NOUN
bam-13787	95	10	in	in	ADP
bam-13787	95	11	younger	young	ADJ
bam-13787	95	12	skin	skin	NOUN
bam-13787	95	13	or	or	CCONJ
bam-13787	95	14	differing	differ	VERB
bam-13787	95	15	expectations	expectation	NOUN
bam-13787	95	16	between	between	ADP
bam-13787	95	17	age	age	NOUN
bam-13787	95	18	groups	group	NOUN
bam-13787	95	19	.	.	PUNCT
bam-13787	96	1	the	the	DET
bam-13787	96	2	areas	area	NOUN
bam-13787	96	3	of	of	ADP
bam-13787	96	4	the	the	DET
bam-13787	96	5	body	body	NOUN
bam-13787	96	6	that	that	PRON
bam-13787	96	7	responded	respond	VERB
bam-13787	96	8	most	most	ADV
bam-13787	96	9	rapidly	rapidly	ADV
bam-13787	96	10	to	to	ADP
bam-13787	96	11	treatment	treatment	NOUN
bam-13787	96	12	were	be	AUX
bam-13787	96	13	the	the	DET
bam-13787	96	14	face	face	NOUN
bam-13787	96	15	,	,	PUNCT
bam-13787	96	16	genitalia	genitalia	NOUN
bam-13787	96	17	,	,	PUNCT
bam-13787	96	18	and	and	CCONJ
bam-13787	96	19	axillary	axillary	ADJ
bam-13787	96	20	regions	region	NOUN
bam-13787	96	21	.	.	PUNCT
bam-13787	97	1	conversely	conversely	ADV
bam-13787	97	2	,	,	PUNCT
bam-13787	97	3	the	the	DET
bam-13787	97	4	hands	hand	NOUN
bam-13787	97	5	,	,	PUNCT
bam-13787	97	6	feet	foot	NOUN
bam-13787	97	7	,	,	PUNCT
bam-13787	97	8	and	and	CCONJ
bam-13787	97	9	body	body	NOUN
bam-13787	97	10	segmental	segmental	ADJ
bam-13787	97	11	vitiligo	vitiligo	PROPN
bam-13787	97	12	exhibited	exhibit	VERB
bam-13787	97	13	the	the	DET
bam-13787	97	14	weakest	weak	ADJ
bam-13787	97	15	response	response	NOUN
bam-13787	97	16	to	to	ADP
bam-13787	97	17	treatment	treatment	NOUN
bam-13787	97	18	.	.	PUNCT
bam-13787	98	1	future	future	ADJ
bam-13787	98	2	studies	study	NOUN
bam-13787	98	3	should	should	AUX
bam-13787	98	4	explore	explore	VERB
bam-13787	98	5	these	these	DET
bam-13787	98	6	age	age	NOUN
bam-13787	98	7	-	-	PUNCT
bam-13787	98	8	related	relate	VERB
bam-13787	98	9	and	and	CCONJ
bam-13787	98	10	body	body	NOUN
bam-13787	98	11	-	-	PUNCT
bam-13787	98	12	region	region	NOUN
bam-13787	98	13	differences	difference	NOUN
bam-13787	98	14	to	to	PART
bam-13787	98	15	optimize	optimize	VERB
bam-13787	98	16	patient	patient	ADJ
bam-13787	98	17	counseling	counseling	NOUN
bam-13787	98	18	and	and	CCONJ
bam-13787	98	19	treatment	treatment	NOUN
bam-13787	98	20	strategies	strategy	NOUN
bam-13787	98	21	.	.	PUNCT
bam-13787	99	1	despite	despite	SCONJ
bam-13787	99	2	the	the	DET
bam-13787	99	3	promising	promising	ADJ
bam-13787	99	4	results	result	NOUN
bam-13787	99	5	,	,	PUNCT
bam-13787	99	6	this	this	DET
bam-13787	99	7	study	study	NOUN
bam-13787	99	8	has	have	VERB
bam-13787	99	9	limitations	limitation	NOUN
bam-13787	99	10	.	.	PUNCT
bam-13787	100	1	the	the	DET
bam-13787	100	2	exclusion	exclusion	NOUN
bam-13787	100	3	of	of	ADP
bam-13787	100	4	patients	patient	NOUN
bam-13787	100	5	with	with	ADP
bam-13787	100	6	comorbid	comorbid	ADJ
bam-13787	100	7	autoimmune	autoimmune	ADJ
bam-13787	100	8	disorders	disorder	NOUN
bam-13787	100	9	may	may	AUX
bam-13787	100	10	limit	limit	VERB
bam-13787	100	11	the	the	DET
bam-13787	100	12	generalizability	generalizability	NOUN
bam-13787	100	13	of	of	ADP
bam-13787	100	14	the	the	DET
bam-13787	100	15	findings	finding	NOUN
bam-13787	100	16	to	to	ADP
bam-13787	100	17	broader	broad	ADJ
bam-13787	100	18	populations	population	NOUN
bam-13787	100	19	.	.	PUNCT
bam-13787	101	1	additionally	additionally	ADV
bam-13787	101	2	,	,	PUNCT
bam-13787	101	3	while	while	SCONJ
bam-13787	101	4	the	the	DET
bam-13787	101	5	two	two	NUM
bam-13787	101	6	-	-	PUNCT
bam-13787	101	7	year	year	NOUN
bam-13787	101	8	follow	follow	NOUN
bam-13787	101	9	-	-	PUNCT
bam-13787	101	10	up	up	NOUN
bam-13787	101	11	period	period	NOUN
bam-13787	101	12	provided	provide	VERB
bam-13787	101	13	significant	significant	ADJ
bam-13787	101	14	insights	insight	NOUN
bam-13787	101	15	into	into	ADP
bam-13787	101	16	treatment	treatment	NOUN
bam-13787	101	17	efficacy	efficacy	NOUN
bam-13787	101	18	and	and	CCONJ
bam-13787	101	19	satisfaction	satisfaction	NOUN
bam-13787	101	20	,	,	PUNCT
bam-13787	101	21	longer	long	ADJ
bam-13787	101	22	-	-	PUNCT
bam-13787	101	23	term	term	NOUN
bam-13787	101	24	studies	study	NOUN
bam-13787	101	25	are	be	AUX
bam-13787	101	26	needed	need	VERB
bam-13787	101	27	to	to	PART
bam-13787	101	28	assess	assess	VERB
bam-13787	101	29	the	the	DET
bam-13787	101	30	durability	durability	NOUN
bam-13787	101	31	of	of	ADP
bam-13787	101	32	these	these	DET
bam-13787	101	33	outcomes	outcome	NOUN
bam-13787	101	34	and	and	CCONJ
bam-13787	101	35	potential	potential	ADJ
bam-13787	101	36	long	long	ADJ
bam-13787	101	37	-	-	PUNCT
bam-13787	101	38	term	term	NOUN
bam-13787	101	39	side	side	NOUN
bam-13787	101	40	effects	effect	NOUN
bam-13787	101	41	.	.	PUNCT
bam-13787	102	1	in	in	ADP
bam-13787	102	2	conclusion	conclusion	NOUN
bam-13787	102	3	,	,	PUNCT
bam-13787	102	4	this	this	DET
bam-13787	102	5	study	study	NOUN
bam-13787	102	6	demonstrates	demonstrate	VERB
bam-13787	102	7	the	the	DET
bam-13787	102	8	revolutionary	revolutionary	ADJ
bam-13787	102	9	potential	potential	NOUN
bam-13787	102	10	of	of	ADP
bam-13787	102	11	avc	avc	PROPN
bam-13787	102	12	-	-	PUNCT
bam-13787	102	13	based	base	VERB
bam-13787	102	14	therapies	therapy	NOUN
bam-13787	102	15	,	,	PUNCT
bam-13787	102	16	particularly	particularly	ADV
bam-13787	102	17	when	when	SCONJ
bam-13787	102	18	combined	combine	VERB
bam-13787	102	19	with	with	ADP
bam-13787	102	20	tofacitinib	tofacitinib	NOUN
bam-13787	102	21	,	,	PUNCT
bam-13787	102	22	in	in	ADP
bam-13787	102	23	the	the	DET
bam-13787	102	24	management	management	NOUN
bam-13787	102	25	of	of	ADP
bam-13787	102	26	vitiligo	vitiligo	NOUN
bam-13787	102	27	.	.	PUNCT
bam-13787	103	1	these	these	DET
bam-13787	103	2	findings	finding	NOUN
bam-13787	103	3	pave	pave	VERB
bam-13787	103	4	the	the	DET
bam-13787	103	5	way	way	NOUN
bam-13787	103	6	for	for	ADP
bam-13787	103	7	more	more	ADV
bam-13787	103	8	personalized	personalized	ADJ
bam-13787	103	9	and	and	CCONJ
bam-13787	103	10	effective	effective	ADJ
bam-13787	103	11	treatment	treatment	NOUN
bam-13787	103	12	approaches	approach	NOUN
bam-13787	103	13	,	,	PUNCT
bam-13787	103	14	addressing	address	VERB
bam-13787	103	15	both	both	CCONJ
bam-13787	103	16	the	the	DET
bam-13787	103	17	clinical	clinical	ADJ
bam-13787	103	18	and	and	CCONJ
bam-13787	103	19	emotional	emotional	ADJ
bam-13787	103	20	challenges	challenge	NOUN
bam-13787	103	21	faced	face	VERB
bam-13787	103	22	by	by	ADP
bam-13787	103	23	patients	patient	NOUN
bam-13787	103	24	with	with	ADP
bam-13787	103	25	vitiligo	vitiligo	PROPN
bam-13787	103	26	.	.	PUNCT
bam-13787	104	1	future	future	ADJ
bam-13787	104	2	research	research	NOUN
bam-13787	104	3	should	should	AUX
bam-13787	104	4	aim	aim	VERB
bam-13787	104	5	to	to	PART
bam-13787	104	6	expand	expand	VERB
bam-13787	104	7	on	on	ADP
bam-13787	104	8	these	these	DET
bam-13787	104	9	results	result	NOUN
bam-13787	104	10	,	,	PUNCT
bam-13787	104	11	exploring	explore	VERB
bam-13787	104	12	the	the	DET
bam-13787	104	13	integration	integration	NOUN
bam-13787	104	14	of	of	ADP
bam-13787	104	15	novel	novel	ADJ
bam-13787	104	16	therapies	therapy	NOUN
bam-13787	104	17	into	into	ADP
bam-13787	104	18	standard	standard	ADJ
bam-13787	104	19	treatment	treatment	NOUN
bam-13787	104	20	protocols	protocol	NOUN
bam-13787	104	21	and	and	CCONJ
bam-13787	104	22	evaluating	evaluate	VERB
bam-13787	104	23	their	their	PRON
bam-13787	104	24	long	long	ADJ
bam-13787	104	25	-	-	PUNCT
bam-13787	104	26	term	term	NOUN
bam-13787	104	27	impact	impact	NOUN
bam-13787	104	28	on	on	ADP
bam-13787	104	29	patient	patient	ADJ
bam-13787	104	30	quality	quality	NOUN
bam-13787	104	31	of	of	ADP
bam-13787	104	32	life	life	NOUN
bam-13787	104	33	.	.	PUNCT
bam-13787	105	1	list	list	NOUN
bam-13787	105	2	of	of	ADP
bam-13787	105	3	abbreviations	abbreviations	PROPN
bam-13787	105	4	avc	avc	PROPN
bam-13787	105	5	,	,	PUNCT
bam-13787	105	6	anti	anti	ADJ
bam-13787	105	7	-	-	ADJ
bam-13787	105	8	vitiligo	vitiligo	ADJ
bam-13787	105	9	cream	cream	NOUN
bam-13787	105	10	vasi	vasi	PROPN
bam-13787	105	11	,	,	PUNCT
bam-13787	105	12	vitiligo	vitiligo	NOUN
bam-13787	105	13	area	area	NOUN
bam-13787	105	14	scoring	score	VERB
bam-13787	105	15	index	index	NOUN
bam-13787	105	16	jak	jak	PROPN
bam-13787	105	17	,	,	PUNCT
bam-13787	105	18	janus	janus	PROPN
bam-13787	105	19	kinase	kinase	PROPN
bam-13787	105	20	anova	anova	PROPN
bam-13787	105	21	,	,	PUNCT
bam-13787	105	22	analysis	analysis	NOUN
bam-13787	105	23	of	of	ADP
bam-13787	105	24	variance	variance	NOUN
bam-13787	105	25	iqr	iqr	PROPN
bam-13787	105	26	,	,	PUNCT
bam-13787	105	27	interquartile	interquartile	ADJ
bam-13787	105	28	range	range	NOUN
bam-13787	105	29	calculator	calculator	NOUN
bam-13787	105	30	informed	inform	VERB
bam-13787	105	31	consent	consent	NOUN
bam-13787	105	32	all	all	DET
bam-13787	105	33	patients	patient	NOUN
bam-13787	105	34	participating	participate	VERB
bam-13787	105	35	in	in	ADP
bam-13787	105	36	this	this	DET
bam-13787	105	37	study	study	NOUN
bam-13787	105	38	signed	sign	VERB
bam-13787	105	39	a	a	DET
bam-13787	105	40	written	write	VERB
bam-13787	105	41	informed	inform	VERB
bam-13787	105	42	consent	consent	NOUN
bam-13787	105	43	form	form	NOUN
bam-13787	105	44	for	for	ADP
bam-13787	105	45	participating	participate	VERB
bam-13787	105	46	in	in	ADP
bam-13787	105	47	this	this	DET
bam-13787	105	48	study	study	NOUN
bam-13787	105	49	.	.	PUNCT
bam-13787	106	1	patient	patient	ADJ
bam-13787	106	2	consent	consent	NOUN
bam-13787	106	3	for	for	ADP
bam-13787	106	4	publication	publication	NOUN
bam-13787	106	5	written	write	VERB
bam-13787	106	6	informed	inform	VERB
bam-13787	106	7	consent	consent	NOUN
bam-13787	106	8	was	be	AUX
bam-13787	106	9	obtained	obtain	VERB
bam-13787	106	10	from	from	ADP
bam-13787	106	11	a	a	DET
bam-13787	106	12	legally	legally	ADV
bam-13787	106	13	authorized	authorize	VERB
bam-13787	106	14	representative(s	representative(s	NOUN
bam-13787	106	15	)	)	PUNCT
bam-13787	106	16	for	for	ADP
bam-13787	106	17	anonymized	anonymize	VERB
bam-13787	106	18	patient	patient	ADJ
bam-13787	106	19	information	information	NOUN
bam-13787	106	20	to	to	PART
bam-13787	106	21	be	be	AUX
bam-13787	106	22	published	publish	VERB
bam-13787	106	23	in	in	ADP
bam-13787	106	24	this	this	DET
bam-13787	106	25	article	article	NOUN
bam-13787	106	26	.	.	PUNCT
bam-13787	107	1	availability	availability	NOUN
bam-13787	107	2	of	of	ADP
bam-13787	107	3	data	datum	NOUN
bam-13787	107	4	and	and	CCONJ
bam-13787	107	5	materials	material	NOUN
bam-13787	107	6	all	all	DET
bam-13787	107	7	data	datum	NOUN
bam-13787	107	8	generated	generate	VERB
bam-13787	107	9	or	or	CCONJ
bam-13787	107	10	analyzed	analyze	VERB
bam-13787	107	11	during	during	ADP
bam-13787	107	12	this	this	DET
bam-13787	107	13	study	study	NOUN
bam-13787	107	14	are	be	AUX
bam-13787	107	15	included	include	VERB
bam-13787	107	16	in	in	ADP
bam-13787	107	17	this	this	DET
bam-13787	107	18	published	publish	VERB
bam-13787	107	19	article	article	NOUN
bam-13787	107	20	.	.	PUNCT
bam-13787	108	1	conflict	conflict	NOUN
bam-13787	108	2	of	of	ADP
bam-13787	108	3	interest	interest	NOUN
bam-13787	108	4	the	the	DET
bam-13787	108	5	authors	author	NOUN
bam-13787	108	6	declare	declare	VERB
bam-13787	108	7	no	no	DET
bam-13787	108	8	potential	potential	ADJ
bam-13787	108	9	conflict	conflict	NOUN
bam-13787	108	10	of	of	ADP
bam-13787	108	11	interest	interest	NOUN
bam-13787	108	12	,	,	PUNCT
bam-13787	108	13	and	and	CCONJ
bam-13787	108	14	all	all	DET
bam-13787	108	15	authors	author	NOUN
bam-13787	108	16	confirm	confirm	VERB
bam-13787	108	17	accuracy	accuracy	NOUN
bam-13787	108	18	.	.	PUNCT
bam-13787	109	1	ethics	ethic	NOUN
bam-13787	109	2	approval	approval	VERB
bam-13787	109	3	the	the	DET
bam-13787	109	4	ethics	ethic	NOUN
bam-13787	109	5	committee	committee	PROPN
bam-13787	109	6	of	of	ADP
bam-13787	109	7	tehran	tehran	PROPN
bam-13787	109	8	university	university	PROPN
bam-13787	109	9	of	of	ADP
bam-13787	109	10	medical	medical	PROPN
bam-13787	109	11	sciences	sciences	PROPN
bam-13787	109	12	approved	approve	VERB
bam-13787	109	13	this	this	DET
bam-13787	109	14	study	study	NOUN
bam-13787	109	15	(	(	PUNCT
bam-13787	109	16	ir.tums.rec.1398.072	ir.tums.rec.1398.072	PROPN
bam-13787	109	17	)	)	PUNCT
bam-13787	109	18	.	.	PUNCT
bam-13787	110	1	the	the	DET
bam-13787	110	2	study	study	NOUN
bam-13787	110	3	is	be	AUX
bam-13787	110	4	conformed	conform	VERB
bam-13787	110	5	with	with	ADP
bam-13787	110	6	the	the	DET
bam-13787	110	7	helsinki	helsinki	PROPN
bam-13787	110	8	declaration	declaration	NOUN
bam-13787	110	9	of	of	ADP
bam-13787	110	10	1964	1964	NUM
bam-13787	110	11	,	,	PUNCT
bam-13787	110	12	as	as	SCONJ
bam-13787	110	13	revised	revise	VERB
bam-13787	110	14	in	in	ADP
bam-13787	110	15	2013	2013	NUM
bam-13787	110	16	,	,	PUNCT
bam-13787	110	17	concerning	concern	VERB
bam-13787	110	18	human	human	ADJ
bam-13787	110	19	and	and	CCONJ
bam-13787	110	20	animal	animal	NOUN
bam-13787	110	21	rights	right	NOUN
bam-13787	110	22	.	.	PUNCT
bam-13787	111	1	corresponding	correspond	VERB
bam-13787	111	2	author	author	NOUN
bam-13787	111	3	mahdis	mahdis	PROPN
bam-13787	111	4	miladi	miladi	NOUN
bam-13787	111	5	,	,	PUNCT
bam-13787	111	6	department	department	NOUN
bam-13787	111	7	of	of	ADP
bam-13787	111	8	pediatrics	pediatric	NOUN
bam-13787	111	9	,	,	PUNCT
bam-13787	111	10	tehran	tehran	PROPN
bam-13787	111	11	university	university	PROPN
bam-13787	111	12	of	of	ADP
bam-13787	111	13	medical	medical	ADJ
bam-13787	111	14	sciences	sciences	PROPN
bam-13787	111	15	,	,	PUNCT
bam-13787	111	16	tehran	tehran	PROPN
bam-13787	111	17	,	,	PUNCT
bam-13787	111	18	iran	iran	PROPN
bam-13787	111	19	and	and	CCONJ
bam-13787	111	20	université	université	PROPN
bam-13787	111	21	côte	côte	PROPN
bam-13787	111	22	d’azur	d’azur	PROPN
bam-13787	111	23	diplôme	diplôme	PROPN
bam-13787	111	24	inter	inter	PROPN
bam-13787	111	25	universitaire	universitaire	PROPN
bam-13787	111	26	,	,	PUNCT
bam-13787	111	27	nice	nice	ADJ
bam-13787	111	28	,	,	PUNCT
bam-13787	111	29	france	france	PROPN
bam-13787	111	30	.	.	PUNCT
bam-13787	112	1	orcid	orcid	PROPN
bam-13787	113	1	i	i	PRON
bam-13787	113	2	d	d	NOUN
bam-13787	113	3	:	:	PUNCT
bam-13787	113	4	0009	0009	NUM
bam-13787	113	5	-	-	PUNCT
bam-13787	113	6	0005	0005	NUM
bam-13787	113	7	-	-	PUNCT
bam-13787	113	8	9973	9973	NUM
bam-13787	113	9	-	-	SYM
bam-13787	113	10	5828	5828	NUM
bam-13787	113	11	e	e	NOUN
bam-13787	113	12	-	-	NOUN
bam-13787	113	13	mail	mail	NOUN
bam-13787	113	14	:	:	PUNCT
bam-13787	113	15	dr.mahdismiladi@yahoo.com	dr.mahdismiladi@yahoo.com	X
bam-13787	113	16	co	co	NOUN
bam-13787	113	17	-	-	NOUN
bam-13787	113	18	author	author	NOUN
bam-13787	113	19	shahzad	shahzad	PROPN
bam-13787	113	20	shirzad	shirzad	PROPN
bam-13787	113	21	oricid	oricid	PROPN
bam-13787	114	1	i	i	PROPN
bam-13787	114	2	d	d	NOUN
bam-13787	114	3	:	:	PUNCT
bam-13787	114	4	0009	0009	NUM
bam-13787	114	5	-	-	SYM
bam-13787	114	6	0000	0000	NUM
bam-13787	114	7	-	-	PUNCT
bam-13787	114	8	2684	2684	NUM
bam-13787	114	9	-	-	SYM
bam-13787	114	10	5405	5405	NUM
bam-13787	114	11	e	e	NOUN
bam-13787	114	12	-	-	NOUN
bam-13787	114	13	mail	mail	NOUN
bam-13787	114	14	:	:	PUNCT
bam-13787	114	15	dr_sh_shirzad@yahoo.com	dr_sh_shirzad@yahoo.com	X
bam-13787	114	16	references	reference	NOUN
bam-13787	114	17	1	1	NUM
bam-13787	114	18	.	.	PUNCT
bam-13787	114	19	ezzedine	ezzedine	PROPN
bam-13787	115	1	k	k	PROPN
bam-13787	115	2	,	,	PUNCT
bam-13787	115	3	lim	lim	PROPN
bam-13787	115	4	hw	hw	PROPN
bam-13787	115	5	,	,	PUNCT
bam-13787	115	6	suzuki	suzuki	PROPN
bam-13787	115	7	t	t	PROPN
bam-13787	115	8	et	et	PROPN
bam-13787	115	9	al	al	PROPN
bam-13787	115	10	.	.	PROPN
bam-13787	115	11	revised	revise	VERB
bam-13787	115	12	classification	classification	NOUN
bam-13787	115	13	/	/	SYM
bam-13787	115	14	nomenclature	nomenclature	NOUN
bam-13787	115	15	of	of	ADP
bam-13787	115	16	vitiligo	vitiligo	ADJ
bam-13787	115	17	and	and	CCONJ
bam-13787	115	18	related	related	ADJ
bam-13787	115	19	issues	issue	NOUN
bam-13787	115	20	:	:	PUNCT
bam-13787	115	21	the	the	DET
bam-13787	115	22	vitiligo	vitiligo	ADJ
bam-13787	115	23	global	global	ADJ
bam-13787	115	24	issues	issue	NOUN
bam-13787	115	25	consensus	consensus	NOUN
bam-13787	115	26	conference	conference	NOUN
bam-13787	115	27	.	.	PUNCT
bam-13787	116	1	pigment	pigment	ADJ
bam-13787	116	2	cell	cell	NOUN
bam-13787	116	3	melanoma	melanoma	NOUN
bam-13787	116	4	res	re	NOUN
bam-13787	116	5	2012;25	2012;25	NUM
bam-13787	116	6	:	:	PUNCT
bam-13787	116	7	e1	e1	NOUN
bam-13787	116	8	-	-	PUNCT
bam-13787	116	9	13	13	NUM
bam-13787	116	10	.	.	PUNCT
bam-13787	117	1	2	2	NUM
bam-13787	117	2	.	.	X
bam-13787	117	3	krüger	krüger	NOUN
bam-13787	117	4	c	c	PROPN
bam-13787	117	5	,	,	PUNCT
bam-13787	117	6	schallreuter	schallreuter	PROPN
bam-13787	117	7	ku	ku	PROPN
bam-13787	117	8	.	.	PUNCT
bam-13787	118	1	a	a	DET
bam-13787	118	2	review	review	NOUN
bam-13787	118	3	of	of	ADP
bam-13787	118	4	the	the	DET
bam-13787	118	5	worldwide	worldwide	ADJ
bam-13787	118	6	prevalence	prevalence	NOUN
bam-13787	118	7	of	of	ADP
bam-13787	118	8	vitiligo	vitiligo	NOUN
bam-13787	118	9	in	in	ADP
bam-13787	118	10	children	child	NOUN
bam-13787	118	11	/	/	SYM
bam-13787	118	12	adolescents	adolescent	NOUN
bam-13787	118	13	and	and	CCONJ
bam-13787	118	14	adults	adult	NOUN
bam-13787	118	15	.	.	PUNCT
bam-13787	119	1	int	int	NOUN
bam-13787	119	2	j	j	PROPN
bam-13787	119	3	dermatol	dermatol	NOUN
bam-13787	119	4	2012;51:1206	2012;51:1206	NUM
bam-13787	119	5	-	-	SYM
bam-13787	119	6	12	12	NUM
bam-13787	119	7	.	.	PUNCT
bam-13787	120	1	3	3	X
bam-13787	120	2	.	.	X
bam-13787	120	3	picardo	picardo	PROPN
bam-13787	120	4	m	m	PROPN
bam-13787	120	5	,	,	PUNCT
bam-13787	120	6	dell’anna	dell’anna	ADJ
bam-13787	120	7	ml	ml	NOUN
bam-13787	120	8	,	,	PUNCT
bam-13787	120	9	ezzedine	ezzedine	PROPN
bam-13787	120	10	k	k	NOUN
bam-13787	120	11	,	,	PUNCT
bam-13787	120	12	et	et	PROPN
bam-13787	120	13	al	al	PROPN
bam-13787	120	14	.	.	PROPN
bam-13787	120	15	vitiligo	vitiligo	PROPN
bam-13787	120	16	.	.	PUNCT
bam-13787	121	1	nat	nat	PROPN
bam-13787	121	2	rev	rev	VERB
bam-13787	121	3	dis	dis	PROPN
bam-13787	121	4	primers	primer	NOUN
bam-13787	121	5	2015;1:15011	2015;1:15011	NUM
bam-13787	121	6	.	.	PUNCT
bam-13787	122	1	4	4	X
bam-13787	122	2	.	.	X
bam-13787	122	3	shah	shah	PROPN
bam-13787	122	4	h	h	PROPN
bam-13787	122	5	,	,	PUNCT
bam-13787	122	6	mehta	mehta	PROPN
bam-13787	122	7	a	a	PROPN
bam-13787	122	8	,	,	PUNCT
bam-13787	122	9	astik	astik	PROPN
bam-13787	122	10	b.	b.	PROPN
bam-13787	122	11	clinical	clinical	PROPN
bam-13787	122	12	and	and	CCONJ
bam-13787	122	13	sociodemographic	sociodemographic	ADJ
bam-13787	122	14	study	study	NOUN
bam-13787	122	15	of	of	ADP
bam-13787	122	16	vitiligo	vitiligo	PROPN
bam-13787	122	17	.	.	PUNCT
bam-13787	123	1	indian	indian	PROPN
bam-13787	123	2	j	j	PROPN
bam-13787	123	3	dermatol	dermatol	PROPN
bam-13787	123	4	venereol	venereol	NOUN
bam-13787	123	5	leprol	leprol	NOUN
bam-13787	123	6	2008;74:701	2008;74:701	NUM
bam-13787	123	7	.	.	PUNCT
bam-13787	123	8	5	5	NUM
bam-13787	123	9	.	.	X
bam-13787	123	10	taïeb	taïeb	NOUN
bam-13787	123	11	a	a	PRON
bam-13787	123	12	,	,	PUNCT
bam-13787	123	13	picardo	picardo	NOUN
bam-13787	123	14	m	m	NOUN
bam-13787	123	15	;	;	PUNCT
bam-13787	123	16	vetf	vetf	NOUN
bam-13787	123	17	members	member	NOUN
bam-13787	123	18	.	.	PUNCT
bam-13787	124	1	the	the	DET
bam-13787	124	2	definition	definition	NOUN
bam-13787	124	3	and	and	CCONJ
bam-13787	124	4	assessment	assessment	NOUN
bam-13787	124	5	of	of	ADP
bam-13787	124	6	vitiligo	vitiligo	NOUN
bam-13787	124	7	:	:	PUNCT
bam-13787	124	8	a	a	DET
bam-13787	124	9	consensus	consensus	NOUN
bam-13787	124	10	report	report	NOUN
bam-13787	124	11	of	of	ADP
bam-13787	124	12	the	the	DET
bam-13787	124	13	vitiligo	vitiligo	ADJ
bam-13787	124	14	european	european	PROPN
bam-13787	124	15	task	task	PROPN
bam-13787	124	16	force	force	NOUN
bam-13787	124	17	.	.	PUNCT
bam-13787	125	1	pigment	pigment	ADJ
bam-13787	125	2	cell	cell	NOUN
bam-13787	125	3	res	re	NOUN
bam-13787	125	4	2007;20:27	2007;20:27	NUM
bam-13787	125	5	-	-	SYM
bam-13787	125	6	35	35	NUM
bam-13787	125	7	.	.	NOUN
bam-13787	126	1	6	6	NUM
bam-13787	126	2	.	.	X
bam-13787	126	3	dahir	dahir	PROPN
bam-13787	126	4	am	am	PROPN
bam-13787	126	5	,	,	PUNCT
bam-13787	126	6	thomsen	thomsen	PROPN
bam-13787	126	7	sf	sf	PROPN
bam-13787	126	8	.	.	PROPN
bam-13787	126	9	comorbidities	comorbiditie	NOUN
bam-13787	126	10	in	in	ADP
bam-13787	126	11	vitiligo	vitiligo	NOUN
bam-13787	126	12	:	:	PUNCT
bam-13787	126	13	comprehensive	comprehensive	ADJ
bam-13787	126	14	review	review	NOUN
bam-13787	126	15	.	.	PUNCT
bam-13787	127	1	int	int	NOUN
bam-13787	127	2	j	j	PROPN
bam-13787	127	3	dermatol	dermatol	NOUN
bam-13787	127	4	2018;57:1157164	2018;57:1157164	NUM
bam-13787	127	5	.	.	PUNCT
bam-13787	128	1	7	7	NUM
bam-13787	128	2	.	.	X
bam-13787	128	3	lee	lee	PROPN
bam-13787	128	4	jh	jh	PROPN
bam-13787	128	5	,	,	PUNCT
bam-13787	128	6	ju	ju	PROPN
bam-13787	128	7	hj	hj	PROPN
bam-13787	128	8	,	,	PUNCT
bam-13787	128	9	seo	seo	PROPN
bam-13787	128	10	jm	jm	PROPN
bam-13787	128	11	,	,	PUNCT
bam-13787	128	12	almurayshid	almurayshid	NOUN
bam-13787	128	13	a	a	PRON
bam-13787	128	14	,	,	PUNCT
bam-13787	128	15	et	et	PROPN
bam-13787	128	16	al	al	PROPN
bam-13787	128	17	.	.	PROPN
bam-13787	128	18	comorbidities	comorbiditie	NOUN
bam-13787	128	19	in	in	ADP
bam-13787	128	20	patients	patient	NOUN
bam-13787	128	21	with	with	ADP
bam-13787	128	22	vitiligo	vitiligo	NOUN
bam-13787	128	23	:	:	PUNCT
bam-13787	128	24	a	a	DET
bam-13787	128	25	systematic	systematic	ADJ
bam-13787	128	26	review	review	NOUN
bam-13787	128	27	and	and	CCONJ
bam-13787	128	28	meta	meta	ADJ
bam-13787	128	29	-	-	PUNCT
bam-13787	128	30	analysis	analysis	NOUN
bam-13787	128	31	.	.	PUNCT
bam-13787	129	1	j	j	PROPN
bam-13787	129	2	invest	invest	VERB
bam-13787	129	3	dermatol	dermatol	NOUN
bam-13787	129	4	2023;143:777789.e6	2023;143:777789.e6	NUM
bam-13787	129	5	.	.	NOUN
bam-13787	129	6	8	8	NUM
bam-13787	129	7	.	.	X
bam-13787	129	8	klisnick	klisnick	PROPN
bam-13787	129	9	a	a	PRON
bam-13787	129	10	,	,	PUNCT
bam-13787	129	11	schmidt	schmidt	PROPN
bam-13787	129	12	j	j	PROPN
bam-13787	129	13	,	,	PUNCT
bam-13787	129	14	dupond	dupond	VERB
bam-13787	129	15	jl	jl	PROPN
bam-13787	129	16	,	,	PUNCT
bam-13787	129	17	et	et	PROPN
bam-13787	129	18	al	al	PROPN
bam-13787	129	19	.	.	PROPN
bam-13787	129	20	le	le	PROPN
bam-13787	129	21	vitiligo	vitiligo	PROPN
bam-13787	129	22	au	au	PROPN
bam-13787	129	23	cours	cours	PROPN
bam-13787	129	24	des	des	PROPN
bam-13787	129	25	syndromes	syndrome	NOUN
bam-13787	129	26	auto	auto	NOUN
bam-13787	129	27	-	-	PUNCT
bam-13787	129	28	immuns	immun	NOUN
bam-13787	129	29	multiples	multiple	NOUN
bam-13787	129	30	:	:	PUNCT
bam-13787	129	31	étude	étude	PROPN
bam-13787	129	32	5	5	NUM
bam-13787	129	33	mailto:dr_sh_shirzad@yahoo.com	mailto:dr_sh_shirzad@yahoo.com	PROPN
bam-13787	129	34	treatments	treatment	NOUN
bam-13787	129	35	for	for	ADP
bam-13787	129	36	vitiligo	vitiligo	NOUN
bam-13787	129	37	vs.	vs.	ADP
bam-13787	129	38	anti	anti	ADJ
bam-13787	129	39	-	-	ADJ
bam-13787	129	40	vitiligo	vitiligo	ADJ
bam-13787	129	41	cream	cream	NOUN
bam-13787	129	42	eur	eur	PROPN
bam-13787	129	43	j	j	PROPN
bam-13787	129	44	transl	transl	PROPN
bam-13787	129	45	myol	myol	ADV
bam-13787	129	46	35	35	NUM
bam-13787	129	47	(	(	PUNCT
bam-13787	129	48	4	4	NUM
bam-13787	129	49	)	)	PUNCT
bam-13787	129	50	13787	13787	NUM
bam-13787	129	51	,	,	PUNCT
bam-13787	129	52	2025	2025	NUM
bam-13787	129	53	doi	doi	NOUN
bam-13787	129	54	:	:	PUNCT
bam-13787	129	55	10.4081	10.4081	NUM
bam-13787	129	56	/	/	SYM
bam-13787	129	57	ejtm.2025.13787	ejtm.2025.13787	X
bam-13787	129	58	rétrospective	rétrospective	X
bam-13787	129	59	de	de	ADP
bam-13787	129	60	11	11	NUM
bam-13787	129	61	observations	observation	NOUN
bam-13787	129	62	et	et	NOUN
bam-13787	129	63	revue	revue	VERB
bam-13787	129	64	de	de	X
bam-13787	129	65	la	la	X
bam-13787	129	66	littérature	littérature	NOUN
bam-13787	130	1	[	[	X
bam-13787	130	2	vitiligo	vitiligo	NOUN
bam-13787	130	3	in	in	ADP
bam-13787	130	4	multiple	multiple	ADJ
bam-13787	130	5	autoimmune	autoimmune	ADJ
bam-13787	130	6	syndrome	syndrome	NOUN
bam-13787	130	7	:	:	PUNCT
bam-13787	130	8	a	a	DET
bam-13787	130	9	retrospective	retrospective	ADJ
bam-13787	130	10	study	study	NOUN
bam-13787	130	11	of	of	ADP
bam-13787	130	12	11	11	NUM
bam-13787	130	13	cases	case	NOUN
bam-13787	130	14	and	and	CCONJ
bam-13787	130	15	a	a	DET
bam-13787	130	16	review	review	NOUN
bam-13787	130	17	of	of	ADP
bam-13787	130	18	the	the	DET
bam-13787	130	19	literature	literature	NOUN
bam-13787	130	20	]	]	PUNCT
bam-13787	130	21	.	.	PUNCT
bam-13787	131	1	rev	rev	PROPN
bam-13787	131	2	med	med	ADJ
bam-13787	131	3	interne	interne	PROPN
bam-13787	131	4	1998;19:348	1998;19:348	PROPN
bam-13787	131	5	-	-	SYM
bam-13787	131	6	52	52	NUM
bam-13787	131	7	.	.	NOUN
bam-13787	132	1	9	9	NUM
bam-13787	132	2	.	.	X
bam-13787	132	3	bleehen	bleehen	PROPN
bam-13787	132	4	ss	ss	PROPN
bam-13787	132	5	.	.	PUNCT
bam-13787	133	1	the	the	DET
bam-13787	133	2	treatment	treatment	NOUN
bam-13787	133	3	of	of	ADP
bam-13787	133	4	vitiligo	vitiligo	NOUN
bam-13787	133	5	with	with	ADP
bam-13787	133	6	topical	topical	ADJ
bam-13787	133	7	corticosteroids	corticosteroid	NOUN
bam-13787	133	8	.	.	PUNCT
bam-13787	134	1	light	light	NOUN
bam-13787	134	2	and	and	CCONJ
bam-13787	134	3	electronmicroscopic	electronmicroscopic	ADJ
bam-13787	134	4	studies	study	NOUN
bam-13787	134	5	.	.	PUNCT
bam-13787	135	1	br	br	PROPN
bam-13787	135	2	j	j	PROPN
bam-13787	135	3	dermatol	dermatol	NOUN
bam-13787	135	4	1976;94:43	1976;94:43	NUM
bam-13787	135	5	-	-	SYM
bam-13787	135	6	50	50	NUM
bam-13787	135	7	.	.	PUNCT
bam-13787	135	8	10	10	NUM
bam-13787	135	9	.	.	PUNCT
bam-13787	136	1	lee	lee	PROPN
bam-13787	136	2	jh	jh	PROPN
bam-13787	136	3	,	,	PUNCT
bam-13787	136	4	kwon	kwon	PROPN
bam-13787	136	5	hs	hs	PROPN
bam-13787	136	6	,	,	PUNCT
bam-13787	136	7	jung	jung	PROPN
bam-13787	136	8	hm	hm	PROPN
bam-13787	136	9	,	,	PUNCT
bam-13787	136	10	et	et	PROPN
bam-13787	136	11	al	al	PROPN
bam-13787	136	12	.	.	PUNCT
bam-13787	137	1	treatment	treatment	NOUN
bam-13787	137	2	outcomes	outcome	NOUN
bam-13787	137	3	of	of	ADP
bam-13787	137	4	topical	topical	ADJ
bam-13787	137	5	calcineurin	calcineurin	NOUN
bam-13787	137	6	inhibitor	inhibitor	NOUN
bam-13787	137	7	therapy	therapy	NOUN
bam-13787	137	8	for	for	ADP
bam-13787	137	9	patients	patient	NOUN
bam-13787	137	10	with	with	ADP
bam-13787	137	11	vitiligo	vitiligo	NOUN
bam-13787	137	12	:	:	PUNCT
bam-13787	137	13	a	a	DET
bam-13787	137	14	systematic	systematic	ADJ
bam-13787	137	15	review	review	NOUN
bam-13787	137	16	and	and	CCONJ
bam-13787	137	17	meta	meta	ADJ
bam-13787	137	18	-	-	PUNCT
bam-13787	137	19	analysis	analysis	NOUN
bam-13787	137	20	.	.	PUNCT
bam-13787	138	1	jama	jama	PROPN
bam-13787	138	2	dermatol	dermatol	NOUN
bam-13787	138	3	2019;155:929	2019;155:929	PROPN
bam-13787	138	4	-	-	SYM
bam-13787	138	5	38	38	NUM
bam-13787	138	6	.	.	PUNCT
bam-13787	139	1	11	11	NUM
bam-13787	139	2	.	.	PUNCT
bam-13787	140	1	kandaswamy	kandaswamy	PROPN
bam-13787	140	2	s	s	PROPN
bam-13787	140	3	,	,	PUNCT
bam-13787	140	4	akhtar	akhtar	PROPN
bam-13787	140	5	n	n	CCONJ
bam-13787	140	6	,	,	PUNCT
bam-13787	140	7	ravindran	ravindran	NOUN
bam-13787	140	8	s	s	PROPN
bam-13787	140	9	,	,	PUNCT
bam-13787	140	10	et	et	PROPN
bam-13787	140	11	al	al	PROPN
bam-13787	140	12	.	.	PROPN
bam-13787	140	13	phototherapy	phototherapy	PROPN
bam-13787	140	14	in	in	ADP
bam-13787	140	15	vitiligo	vitiligo	NOUN
bam-13787	140	16	:	:	PUNCT
bam-13787	140	17	assessing	assess	VERB
bam-13787	140	18	the	the	DET
bam-13787	140	19	compliance	compliance	NOUN
bam-13787	140	20	,	,	PUNCT
bam-13787	140	21	response	response	NOUN
bam-13787	140	22	and	and	CCONJ
bam-13787	140	23	patient	patient	NOUN
bam-13787	140	24	’s	’s	PART
bam-13787	140	25	perception	perception	NOUN
bam-13787	140	26	about	about	ADP
bam-13787	140	27	disease	disease	NOUN
bam-13787	140	28	and	and	CCONJ
bam-13787	140	29	treatment	treatment	NOUN
bam-13787	140	30	.	.	PUNCT
bam-13787	141	1	indian	indian	PROPN
bam-13787	141	2	j	j	PROPN
bam-13787	141	3	dermatol	dermatol	NOUN
bam-13787	141	4	2013;58:325	2013;58:325	PROPN
bam-13787	141	5	.	.	PROPN
bam-13787	141	6	12	12	NUM
bam-13787	141	7	.	.	PUNCT
bam-13787	142	1	faraj	faraj	PROPN
bam-13787	142	2	s	s	PROPN
bam-13787	142	3	,	,	PUNCT
bam-13787	142	4	kemp	kemp	PROPN
bam-13787	142	5	eh	eh	PROPN
bam-13787	142	6	,	,	PUNCT
bam-13787	142	7	gawkrodger	gawkrodger	NOUN
bam-13787	142	8	dj	dj	PROPN
bam-13787	142	9	.	.	PUNCT
bam-13787	143	1	patho	patho	NOUN
bam-13787	143	2	-	-	PUNCT
bam-13787	143	3	immunological	immunological	ADJ
bam-13787	143	4	mechanisms	mechanism	NOUN
bam-13787	143	5	of	of	ADP
bam-13787	143	6	vitiligo	vitiligo	NOUN
bam-13787	143	7	:	:	PUNCT
bam-13787	143	8	the	the	DET
bam-13787	143	9	role	role	NOUN
bam-13787	143	10	of	of	ADP
bam-13787	143	11	the	the	DET
bam-13787	143	12	innate	innate	ADJ
bam-13787	143	13	and	and	CCONJ
bam-13787	143	14	adaptive	adaptive	ADJ
bam-13787	143	15	immunities	immunity	NOUN
bam-13787	143	16	and	and	CCONJ
bam-13787	143	17	environmental	environmental	ADJ
bam-13787	143	18	stress	stress	NOUN
bam-13787	143	19	factors	factor	NOUN
bam-13787	143	20	.	.	PUNCT
bam-13787	144	1	clin	clin	PROPN
bam-13787	144	2	exp	exp	NOUN
bam-13787	144	3	immunol	immunol	NOUN
bam-13787	144	4	2022;207:27	2022;207:27	NUM
bam-13787	144	5	-	-	SYM
bam-13787	144	6	43	43	NUM
bam-13787	144	7	.	.	PUNCT
bam-13787	144	8	13	13	NUM
bam-13787	144	9	.	.	PUNCT
bam-13787	145	1	chang	chang	PROPN
bam-13787	145	2	wl	wl	PROPN
bam-13787	145	3	,	,	PUNCT
bam-13787	145	4	ko	ko	PROPN
bam-13787	145	5	ch	ch	PROPN
bam-13787	145	6	.	.	PUNCT
bam-13787	146	1	the	the	DET
bam-13787	146	2	role	role	NOUN
bam-13787	146	3	of	of	ADP
bam-13787	146	4	oxidative	oxidative	ADJ
bam-13787	146	5	stress	stress	NOUN
bam-13787	146	6	in	in	ADP
bam-13787	146	7	vitiligo	vitiligo	NOUN
bam-13787	146	8	:	:	PUNCT
bam-13787	146	9	an	an	DET
bam-13787	146	10	update	update	NOUN
bam-13787	146	11	on	on	ADP
bam-13787	146	12	its	its	PRON
bam-13787	146	13	pathogenesis	pathogenesis	NOUN
bam-13787	146	14	and	and	CCONJ
bam-13787	146	15	therapeutic	therapeutic	ADJ
bam-13787	146	16	implications	implication	NOUN
bam-13787	146	17	.	.	PUNCT
bam-13787	147	1	cells	cell	NOUN
bam-13787	147	2	2023;12:936	2023;12:936	VERB
bam-13787	147	3	.	.	PUNCT
bam-13787	148	1	14	14	NUM
bam-13787	148	2	.	.	PUNCT
bam-13787	149	1	bharti	bharti	PROPN
bam-13787	149	2	n	n	PROPN
bam-13787	149	3	,	,	PUNCT
bam-13787	149	4	banerjee	banerjee	PROPN
bam-13787	149	5	r	r	PROPN
bam-13787	149	6	,	,	PUNCT
bam-13787	149	7	achalare	achalare	PROPN
bam-13787	149	8	a	a	X
bam-13787	149	9	,	,	PUNCT
bam-13787	149	10	kasibhatla	kasibhatla	PROPN
bam-13787	149	11	sm	sm	PROPN
bam-13787	149	12	,	,	PUNCT
bam-13787	149	13	joshi	joshi	PROPN
bam-13787	149	14	r.	r.	PROPN
bam-13787	149	15	estimation	estimation	PROPN
bam-13787	149	16	of	of	ADP
bam-13787	149	17	genetic	genetic	ADJ
bam-13787	149	18	variation	variation	NOUN
bam-13787	149	19	in	in	ADP
bam-13787	149	20	vitiligo	vitiligo	NOUN
bam-13787	149	21	associated	associate	VERB
bam-13787	149	22	genes	gene	NOUN
bam-13787	149	23	:	:	PUNCT
bam-13787	149	24	population	population	NOUN
bam-13787	149	25	genomics	genomic	NOUN
bam-13787	149	26	perspective	perspective	NOUN
bam-13787	149	27	.	.	PUNCT
bam-13787	150	1	bmc	bmc	PROPN
bam-13787	150	2	genom	genom	PROPN
bam-13787	150	3	data	datum	NOUN
bam-13787	150	4	2024;25:72	2024;25:72	NUM
bam-13787	150	5	.	.	PUNCT
bam-13787	151	1	15	15	NUM
bam-13787	151	2	.	.	PUNCT
bam-13787	151	3	spritz	spritz	PROPN
bam-13787	151	4	ra	ra	PROPN
bam-13787	151	5	,	,	PUNCT
bam-13787	151	6	andersen	andersen	PROPN
bam-13787	151	7	gh	gh	PROPN
bam-13787	151	8	.	.	PUNCT
bam-13787	152	1	genetics	genetic	NOUN
bam-13787	152	2	of	of	ADP
bam-13787	152	3	vitiligo	vitiligo	NOUN
bam-13787	152	4	.	.	PUNCT
bam-13787	153	1	dermatol	dermatol	NOUN
bam-13787	153	2	clin	clin	PROPN
bam-13787	153	3	2017;35:245	2017;35:245	PROPN
bam-13787	153	4	-	-	PROPN
bam-13787	153	5	55	55	NUM
bam-13787	153	6	.	.	PUNCT
bam-13787	153	7	16	16	NUM
bam-13787	153	8	.	.	PUNCT
bam-13787	154	1	inoue	inoue	PROPN
bam-13787	154	2	s	s	PROPN
bam-13787	154	3	,	,	PUNCT
bam-13787	154	4	suzuki	suzuki	PROPN
bam-13787	154	5	t	t	PROPN
bam-13787	154	6	,	,	PUNCT
bam-13787	154	7	sano	sano	PROPN
bam-13787	154	8	s	s	PROPN
bam-13787	154	9	,	,	PUNCT
bam-13787	154	10	katayama	katayama	PROPN
bam-13787	154	11	i.	i.	PROPN
bam-13787	154	12	jak	jak	PROPN
bam-13787	154	13	inhibitors	inhibitor	NOUN
bam-13787	154	14	for	for	ADP
bam-13787	154	15	the	the	DET
bam-13787	154	16	treatment	treatment	NOUN
bam-13787	154	17	of	of	ADP
bam-13787	154	18	vitiligo	vitiligo	NOUN
bam-13787	154	19	.	.	PUNCT
bam-13787	155	1	j	j	PROPN
bam-13787	155	2	dermatol	dermatol	NOUN
bam-13787	155	3	sci	sci	PROPN
bam-13787	155	4	2024;113	2024;113	NUM
bam-13787	155	5	:	:	PUNCT
bam-13787	155	6	86	86	NUM
bam-13787	155	7	-	-	SYM
bam-13787	155	8	92	92	NUM
bam-13787	155	9	.	.	PUNCT
bam-13787	156	1	17	17	NUM
bam-13787	156	2	.	.	PUNCT
bam-13787	157	1	qi	qi	PROPN
bam-13787	157	2	f	f	PROPN
bam-13787	157	3	,	,	PUNCT
bam-13787	157	4	liu	liu	PROPN
bam-13787	157	5	f	f	PROPN
bam-13787	157	6	,	,	PUNCT
bam-13787	157	7	gao	gao	PROPN
bam-13787	157	8	l.	l.	PROPN
bam-13787	157	9	janus	janus	PROPN
bam-13787	157	10	kinase	kinase	PROPN
bam-13787	157	11	inhibitors	inhibitor	NOUN
bam-13787	157	12	in	in	ADP
bam-13787	157	13	the	the	DET
bam-13787	157	14	treatment	treatment	NOUN
bam-13787	157	15	of	of	ADP
bam-13787	157	16	vitiligo	vitiligo	NOUN
bam-13787	157	17	:	:	PUNCT
bam-13787	157	18	a	a	DET
bam-13787	157	19	review	review	NOUN
bam-13787	157	20	.	.	PUNCT
bam-13787	158	1	front	front	ADJ
bam-13787	158	2	immunol	immunol	NOUN
bam-13787	158	3	2021;12	2021;12	PROPN
bam-13787	158	4	:	:	PUNCT
bam-13787	158	5	790125	790125	NUM
bam-13787	158	6	.	.	PUNCT
bam-13787	159	1	18	18	NUM
bam-13787	159	2	.	.	PUNCT
bam-13787	159	3	lee	lee	PROPN
bam-13787	159	4	h	h	PROPN
bam-13787	159	5	,	,	PUNCT
bam-13787	159	6	cowan	cowan	PROPN
bam-13787	159	7	tl	tl	PROPN
bam-13787	159	8	,	,	PUNCT
bam-13787	159	9	daniel	daniel	PROPN
bam-13787	159	10	bs	bs	PROPN
bam-13787	159	11	,	,	PUNCT
bam-13787	159	12	murrell	murrell	PROPN
bam-13787	159	13	df	df	PROPN
bam-13787	159	14	.	.	PUNCT
bam-13787	160	1	a	a	DET
bam-13787	160	2	review	review	NOUN
bam-13787	160	3	of	of	ADP
bam-13787	160	4	jak	jak	PROPN
bam-13787	160	5	and	and	CCONJ
bam-13787	160	6	il-23	il-23	VERB
bam-13787	160	7	inhibitors	inhibitor	NOUN
bam-13787	160	8	to	to	PART
bam-13787	160	9	treat	treat	VERB
bam-13787	160	10	vitiligo	vitiligo	NOUN
bam-13787	160	11	.	.	PUNCT
bam-13787	161	1	australas	australas	PROPN
bam-13787	161	2	j	j	PROPN
bam-13787	161	3	dermatol	dermatol	NOUN
bam-13787	161	4	2023;64:204–12	2023;64:204–12	PROPN
bam-13787	161	5	.	.	PROPN
bam-13787	161	6	19	19	NUM
bam-13787	161	7	.	.	PUNCT
bam-13787	162	1	karagaiah	karagaiah	PROPN
bam-13787	162	2	p	p	PROPN
bam-13787	162	3	,	,	PUNCT
bam-13787	162	4	schwartz	schwartz	PROPN
bam-13787	162	5	ra	ra	PROPN
bam-13787	162	6	,	,	PUNCT
bam-13787	162	7	lotti	lotti	PROPN
bam-13787	162	8	t	t	PROPN
bam-13787	162	9	,	,	PUNCT
bam-13787	162	10	et	et	PROPN
bam-13787	162	11	al	al	PROPN
bam-13787	162	12	.	.	PROPN
bam-13787	162	13	biologic	biologic	PROPN
bam-13787	162	14	and	and	CCONJ
bam-13787	162	15	targeted	target	VERB
bam-13787	162	16	therapeutics	therapeutic	NOUN
bam-13787	162	17	in	in	ADP
bam-13787	162	18	vitiligo	vitiligo	NOUN
bam-13787	162	19	.	.	PUNCT
bam-13787	163	1	j	j	PROPN
bam-13787	163	2	cosmet	cosmet	VERB
bam-13787	163	3	dermatol	dermatol	NOUN
bam-13787	163	4	2023;22:64	2023;22:64	NUM
bam-13787	163	5	-	-	SYM
bam-13787	163	6	73	73	NUM
bam-13787	163	7	.	.	PUNCT
bam-13787	164	1	20	20	NUM
bam-13787	164	2	.	.	PUNCT
bam-13787	165	1	grossmann	grossmann	PROPN
bam-13787	165	2	mc	mc	PROPN
bam-13787	165	3	,	,	PUNCT
bam-13787	165	4	haidari	haidari	PROPN
bam-13787	165	5	w	w	PROPN
bam-13787	165	6	,	,	PUNCT
bam-13787	165	7	feldman	feldman	PROPN
bam-13787	165	8	sr	sr	PROPN
bam-13787	165	9	.	.	PUNCT
bam-13787	166	1	a	a	DET
bam-13787	166	2	review	review	NOUN
bam-13787	166	3	on	on	ADP
bam-13787	166	4	the	the	DET
bam-13787	166	5	use	use	NOUN
bam-13787	166	6	of	of	ADP
bam-13787	166	7	topical	topical	ADJ
bam-13787	166	8	ruxolitinib	ruxolitinib	NOUN
bam-13787	166	9	for	for	ADP
bam-13787	166	10	the	the	DET
bam-13787	166	11	treatment	treatment	NOUN
bam-13787	166	12	of	of	ADP
bam-13787	166	13	vitiligo	vitiligo	NOUN
bam-13787	166	14	.	.	PUNCT
bam-13787	167	1	j	j	PROPN
bam-13787	167	2	drugs	drug	NOUN
bam-13787	167	3	dermatol	dermatol	VERB
bam-13787	167	4	2023;22:664	2023;22:664	NOUN
bam-13787	167	5	-	-	SYM
bam-13787	167	6	67	67	NUM
bam-13787	167	7	.	.	PUNCT
bam-13787	167	8	21	21	NUM
bam-13787	167	9	.	.	PUNCT
bam-13787	168	1	tavoletti	tavoletti	PROPN
bam-13787	168	2	g	g	PROPN
bam-13787	168	3	,	,	PUNCT
bam-13787	168	4	avallone	avallone	NOUN
bam-13787	168	5	g	g	PROPN
bam-13787	168	6	,	,	PUNCT
bam-13787	168	7	conforti	conforti	PROPN
bam-13787	168	8	c	c	PROPN
bam-13787	168	9	,	,	PUNCT
bam-13787	168	10	et	et	PROPN
bam-13787	168	11	al	al	PROPN
bam-13787	168	12	.	.	PUNCT
bam-13787	168	13	topical	topical	ADJ
bam-13787	168	14	ruxolitinib	ruxolitinib	NOUN
bam-13787	168	15	:	:	PUNCT
bam-13787	168	16	a	a	DET
bam-13787	168	17	new	new	ADJ
bam-13787	168	18	treatment	treatment	NOUN
bam-13787	168	19	for	for	ADP
bam-13787	168	20	vitiligo	vitiligo	NOUN
bam-13787	168	21	.	.	PUNCT
bam-13787	169	1	j	j	PROPN
bam-13787	169	2	eur	eur	PROPN
bam-13787	169	3	acad	acad	PROPN
bam-13787	169	4	dermatol	dermatol	NOUN
bam-13787	169	5	venereol	venereol	NOUN
bam-13787	169	6	2023;37:2222	2023;37:2222	PROPN
bam-13787	169	7	-	-	SYM
bam-13787	169	8	30	30	NUM
bam-13787	169	9	.	.	PUNCT
bam-13787	170	1	22	22	NUM
bam-13787	170	2	.	.	PUNCT
bam-13787	171	1	rosmarin	rosmarin	PROPN
bam-13787	171	2	d	d	PROPN
bam-13787	171	3	,	,	PUNCT
bam-13787	171	4	pandya	pandya	PROPN
bam-13787	171	5	ag	ag	PROPN
bam-13787	171	6	,	,	PUNCT
bam-13787	171	7	lebwohl	lebwohl	PROPN
bam-13787	171	8	m	m	PROPN
bam-13787	171	9	,	,	PUNCT
bam-13787	171	10	et	et	PROPN
bam-13787	171	11	al	al	PROPN
bam-13787	171	12	.	.	PROPN
bam-13787	171	13	ruxolitinib	ruxolitinib	PROPN
bam-13787	171	14	cream	cream	NOUN
bam-13787	171	15	for	for	ADP
bam-13787	171	16	treatment	treatment	NOUN
bam-13787	171	17	of	of	ADP
bam-13787	171	18	vitiligo	vitiligo	NOUN
bam-13787	171	19	:	:	PUNCT
bam-13787	171	20	a	a	DET
bam-13787	171	21	randomised	randomised	ADJ
bam-13787	171	22	,	,	PUNCT
bam-13787	171	23	controlled	control	VERB
bam-13787	171	24	,	,	PUNCT
bam-13787	171	25	phase	phase	NOUN
bam-13787	171	26	2	2	NUM
bam-13787	171	27	trial	trial	NOUN
bam-13787	171	28	.	.	PUNCT
bam-13787	172	1	lancet	lancet	PROPN
bam-13787	172	2	2020;396:110	2020;396:110	PROPN
bam-13787	172	3	-	-	SYM
bam-13787	172	4	20	20	NUM
bam-13787	172	5	.	.	PUNCT
bam-13787	172	6	23	23	NUM
bam-13787	172	7	.	.	PUNCT
bam-13787	173	1	cervelli	cervelli	PROPN
bam-13787	173	2	v	v	PROPN
bam-13787	173	3	,	,	PUNCT
bam-13787	173	4	de	de	PROPN
bam-13787	173	5	angelis	angelis	PROPN
bam-13787	173	6	b	b	PROPN
bam-13787	173	7	,	,	PUNCT
bam-13787	173	8	balzani	balzani	PROPN
bam-13787	173	9	a	a	X
bam-13787	173	10	,	,	PUNCT
bam-13787	173	11	et	et	PROPN
bam-13787	173	12	al	al	PROPN
bam-13787	173	13	.	.	PUNCT
bam-13787	174	1	treatment	treatment	NOUN
bam-13787	174	2	of	of	ADP
bam-13787	174	3	stable	stable	ADJ
bam-13787	174	4	vitiligo	vitiligo	NOUN
bam-13787	174	5	by	by	ADP
bam-13787	174	6	recell	recell	NOUN
bam-13787	174	7	system	system	NOUN
bam-13787	174	8	.	.	PUNCT
bam-13787	175	1	acta	acta	PROPN
bam-13787	175	2	dermatovenerol	dermatovenerol	PROPN
bam-13787	175	3	croat	croat	PROPN
bam-13787	175	4	2009;17:273	2009;17:273	PROPN
bam-13787	175	5	-	-	SYM
bam-13787	175	6	8	8	NUM
bam-13787	175	7	.	.	NUM
bam-13787	175	8	24	24	NUM
bam-13787	175	9	.	.	PUNCT
bam-13787	176	1	cervelli	cervelli	PROPN
bam-13787	176	2	v	v	PROPN
bam-13787	176	3	,	,	PUNCT
bam-13787	176	4	spallone	spallone	NOUN
bam-13787	176	5	d	d	NOUN
bam-13787	176	6	,	,	PUNCT
bam-13787	176	7	lucarini	lucarini	PROPN
bam-13787	176	8	l	l	PROPN
bam-13787	176	9	,	,	PUNCT
bam-13787	176	10	et	et	PROPN
bam-13787	176	11	al	al	PROPN
bam-13787	176	12	.	.	PUNCT
bam-13787	177	1	treatment	treatment	NOUN
bam-13787	177	2	of	of	ADP
bam-13787	177	3	stable	stable	ADJ
bam-13787	177	4	vitiligo	vitiligo	NOUN
bam-13787	177	5	hands	hand	NOUN
bam-13787	177	6	by	by	ADP
bam-13787	177	7	recell	recell	NOUN
bam-13787	177	8	system	system	NOUN
bam-13787	177	9	:	:	PUNCT
bam-13787	177	10	a	a	DET
bam-13787	177	11	preliminary	preliminary	ADJ
bam-13787	177	12	report	report	NOUN
bam-13787	177	13	.	.	PUNCT
bam-13787	178	1	eur	eur	PROPN
bam-13787	178	2	rev	rev	PROPN
bam-13787	178	3	med	med	PROPN
bam-13787	178	4	pharmacol	pharmacol	PROPN
bam-13787	178	5	sci	sci	PROPN
bam-13787	178	6	2010;14:691	2010;14:691	PROPN
bam-13787	178	7	-	-	SYM
bam-13787	178	8	4	4	NUM
bam-13787	178	9	.	.	NUM
bam-13787	178	10	25	25	NUM
bam-13787	178	11	.	.	PUNCT
bam-13787	179	1	mulekar	mulekar	PROPN
bam-13787	179	2	sv	sv	PROPN
bam-13787	179	3	,	,	PUNCT
bam-13787	179	4	ghwish	ghwish	PROPN
bam-13787	179	5	b	b	NOUN
bam-13787	179	6	,	,	PUNCT
bam-13787	179	7	al	al	PROPN
bam-13787	179	8	issa	issa	PROPN
bam-13787	179	9	a	a	PROPN
bam-13787	179	10	,	,	PUNCT
bam-13787	179	11	al	al	PROPN
bam-13787	179	12	eisa	eisa	PROPN
bam-13787	179	13	a.	a.	NOUN
bam-13787	179	14	treatment	treatment	NOUN
bam-13787	179	15	of	of	ADP
bam-13787	179	16	vitiligo	vitiligo	ADJ
bam-13787	179	17	lesions	lesion	NOUN
bam-13787	179	18	by	by	ADP
bam-13787	179	19	recell	recell	NOUN
bam-13787	179	20	vs.	vs.	ADP
bam-13787	179	21	conventional	conventional	ADJ
bam-13787	179	22	melanocyte	melanocyte	NOUN
bam-13787	179	23	-	-	PUNCT
bam-13787	179	24	keratinocyte	keratinocyte	NOUN
bam-13787	179	25	transplantation	transplantation	NOUN
bam-13787	179	26	:	:	PUNCT
bam-13787	179	27	a	a	DET
bam-13787	179	28	pilot	pilot	NOUN
bam-13787	179	29	study	study	NOUN
bam-13787	179	30	.	.	PUNCT
bam-13787	180	1	br	br	PROPN
bam-13787	180	2	j	j	PROPN
bam-13787	180	3	dermatol	dermatol	NOUN
bam-13787	180	4	2008;158:45	2008;158:45	NUM
bam-13787	180	5	-	-	SYM
bam-13787	180	6	9	9	NUM
bam-13787	180	7	.	.	NOUN
bam-13787	180	8	26	26	NUM
bam-13787	180	9	.	.	PUNCT
bam-13787	181	1	salloum	salloum	PROPN
bam-13787	181	2	a	a	PRON
bam-13787	181	3	,	,	PUNCT
bam-13787	181	4	bazzi	bazzi	NOUN
bam-13787	181	5	n	n	CCONJ
bam-13787	181	6	,	,	PUNCT
bam-13787	181	7	maalouf	maalouf	PROPN
bam-13787	181	8	d	d	NOUN
bam-13787	181	9	,	,	PUNCT
bam-13787	181	10	habre	habre	NOUN
bam-13787	181	11	m.	m.	NOUN
bam-13787	181	12	microneedling	microneedle	VERB
bam-13787	181	13	in	in	ADP
bam-13787	181	14	vitiligo	vitiligo	NOUN
bam-13787	181	15	:	:	PUNCT
bam-13787	181	16	a	a	DET
bam-13787	181	17	systematic	systematic	ADJ
bam-13787	181	18	review	review	NOUN
bam-13787	181	19	.	.	PUNCT
bam-13787	182	1	dermatol	dermatol	NOUN
bam-13787	182	2	ther	ther	ADV
bam-13787	182	3	2020;33	2020;33	NUM
bam-13787	182	4	:	:	PUNCT
bam-13787	182	5	e14297	e14297	PROPN
bam-13787	182	6	.	.	PROPN
bam-13787	182	7	27	27	NUM
bam-13787	182	8	.	.	PUNCT
bam-13787	183	1	atefi	atefi	PROPN
bam-13787	183	2	n	n	CCONJ
bam-13787	183	3	,	,	PUNCT
bam-13787	183	4	ziaeifar	ziaeifar	PROPN
bam-13787	183	5	e	e	NOUN
bam-13787	183	6	,	,	PUNCT
bam-13787	183	7	seirafianpour	seirafianpour	NOUN
bam-13787	183	8	f	f	NOUN
bam-13787	183	9	,	,	PUNCT
bam-13787	183	10	et	et	PROPN
bam-13787	183	11	al	al	PROPN
bam-13787	183	12	.	.	PUNCT
bam-13787	183	13	evaluation	evaluation	NOUN
bam-13787	183	14	of	of	ADP
bam-13787	183	15	efficacy	efficacy	NOUN
bam-13787	183	16	and	and	CCONJ
bam-13787	183	17	safety	safety	NOUN
bam-13787	183	18	of	of	ADP
bam-13787	183	19	vitiligo	vitiligo	ADJ
bam-13787	183	20	treatment	treatment	NOUN
bam-13787	183	21	with	with	ADP
bam-13787	183	22	microneedling	microneedling	NOUN
bam-13787	183	23	combined	combine	VERB
bam-13787	183	24	with	with	ADP
bam-13787	183	25	n	n	X
bam-13787	183	26	-	-	PUNCT
bam-13787	183	27	acetylcysteine	acetylcysteine	NOUN
bam-13787	183	28	and	and	CCONJ
bam-13787	183	29	microneedling	microneedle	VERB
bam-13787	183	30	alone	alone	ADV
bam-13787	183	31	:	:	PUNCT
bam-13787	183	32	a	a	DET
bam-13787	183	33	double	double	ADJ
bam-13787	183	34	-	-	PUNCT
bam-13787	183	35	blinded	blind	VERB
bam-13787	183	36	randomized	randomize	VERB
bam-13787	183	37	controlled	control	VERB
bam-13787	183	38	clinical	clinical	ADJ
bam-13787	183	39	trial	trial	NOUN
bam-13787	183	40	.	.	PUNCT
bam-13787	184	1	j	j	PROPN
bam-13787	184	2	cosmet	cosmet	VERB
bam-13787	184	3	dermatol	dermatol	NOUN
bam-13787	184	4	2024;23	2024;23	NUM
bam-13787	184	5	:	:	PUNCT
bam-13787	184	6	2220	2220	NUM
bam-13787	184	7	-	-	SYM
bam-13787	184	8	30	30	NUM
bam-13787	184	9	.	.	PUNCT
bam-13787	185	1	28	28	NUM
bam-13787	185	2	.	.	PUNCT
bam-13787	186	1	konstantinova	konstantinova	PROPN
bam-13787	187	1	va	va	PROPN
bam-13787	187	2	,	,	PUNCT
bam-13787	187	3	olisova	olisova	PROPN
bam-13787	187	4	oy	oy	PROPN
bam-13787	187	5	,	,	PUNCT
bam-13787	187	6	gladko	gladko	PROPN
bam-13787	187	7	vv	vv	PROPN
bam-13787	187	8	,	,	PUNCT
bam-13787	187	9	burova	burova	PROPN
bam-13787	187	10	ep	ep	PROPN
bam-13787	187	11	.	.	PROPN
bam-13787	187	12	vitiligo	vitiligo	VERB
bam-13787	187	13	new	new	ADJ
bam-13787	187	14	treatment	treatment	NOUN
bam-13787	187	15	approach	approach	NOUN
bam-13787	187	16	.	.	PUNCT
bam-13787	188	1	clin	clin	PROPN
bam-13787	188	2	cosmet	cosmet	PROPN
bam-13787	188	3	investig	investig	NOUN
bam-13787	188	4	dermatol	dermatol	NOUN
bam-13787	188	5	2019;12:911	2019;12:911	NUM
bam-13787	188	6	-	-	SYM
bam-13787	188	7	7	7	NUM
bam-13787	188	8	.	.	NOUN
bam-13787	188	9	29	29	NUM
bam-13787	188	10	.	.	PUNCT
bam-13787	189	1	world	world	PROPN
bam-13787	189	2	medical	medical	PROPN
bam-13787	189	3	association	association	PROPN
bam-13787	189	4	.	.	PUNCT
bam-13787	190	1	world	world	PROPN
bam-13787	190	2	medical	medical	PROPN
bam-13787	190	3	association	association	PROPN
bam-13787	190	4	declaration	declaration	PROPN
bam-13787	190	5	of	of	ADP
bam-13787	190	6	helsinki	helsinki	PROPN
bam-13787	190	7	:	:	PUNCT
bam-13787	190	8	ethical	ethical	ADJ
bam-13787	190	9	principles	principle	NOUN
bam-13787	190	10	for	for	ADP
bam-13787	190	11	medical	medical	ADJ
bam-13787	190	12	research	research	NOUN
bam-13787	190	13	involving	involve	VERB
bam-13787	190	14	human	human	ADJ
bam-13787	190	15	subjects	subject	NOUN
bam-13787	190	16	.	.	PUNCT
bam-13787	191	1	jama	jama	PROPN
bam-13787	191	2	2013;310:2191	2013;310:2191	NUM
bam-13787	191	3	-	-	SYM
bam-13787	191	4	4	4	NUM
bam-13787	191	5	.	.	NOUN
bam-13787	191	6	30	30	NUM
bam-13787	191	7	.	.	PUNCT
bam-13787	192	1	sun	sun	PROPN
bam-13787	192	2	x	x	PROPN
bam-13787	192	3	-	-	PROPN
bam-13787	192	4	k	k	PROPN
bam-13787	192	5	,	,	PUNCT
bam-13787	192	6	sheng	sheng	PROPN
bam-13787	192	7	a	a	PROPN
bam-13787	192	8	-	-	PUNCT
bam-13787	192	9	q	q	NOUN
bam-13787	192	10	,	,	PUNCT
bam-13787	192	11	xu	xu	PROPN
bam-13787	192	12	a	a	PROPN
bam-13787	192	13	-	-	PUNCT
bam-13787	192	14	e.	e.	PROPN
bam-13787	192	15	tofacitinib	tofacitinib	PROPN
bam-13787	192	16	for	for	ADP
bam-13787	192	17	the	the	DET
bam-13787	192	18	treatment	treatment	NOUN
bam-13787	192	19	of	of	ADP
bam-13787	192	20	refractory	refractory	NOUN
bam-13787	192	21	progressive	progressive	ADJ
bam-13787	192	22	vitiligo	vitiligo	VERB
bam-13787	192	23	:	:	PUNCT
bam-13787	192	24	a	a	DET
bam-13787	192	25	retrospective	retrospective	ADJ
bam-13787	192	26	case	case	NOUN
bam-13787	192	27	series	series	NOUN
bam-13787	192	28	.	.	PUNCT
bam-13787	193	1	dermatol	dermatol	NOUN
bam-13787	193	2	ther	ther	ADV
bam-13787	194	1	2024,9944826	2024,9944826	NUM
bam-13787	194	2	.	.	PUNCT
bam-13787	195	1	31	31	NUM
bam-13787	195	2	.	.	PUNCT
bam-13787	196	1	maghfour	maghfour	PROPN
bam-13787	196	2	j	j	PROPN
bam-13787	196	3	,	,	PUNCT
bam-13787	196	4	hamzavi	hamzavi	PROPN
bam-13787	196	5	ih	ih	PRON
bam-13787	196	6	,	,	PUNCT
bam-13787	196	7	mohammad	mohammad	PROPN
bam-13787	196	8	tf	tf	PROPN
bam-13787	196	9	.	.	PUNCT
bam-13787	197	1	an	an	DET
bam-13787	197	2	updated	update	VERB
bam-13787	197	3	review	review	NOUN
bam-13787	197	4	on	on	ADP
bam-13787	197	5	systemic	systemic	ADJ
bam-13787	197	6	and	and	CCONJ
bam-13787	197	7	targeted	target	VERB
bam-13787	197	8	therapies	therapy	NOUN
bam-13787	197	9	for	for	ADP
bam-13787	197	10	vitiligo	vitiligo	NOUN
bam-13787	197	11	.	.	PUNCT
bam-13787	198	1	dermatol	dermatol	NOUN
bam-13787	198	2	rev	rev	PROPN
bam-13787	198	3	2022;3:313	2022;3:313	PROPN
bam-13787	198	4	-	-	SYM
bam-13787	198	5	25	25	NUM
bam-13787	198	6	.	.	PUNCT
bam-13787	199	1	disclaimer	disclaimer	NOUN
bam-13787	199	2	all	all	DET
bam-13787	199	3	claims	claim	NOUN
bam-13787	199	4	expressed	express	VERB
bam-13787	199	5	in	in	ADP
bam-13787	199	6	this	this	DET
bam-13787	199	7	article	article	NOUN
bam-13787	199	8	are	be	AUX
bam-13787	199	9	solely	solely	ADV
bam-13787	199	10	those	those	PRON
bam-13787	199	11	of	of	ADP
bam-13787	199	12	the	the	DET
bam-13787	199	13	authors	author	NOUN
bam-13787	199	14	and	and	CCONJ
bam-13787	199	15	do	do	AUX
bam-13787	199	16	not	not	PART
bam-13787	199	17	necessarily	necessarily	ADV
bam-13787	199	18	represent	represent	VERB
bam-13787	199	19	those	those	PRON
bam-13787	199	20	of	of	ADP
bam-13787	199	21	their	their	PRON
bam-13787	199	22	affiliated	affiliated	ADJ
bam-13787	199	23	organizations	organization	NOUN
bam-13787	199	24	,	,	PUNCT
bam-13787	199	25	or	or	CCONJ
bam-13787	199	26	those	those	PRON
bam-13787	199	27	of	of	ADP
bam-13787	199	28	the	the	DET
bam-13787	199	29	publisher	publisher	NOUN
bam-13787	199	30	,	,	PUNCT
bam-13787	199	31	the	the	DET
bam-13787	199	32	editors	editor	NOUN
bam-13787	199	33	and	and	CCONJ
bam-13787	199	34	the	the	DET
bam-13787	199	35	reviewers	reviewer	NOUN
bam-13787	199	36	.	.	PUNCT
bam-13787	200	1	any	any	DET
bam-13787	200	2	product	product	NOUN
bam-13787	200	3	that	that	PRON
bam-13787	200	4	may	may	AUX
bam-13787	200	5	be	be	AUX
bam-13787	200	6	evaluated	evaluate	VERB
bam-13787	200	7	in	in	ADP
bam-13787	200	8	this	this	DET
bam-13787	200	9	article	article	NOUN
bam-13787	200	10	or	or	CCONJ
bam-13787	200	11	claim	claim	NOUN
bam-13787	200	12	that	that	PRON
bam-13787	200	13	may	may	AUX
bam-13787	200	14	be	be	AUX
bam-13787	200	15	made	make	VERB
bam-13787	200	16	by	by	ADP
bam-13787	200	17	its	its	PRON
bam-13787	200	18	manufacturer	manufacturer	NOUN
bam-13787	200	19	is	be	AUX
bam-13787	200	20	not	not	PART
bam-13787	200	21	guaranteed	guarantee	VERB
bam-13787	200	22	or	or	CCONJ
bam-13787	200	23	endorsed	endorse	VERB
bam-13787	200	24	by	by	ADP
bam-13787	200	25	the	the	DET
bam-13787	200	26	publisher	publisher	NOUN
bam-13787	200	27	.	.	PUNCT
bam-13787	201	1	submitted	submit	VERB
bam-13787	201	2	:	:	PUNCT
bam-13787	201	3	2	2	NUM
bam-13787	201	4	march	march	NOUN
bam-13787	201	5	2025	2025	NUM
bam-13787	201	6	.	.	PUNCT
bam-13787	202	1	accepted	accept	VERB
bam-13787	202	2	:	:	PUNCT
bam-13787	202	3	11	11	NUM
bam-13787	202	4	march	march	NOUN
bam-13787	202	5	2025	2025	NUM
bam-13787	202	6	.	.	PUNCT
bam-13787	203	1	early	early	ADJ
bam-13787	203	2	access	access	NOUN
bam-13787	203	3	:	:	PUNCT
bam-13787	203	4	26	26	NUM
bam-13787	203	5	may	may	PROPN
bam-13787	203	6	2025	2025	NUM
bam-13787	203	7	.	.	PUNCT
bam-13787	204	1	6	6	NUM